
<html lang="en"     class="pb-page"  data-request-id="4524484c-5442-4243-b92d-84005fd6e823"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm500457x;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-11"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor" /></meta><meta name="dc.Creator" content="Monika  Szabo" /></meta><meta name="dc.Creator" content="Carmen  Klein Herenbrink" /></meta><meta name="dc.Creator" content="Arthur  Christopoulos" /></meta><meta name="dc.Creator" content="J. Robert  Lane" /></meta><meta name="dc.Creator" content="Ben  Capuano" /></meta><meta name="dc.Description" content="Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D2 receptor (D2R)...." /></meta><meta name="Description" content="Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D2 receptor (D2R)...." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 30, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500457x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500457x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500457x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500457x" /></link>
        
    
    

<title>Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500457x" /></meta><meta property="og:title" content="Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0015.jpeg" /></meta><meta property="og:description" content="Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D2 receptor (D2R). We investigated the determinants of efficacy, affinity, and bias for three privileged structures for the D2R, exploring changes to linker length and incorporation of a heterocyclic unit. Profiling the compounds in two signaling assays (cAMP and pERK1/2) allowed us to identify and quantify determinants of biased agonism at the D2R. Substitution on the phenylpiperazine privileged structures (2-methoxy vs 2,3-dichloro) influenced bias when the thienopyridine heterocycle was absent. Upon inclusion of the thienopyridine unit, the substitution pattern (4,6-dimethyl vs 5-chloro-6-methoxy-4-methyl) had a significant effect on bias that overruled the effect of the phenylpiperazine substitution pattern. This latter observation could be reconciled with an extended binding mode for these compounds, whereby the interaction of the heterocycle with a secondary binding pocket may engender bias." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500457x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500457x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500457x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500457x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500457x&amp;href=/doi/10.1021/jm500457x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4924-4939</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5004528" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5004705" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D<sub>2</sub> Receptor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monika++Szabo">Monika Szabo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Klein+Herenbrink">Carmen Klein Herenbrink</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arthur++Christopoulos">Arthur Christopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Robert++Lane">J. Robert Lane</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Capuano">Ben Capuano</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Medicinal Chemistry and <sup>‡</sup>Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div><div class="corresp-info"><strong>*</strong>J.R.L.: phone, +613 9903 9095; fax, +613 9903 9581; e-mail, <a href="/cdn-cgi/l/email-protection#d0a2bfb2febcb1beb590bdbfbeb1a3b8feb5b4a5"><span class="__cf_email__" data-cfemail="bdcfd2df93d1dcd3d8fdd0d2d3dcced593d8d9c8">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>B.C.: phone, +61 3 9903 9556; fax, +61 3 9903 9581; e-mail, <a href="/cdn-cgi/l/email-protection#066463682865677673676869466b696867756e28636273"><span class="__cf_email__" data-cfemail="492b2c27672a28393c28272609242627283a21672c2d3c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500457x&amp;href=/doi/10.1021%2Fjm500457x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4924–4939</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 14, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 March 2014</li><li><span class="item_label"><b>Published</b> online</span>30 May 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 June 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500457x" title="DOI URL">https://doi.org/10.1021/jm500457x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4924%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMonika%2BSzabo%252C%2BCarmen%2BKlein%2BHerenbrink%252C%2BArthur%2BChristopoulos%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D11%26contentID%3Djm500457x%26title%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BPrivileged%2BStructures%2BLead%2Bto%2Bthe%2BDiscovery%2Bof%2BNovel%2BBiased%2BLigands%2Bat%2Bthe%2BDopamine%2BD2%2BReceptor%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4939%26publicationDate%3DJune%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500457x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2319</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500457x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure–Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Monika&quot;,&quot;last_name&quot;:&quot;Szabo&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Klein Herenbrink&quot;},{&quot;first_name&quot;:&quot;Arthur&quot;,&quot;last_name&quot;:&quot;Christopoulos&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Robert Lane&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Capuano&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4924-4939&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500457x&quot;},&quot;abstract&quot;:&quot;Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D2 receptor (D2R). We investigated the determinants of efficacy, affinity, and bias for three privileged structures for the D2R, exploring changes to linker length and incorporation of a heterocyclic unit. Profiling the compounds in two signaling assays (cAMP and pERK1/2) allowed us to identify and quantify determinants of biased agonism at the D2R. Substitution on the phenylpiperazine privileged structures (2-methoxy vs 2,3-dichloro) influenced bias when the thienopyridine heterocycle was absent. Upon inclusion of the thienopyridine unit, the substitution pattern (4,6-dimethyl vs 5-chloro-6-methoxy-4-methyl) had a significant effect on bias that overruled the effect of the phenylpiperazine substitution pattern. This latter observation could be reconciled with an extended binding mode for these compounds, whereby the interaction of t&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500457x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500457x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500457x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500457x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500457x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500457x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500457x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500457x&amp;href=/doi/10.1021/jm500457x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500457x" /></input><a href="/doi/pdf/10.1021/jm500457x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500457x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500457x%26sid%3Dliteratum%253Aachs%26pmid%3D24827597%26genre%3Darticle%26aulast%3DSzabo%26date%3D2014%26atitle%3DStructure%25E2%2580%2593Activity%2BRelationships%2Bof%2BPrivileged%2BStructures%2BLead%2Bto%2Bthe%2BDiscovery%2Bof%2BNovel%2BBiased%2BLigands%2Bat%2Bthe%2BDopamine%2BD2%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D11%26spage%3D4924%26epage%3D4939%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jmcmar.2014.57.issue-11/production/jmcmar.2014.57.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Biased agonism at GPCRs highlights the potential for the discovery and design of pathway-selective ligands and may confer therapeutic advantages to ligands targeting the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R). We investigated the determinants of efficacy, affinity, and bias for three privileged structures for the D<sub>2</sub>R, exploring changes to linker length and incorporation of a heterocyclic unit. Profiling the compounds in two signaling assays (cAMP and pERK1/2) allowed us to identify and quantify determinants of biased agonism at the D<sub>2</sub>R. Substitution on the phenylpiperazine privileged structures (2-methoxy vs 2,3-dichloro) influenced bias when the thienopyridine heterocycle was absent. Upon inclusion of the thienopyridine unit, the substitution pattern (4,6-dimethyl vs 5-chloro-6-methoxy-4-methyl) had a significant effect on bias that overruled the effect of the phenylpiperazine substitution pattern. This latter observation could be reconciled with an extended binding mode for these compounds, whereby the interaction of the heterocycle with a secondary binding pocket may engender bias.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dopamine receptors (DRs) belong to the G-protein-coupled receptor (GPCR) superfamily that is characterized by seven transmembrane (TM) domains. There are five receptor subtypes (D<sub>1</sub>–D<sub>5</sub>) expressed both in the central nervous system (CNS) and in the periphery.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In the CNS the dopamine D<sub>2</sub> receptor (D<sub>2</sub>R) is a primary target for the treatment of disease including Parkinson’s and schizophrenia.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Antipsychotics have evolved from first generation antipsychotics (FGAs), which act as D<sub>2</sub> antagonists, to second generation antipsychotics (SGAs), which display robust polypharmacology with high affinities for GPCRs in addition to the D<sub>2</sub>R.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Aripiprazole (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is classified as a third generation antipsychotic (TGA). This comes from its unique pharmacological profile, as it is a potent partial agonist at both presynaptic and postsynaptic D<sub>2</sub> receptors while also displaying partial agonist activity at the serotonin 5-HT<sub>1A</sub> receptor.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> The exploration of D<sub>2</sub>R partial agonists for treating schizophrenia was driven by the hypothesis that they would stabilize levels of dopamine in the CNS but avoid the extrapyramidal side effects associated with complete D<sub>2</sub>R blockade (for a detailed review of the use of partial agonists in the treatment of schizophrenia and other related psychoactive disorders, see Tamminga et al.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a>). Since the discovery of aripiprazole, other partial agonists have emerged, such as cariprazine (<b>2</b>), brexpiprazole (<b>3</b>), and bifeprunox (<b>4</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), with <b>2</b> currently awaiting FDA approval and <b>3</b> in phase III clinical trials for the treatment of schizophrenia.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Partial agonists: aripiprazole (<b>1</b>), cariprazine (<b>2</b>), brexpiprazole (<b>3</b>), and bifeprunox (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Biased agonism (sometimes termed “functional selectivity” or “stimulus bias”) refers to the phenomenon by which different agonists acting at the same receptor can stabilize distinct receptor conformations linked to different functional responses.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> Of interest, aripiprazole has been identified as a ligand that displays biased agonism, and evidence has been provided that this bias may contribute to its antipsychotic efficacy.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Previous SAR studies, focused on aripiprazole, revealed that small structural changes to the phenylpiperazine core, the linker region, and the bicyclic heterocycle resulted in changes in biased agonism. These studies identified novel D<sub>2</sub>R ligands that displayed bias toward the recruitment of β-arrestin.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Further examples of biased agonists targeting the D<sub>2</sub>R have been provided by a number of groups, including Mailman et al. with dihydrexidine,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Tschammer et al. with 1,4-disubstituted phenylpiperazines,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and Shonberg et al. with tetrahydroisoquinoline derivatives.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Privileged structures are often versatile scaffolds that can be functionalized to produce ligands that may be selective for a class of receptors and, more ideally, a single receptor target.<a onclick="showRef(event, 'ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22 ref23">(20-23)</a> Privileged structures can be “built in” to a molecule by replacing certain functional groups or can be used as the starting scaffold, where one can “build out” to create an optimized ligand. The aim of the current study was to investigate the structure–activity relationships underlying affinity and efficacy of distinct privileged structures for the D<sub>2</sub>R. Many ligands targeting the D<sub>2</sub>R incorporate a substituted phenylpiperazine; therefore, we selected 2-methoxyphenylpiperazine (<b>5</b>) and 2,3-dichlorophenylpiperazine (<b>6</b>) to use as privileged structures in our study (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). We also investigated 4,4-chlorophenyl-4-hydroxypiperidine (<b>7</b>), as it represents a common structural feature of two very potent D<sub>2</sub> antagonists, haloperidol (<b>8</b>) and L-741,626 (<b>9</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Another structural attribute of many D<sub>2</sub>R targeting antagonists and partial agonists is the incorporation of a linker to the ionizable nitrogen, usually from two to five atoms in length followed by a heterocyclic group. For example, the two antipsychotics risperidone (<b>10</b>) and ziprasidone (<b>11</b>), while devoid of a substituted phenylpiperazine moiety, retain either a piperazine or a piperidine system to bear the ionizable nitrogen, a spacer, and a heterobicyclic group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Such scaffolds have been shown to confer subtype selectivity across the D<sub>2</sub>-like receptor subfamily.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> However, of relevance to this study, Newman and co-workers revealed that the presence of a heterocyclic group, or even the linker alone, could modulate the efficacy of compounds based on <b>6</b> in an assay measuring activation of a Gα<sub>o1</sub> G protein. In contrast, an equivalent compound based on <b>5</b> displayed no agonism at this assay end point.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These observations beg the question whether such structural determinants of efficacy are consistent across different signaling end points or whether they differ and thus engender biased agonism.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Privileged structures: 2-methoxyphenylpiperazine (<b>5</b>), 2,3-dichlorophenylpiperazine (<b>6</b>), and 4,4-chlorophenyl-4-hydroxypiperidine (<b>7</b>). Antipsychotics and/or potent D<sub>2</sub>R antagonists: haloperidol (<b>8</b>), L-741,626 (<b>9</b>), risperidone (<b>10</b>), and ziprasidone (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In our study, we have synthesized and characterized a focused library of novel D<sub>2</sub>R antagonists and partial agonists based on a previously described structural model<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) incorporating the aforementioned three privileged structures, different spacer lengths (ranging from two to six carbon atoms), and novel heterocyclic units identified from our in-house muscarinic GPCR drug discovery program. These versatile heterocyclic motifs were selected, as they exhibit structural similarities to that of the tetrahydroquinolinone moiety of aripiprazole. Additionally, the use of a thiophene has previously been shown to be advantageous in increasing the affinity for D<sub>2</sub>-like receptor subtypes, relating to its electron-rich system and its ability to form hydrophobic interactions within a binding pocket, essentially acting as an isostere of benzene.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> As such, we envisioned that our thienopyridine scaffolds may also exhibit these properties. The ligands generated were evaluated using in vitro assays to measure their ability to displace [<sup>3</sup>H]spiperone binding at the D<sub>2</sub>R and to stimulate ERK1/2 phosphorylation through activation of the D<sub>2</sub>R. For selected compounds, we extended our characterization to a second functional assay, inhibition of forskolin-induced cAMP production, to allow identification and quantification of biased agonism.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model pharmacophore for the development of novel D<sub>2</sub>R antagonists and/or partial agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">Derivatives of the previously described privileged structures (<b>5</b>–<b>7</b>) were synthesized utilizing a single linkage point, namely, the aliphatic nitrogen of the piperazine or piperidine, and included chain lengths of two to six carbon atoms (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). To furnish derivatives with linker lengths of two to three carbon atoms, we commenced with bromoalkanamines (<b>15a</b>,<b>b</b>) and subsequently Boc-protected the amines to afford the intermediates <b>16a</b>,<b>b</b>. These compounds were then reacted with <b>5</b> or <b>7</b> to give products <b>17a</b>,<b>b</b> and <b>18a</b>,<b>b</b> in yields ranging from 34% to 93%. We utilized a modified pathway for generating the required analogues <b>17c</b>–<b>e</b> and <b>18c</b>–<b>e</b>, since linker lengths greater than four carbon atoms were not directly available as the bromoalkanamines. Aminoalkanols (<b>12c</b>–<b>e</b>) with carbon atom spacers of four to six were Boc-protected to give intermediates <b>13c</b>–<b>e</b> in excellent yields (83–96%). The primary alcohol functionality was activated with methanesulfonyl chloride to generate the mesylated intermediates <b>14c</b>–<b>e</b>. Because of the reactivity and/or stability of the mesylated compounds, the formation of products was confirmed by the disappearance of starting material via TLC and then reacted immediately without further purification in the next reaction. Subsequent reaction of <b>5</b> or <b>7</b> with the mesylates <b>14c</b>–<b>e</b> produced analogues <b>17c</b>–<b>e</b> and <b>18c</b>–<b>e</b>. To furnish the five carbon atom spaced Boc protected 2,3-dichlorophenylpiperazine (<b>19</b>), the mesylate <b>14d</b> was reacted with <b>6</b> under the same conditions as described above.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Linker Lengths Incorporating Privileged Structures<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc anhydride, Et<sub>3</sub>N, DCM, rt, 1–1.5 h, 28–96%; (b) methanesulfonyl chloride, Et<sub>3</sub>N, DCM, 0 °C → rt; (c) <b>5</b>, <b>6</b>, or <b>7</b>, CH<sub>3</sub>CN, reflux, 24 h, 28–64%; (d) <b>5</b> or <b>7</b>, NaI, DIPEA, CH<sub>3</sub>CN, reflux, 24 h, 34–93%.</p></p></figure><div class="NLM_p">Synthesis of the thienopyridine scaffold is represented in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and commences with reacting 2-cyanoacetamide (<b>20</b>) with phosphorus pentasulfide (P<sub>4</sub>S<sub>10</sub>) to afford 2-cyanothioacetamide (<b>21</b>) in approximately 30% after recrystallization. To synthesize the 4,6-dimethylthienopyridine compound, <b>21</b> was reacted with acetylacetone under basic conditions to form the 4,6-dimethyl substituted pyridine core (<b>22</b>) in 67% yield. Subsequent reaction of <b>22</b> with ethyl 2-chloroacetate under basic conditions gave the monocyclic ethyl ester (<b>23</b>). The monocyclic structure was successfully converted to the bicyclic form (<b>24</b>) in rapid time (15 min) in the presence of 1 M aqueous potassium hydroxide. Ester hydrolysis of <b>24</b> using 2 M sodium hydroxide in ethanol, followed by acidic workup, gave the first key thienopyridine core carboxylic acid (<b>25</b>). To furnish the 5-chloro-6-methoxy-4-methylthienopyridine scaffold, compound <b>21</b> was reacted with methyl acetoacetate and morpholine which initially afforded the product as the morpholinium salt. The desired thiol (<b>26</b>) was isolated in the free form by acidification with 1 M aqueous hydrochloric acid. Further reaction with ethyl chloroacetate gave the monocyclic ethyl ester (<b>27</b>) in good yield (81%). In order to convert the pyridinone into the corresponding pyridine alkyl ether, <b>27</b> was reacted with iodomethane under basic conditions. One equivalent of a stronger base, such as 1 M aqueous potassium hydroxide, was necessary to ensure complete conversion to the thienopyridine scaffold (<b>28</b>). It was imperative to protect the free amine of the bicycle prior to chlorination at the 5′ position to avoid N-halogenation. Phthalic anhydride was employed under acidic conditions which resulted in the phthalimide-protected product (<b>29</b>) in good yield. <i>N</i>-Chlorosuccinimide (NCS) was used to install the chlorine atom at the 5′ position to give <b>30</b> in excellent yield. Subsequent removal of the phthalimide protecting group using hydrazine monohydrate afforded <b>31</b> in excellent yield. Finally, the base-catalyzed ester hydrolysis conditions mentioned earlier were commissioned that, following acidic workup, afforded the key carboxylic acid intermediate compound, <b>32</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Key Thienopyridine Scaffolds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) P<sub>4</sub>S<sub>10</sub>, EtOAc, reflux 1.5–4 h, 30%; (b) acetylacetone, KOH, MeOH, reflux, 4 h, 67%; (c) ethyl 2-chloroacetate, Et<sub>3</sub>N, 0 °C → rt, 3.5 h, 86%; (d) 1 M KOH, DMF, rt, 15 min, 93%; (e) 2 M NaOH, EtOH, reflux, 4 h, 83%; (f) methyl acetoacetate, morpholine, EtOH, reflux 8 h, 51%; (g) ethyl 2-chloroacetate, Et<sub>3</sub>N, DMF, 0 °C → rt, 5 h, 81%; (h) (i) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 4 h, rt; (ii) 1 M KOH, 15 min, 58%; (i) phthalic anhydride, AcOH, reflux, 20 h, 55%; (j) <i>N</i>-chlorosuccinimide, conc HCl, EtOH, reflux, 1.5 h, 93%; (k) (NH<sub>2</sub>)<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux, 3 h, 84%; (l) 2 M NaOH, EtOH, reflux, 1.5 h, 84%.</p></p></figure><div class="NLM_p">The syntheses of the target compounds incorporating privileged structures <b>5</b>, <b>6</b>, and <b>7</b> and the thienopyridine scaffolds are summarized in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. We initially combined the 4,4-chlorophenyl-4-hydroxypiperidine analogues (<b>17a</b>–<b>e</b>), which were deprotected prior to use, with the 4,6-dimethylthienopyridinecarboxylic acid (<b>25</b>). This was carried out using a BOP-mediated coupling reaction to give analogues <b>33a</b>–<b>e</b> in 31–56% yield. Similarly the 2-methoxyphenylpiperazine analogues <b>18a</b>–<b>e</b> following Boc deprotection were coupled to the carboxylic acid <b>32</b> to furnish the target compounds <b>34a</b>–<b>e</b> in respectable yield. Compound <b>19</b>, following removal of the protecting group, was then immediately reacted with <b>32</b> to yield the analogue <b>35</b>, while compound <b>25</b> furnished analogue <b>36</b>. Reaction of the carboxylic acid precursor <b>25</b> with <b>18d</b> (Boc deprotected) in the presence of BOP also afforded compound <b>37</b> in respectable yield.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Full Length Structures Including Privileged Structures, Linker, and Thienopyridine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Compounds <b>17a</b>–<b>e</b>, <b>18a</b>–<b>e</b>, and <b>19</b> were all deprotected prior to performing the coupling reaction. (a) BOP reagent, DIPEA, DMF, rt, 1–12 h, 29–70%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Pharmacology</h3><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> Binding Characterization of Privileged Structures and Linkers</h4><div class="NLM_p">Both <b>5</b> and <b>6</b> privileged structures have been evaluated in terms of their ability to bind the D<sub>2</sub>R in a previous study.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We therefore evaluated the binding affinities of <b>7</b>, incorporating linker lengths of two to six carbon atoms and conserving the Boc group for stability purposes and to add lipophilicity to the end of the linker, with equivalent <b>5</b> structures as comparators. As expected, both privileged structures (<b>5</b> and <b>7</b>) demonstrated poor binding affinity (∼10 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), most likely because of their small fragment-like size that confers minimal points for contact with residues in the D<sub>2</sub>R orthosteric pocket. Modest increases in affinity were observed upon addition of the linkers to <b>7</b> (<b>17a</b>–<b>e</b>) with the six carbon atom linker (<b>17e</b>) conferring a 10-fold increase in affinity. Comparatively, a more pronounced increase in binding affinity was evident for the 2-methoxyphenylpiperazine derivatives (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Analogues containing a three, four, or five carbon atom linker (<b>18b</b>–<b>d</b>) demonstrated enhanced affinity compared to the two carbon atom linker (<b>18a</b>), with these analogues displaying a 200-fold increase in affinity compared to <b>5</b> alone. However, there seems to be no clear linker length dependence for affinity within this set of compounds <b>18b</b>–<b>e</b> (<i>n</i> = 3–6).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Data at the Dopamine D<sub>2</sub>R for 2-Methoxyphenylpiperazine and 4,4-Chlorophenyl-4-hydroxypiperidine Linker Derivatives<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0009.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Compounds were tested against [<sup>3</sup>H]spiperone through competition binding studies using D<sub>2L</sub> CHO cell membranes. Data represent the mean ± SEM of three separate experiments performed in duplicate.</p></div></div><div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Binding Characterization of Full-Length Structures</h4><div class="NLM_p">We then investigated the effect of the addition of a heterocyclic group to each of the linkers as indicated in our model pharmacophore (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). While the substitution pattern on each of the heterocycles listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> is different (4,6-dimethyl vs 5-chloro-6-methoxy-4-methyl), the general core of the heterocycle (thienopyridine) is the same. The subtle differences in these substitutions and their consequences on pharmacology at the D<sub>2</sub>R will be explored at a later stage in our SAR study. The results in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> showed that analogues based on privileged structure <b>7</b> (<b>33a</b>–<b>e</b>) bind the D<sub>2</sub>R with only moderate affinity (micromolar range) with no significant increase compared to the equivalent linker precursors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). A similar analogue using privileged structure <b>7</b> in combination with the heterocycle present in aripiprazole (dihydroquinolinone) showed poor binding affinity at the D<sub>2</sub>R;<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> therefore, this is consistent with our results. Structures incorporating <b>5</b> retained their affinity, and in the cases of the two and six carbon atom spacers (<b>34a</b> and <b>34e</b>), their binding affinities were improved in comparison to their linker precursors (<b>18a</b> and <b>18e</b>). On this occasion, a definite trend of increasing binding affinity with carbon linker length was evident, with the six carbon atom linker derivative (<b>34e</b>) as the standout displaying subnanomolar affinity (<i>K</i><sub>i</sub> = 0.6 nM). This notable enhancement in affinity is supported by literature that describes a secondary hydrophobic pocket in the D<sub>2</sub>R that is only reached via longer chain lengths. Interaction with this secondary pocket has been demonstrated to confer both increases in affinity and subtype selectivity.<a onclick="showRef(event, 'ref18 ref26 ref31'); return false;" href="javascript:void(0);" class="ref ref18 ref26 ref31">(18, 26, 31)</a> While we acknowledge that the heterocycles added to these two distinct privileged structures are subtly different, the lack of affinity gain observed for the 4,6-dimethyl substituted thienopyridine derivatives (<b>33a</b>–<b>e</b>) is unlikely to be attributed to this difference.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Data at the Dopamine D<sub>2</sub>R for 2-Methoxyphenylpiperazine and 4,4-Chlorophenyl-4-hydroxypiperidine Full Length Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compounds are tested against [<sup>3</sup>H]spiperone through competition binding studies using D<sub>2L</sub> CHO cell membranes. Data represent the mean ± SEM of three separate experiments performed in duplicate.</p></div></div><div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> SAR of 2-Methoxyphenylpiperazine Linkers and Full Structures: ERK1/2 Phosphorylation Assays</h4><div class="NLM_p">To expand on our initial results with the <b>5</b> and <b>7</b> series linkers and full structures (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), we tested these compounds in functional ERK1/2 phosphorylation (pERK1/2) assays. Analogues <b>5</b>, <b>7</b>, <b>17a</b>–<b>e</b>, <b>18a</b>–<b>e</b>, <b>33a</b>–<b>c</b>, and <b>34a</b>–<b>e</b> at 10 μM were initially tested in time-course assays to identify potential agonists and determine the appropriate peak stimulation time for subsequent construction of concentration–response curves. Compounds derived from <b>7</b> displayed no agonism (data not shown). As such, while also considering their poor binding affinities, we did not pursue these compounds for further characterization. Ligands <b>5</b>, <b>18a</b>, and <b>18e</b> were determined to be antagonists (based on time-course data and binding data). They were further analyzed in a pERK1/2 assay for their ability to antagonize a 10 nM concentration of dopamine, to obtain values of inhibitory potency (pIC<sub>50</sub>) for both compounds. We observed a striking increase in inhibitory potency from the parent molecule <b>5</b> (>1000 nM) to compounds containing a linker (<b>18a</b>, 93.3 nM; <b>18e</b>, 3.98 nM). The remainder of compounds displayed agonism in our time-course experiments (<b>18b</b>–<b>d</b>). These analogues exhibited partial agonism, consistent with the observations of Newman et al. using similar linked derivatives of <b>5</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The four-carbon atom spacer <b>18c</b> has a lower <i>E</i><sub>max</sub> (the maximum stimulation achieved as a percentage of the maximal effect of dopamine, <i>E</i><sub>max</sub> = 13 ± 1) compared to the five-carbon atom spacer <b>18d</b> (<i>E</i><sub>max</sub> = 19 ± 1). The three-carbon atom spacer analogue (<b>18b)</b> displayed a significantly higher <i>E</i><sub>max</sub> of 31 ± 1 (<i>P</i> < 0.05). An enhancement of affinity at the D<sub>2</sub>R was observed for a similar series of compounds upon addition of alkyl linkers to <b>5</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We also observed an enhancement of affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) consistent with the hypothesis of Newman et al. whereby this increase in affinity is conferred by additional hydrophobic interactions between residues within the orthosteric pocket of the D<sub>2</sub>R and the linker. However, we also observe a gain in agonist efficacy that is dependent on linker length (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). This pattern is distinct from the lack of effect of the addition of a linker to the scaffold of <b>5</b> observed by Newman et al. This discrepancy could be due to the subtle differences between the two sets of compounds, the different cell backgrounds used in these experiments, or the different assay end point used to measure agonism (pERK1/2 of our study vs Gα<sub>o1</sub> G protein coupling of Newman et al).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional ERK1/2 Phosphorylation Assays at the Dopamine D<sub>2</sub> Receptor for 2-Methoxyphenylpiperazine Linker Derivatives<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0011.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">pIC<sub>50</sub> ± SEM (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> ± SEM (EC<sub>50</sub>, nM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± SEM (% DA)<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">na</td><td class="colsep0 rowsep0" align="left"><6 (>1000)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18a</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">7.03 ± 0.54 (93.3)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18b</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.41 ± 0.15 (0.39)</td><td class="colsep0 rowsep0" align="left">31 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18c</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">9.22 ± 0.25 (0.60)</td><td class="colsep0 rowsep0" align="left">13 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18d</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.84 ± 0.16 (1.43)</td><td class="colsep0 rowsep0" align="left">19 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18e</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">8.40 ± 0.29 (3.98)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data represent the mean ± SEM of three to four separate experiments performed in duplicate.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Values are obtained via interacting ligands with a 10 nM concentration of dopamine.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Values are obtained via concentration–response assays at the appropriate stimulation time.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last"><i>E</i><sub>max</sub> data are represented as a % of the maximal effect of dopamine (DA).</p></div></div></div><div class="NLM_p">Next we investigated if such linker length dependencies in efficacy are also observed for those compounds with a heterocyclic group attached to the linker. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> represents the functional data for compounds <b>34a</b>–<b>e</b> at the D<sub>2</sub>R. We identified compounds <b>34a</b>–<b>c</b> (linker lengths from two to four carbon atoms) as antagonists and compounds <b>34d</b>–<b>e</b> (with linker lengths of five and six carbon atoms, respectively) as partial agonists. This pattern is distinct from the linker only compounds (<b>18a</b>–<b>e</b>) in which a linker length of three carbon atoms was optimal in terms of the maximal effect of the agonist. The partial agonists <b>34d</b> and <b>34e</b> displayed the same maximum response at the D<sub>2</sub>R (<i>E</i><sub>max</sub>= 17 ± 4 and 14 ± 2, respectively). Moreover, the partial agonism observed in the five carbon atom 2-methoxyphenylpiperazine linker (<b>18d</b>, <i>E</i><sub>max</sub> = 19 ± 1) was maintained upon incorporation of the heterocyclic group to the linker (<b>34d</b>, <i>E</i><sub>max</sub> = 17 ± 4). Compounds <b>34a</b>–<b>c</b> displayed no gain in functional affinity (p<i>K</i><sub>B</sub>) compared to the parent molecule <b>5</b>.</div><div class="NLM_p">In combination, these data highlight that subtle changes to the linker length appear to be important in switching between antagonism and partial agonism. Of note, the pattern is different for linker analogues as opposed to the extended structures with a heterocycle group suggesting a different binding mode at the D<sub>2</sub>R.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional ERK1/2 Phosphorylation Assays at the Dopamine D<sub>2</sub>R for Compounds Containing the 2-Methoxyphenylpiperazine Privileged Structure<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0012.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">p<i>K</i><sub>B</sub> ± SEM (<i>K</i><sub>B</sub>, nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> ± SEM (EC<sub>50</sub>, nM)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> ± SEM (% DA)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>5</b></td><td class="colsep0 rowsep0" align="left" valign="middle">na</td><td class="colsep0 rowsep0" align="left" valign="middle">6.32 ± 0.18 (479)</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>34a</b></td><td class="colsep0 rowsep0" align="left" valign="middle">2</td><td class="colsep0 rowsep0" align="left" valign="middle">6.45 ± 0.17 (355)</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>34b</b></td><td class="colsep0 rowsep0" align="left" valign="middle">3</td><td class="colsep0 rowsep0" align="left" valign="middle">6.13 ± 0.16 (741)</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>34c</b></td><td class="colsep0 rowsep0" align="left" valign="middle">4</td><td class="colsep0 rowsep0" align="left" valign="middle">6.31 ± 0.14 (490)</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>34d</b></td><td class="colsep0 rowsep0" align="left" valign="middle">5</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle">8.57 ± 0.66 (2.69)</td><td class="colsep0 rowsep0" align="left" valign="middle">17 ± 4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left" valign="middle"><b>34e</b></td><td class="colsep0 rowsep0" align="left" valign="middle">6</td><td class="colsep0 rowsep0" align="left" valign="middle"> </td><td class="colsep0 rowsep0" align="left" valign="middle">8.26 ± 0.31 (5.49)</td><td class="colsep0 rowsep0" align="left" valign="middle">14 ± 2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data are the mean of four to five experiments ± SEM.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Data are based on interaction studies with varying concentrations of dopamine. Data are fit to the Gaddum–Schild model of competitive antagonism using Graph Pad Prism (version 6) with Schild slopes constrained to 1.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Values are attained from concentration–response curves at the appropriate concentration and stimulation time.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last"><i>E</i><sub>max</sub> data are represented as a % of the maximal effect of dopamine (DA).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Biased Agonism at the D<sub>2</sub>R</h4><div class="NLM_p">The partial agonists <b>34d</b> and <b>34e</b> displayed similar binding affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and functional activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The 2,3-dichlorophenylpiperazine moiety and the aromatic bicycle of aripiprazole are separated by a five-atom spacer. This is analogous to the five carbon atom spacer separating the substituted thienopyridine and the 2-methoxyphenylpiperazine motif of compound <b>34d</b>. Therefore, we decided to further investigate <b>34d</b> based upon its linker length and structural similarity to aripiprazole. In particular, given that a number of studies have described aripiprazole as a biased agonist,<a onclick="showRef(event, 'ref8 ref13'); return false;" href="javascript:void(0);" class="ref ref8 ref13">(8, 13)</a> we extended our characterization of a limited number of compounds to activity at two assay end points, ERK1/2 phosphorylation and inhibition of forskolin stimulated cAMP production. In order to gain some preliminary SAR around this compound, we synthesized a small number of compounds related to <b>34d</b>. We retained the five-carbon atom linker for all derivatives and instead focused on subtle structural changes to the phenylpiperazine scaffold and the aromatic heterocyclic unit (thienopyridine scaffold). We utilized the 2,3-dichlorophenylpiperazine moiety present in aripiprazole and attached a five carbon atom spacer with the Boc appendage to generate ligand <b>19</b>. This compound was used as a comparator to compound <b>18d</b> which contains the same spacer but with the 2-methoxyphenylpiperazine moiety. We subsequently replaced the 2-methoxyphenylpiperazine moiety of <b>34d</b> with the 2,3-dichlorophenylpiperazine moiety to generate the target compound <b>35</b>. We also synthesized a further two analogues incorporating the simplified 4,6-dimethylthienopyridine to explore whether substitution around the thienopyridine core engendered an influence on bias. These structural motifs were combined with <b>6</b> and <b>5</b> to give <b>36</b> and <b>37</b>, respectively.</div><div class="NLM_p">The new structures (<b>19</b> and <b>35</b>–<b>37</b>) were first tested in a binding assay to measure their biochemical affinity for the D<sub>2</sub>R (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Compound <b>6</b> displayed a micromolar binding affinity for the D<sub>2</sub>R similar to that of the other two privileged structures (<b>5</b> and <b>7</b>). A small but significant (3-fold) increase in affinity was observed upon addition of a heterocyclic unit (compounds <b>35</b> and <b>36</b>) to the linker derivative of <b>6</b>, compound <b>19</b> (<i>P</i> < 0.05). There is, however, no difference in the binding affinities of compounds <b>35</b>–<b>37</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Binding Data for Compounds at the D<sub>2</sub>R That Incorporate 2,3-Dichlorophenylpiperazine and Have Variations to the Thienopyridine Unit<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Compounds are tested using [<sup>3</sup>H]spiperone through competition binding studies using D<sub>2L</sub> CHO cell membranes.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Data represent the mean ± SEM of three separate experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">Given that the new set of analogues all exhibited noteworthy binding affinities (42.6–9.1 nM) for the D<sub>2</sub>R, we extended our characterization to functional assays. Compounds <b>18d</b>, <b>19</b>, <b>34d</b>, <b>35</b>–<b>37</b>, the reference agonist dopamine, and control ligand aripiprazole were tested in pERK1/2 and cAMP (inhibition of forskolin-induced cAMP production) signaling pathways (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). We utilized a derivation of the operational model of agonism<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to quantify bias by determining a transduction coefficient, log(τ/<i>K</i><sub>A</sub>), for all ligands at both pathways.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> This transduction coefficient is a descriptor of the agonist effect of a single pathway that takes into account the intrinsic efficacy (τ) of the compound and its affinity (<i>K</i><sub>A</sub>) for the receptor coupled to that signaling pathway. The results from performing these analyses are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C. For values of potency (pEC<sub>50</sub>) and maximal stimulation (<i>E</i><sub>max</sub>) for all compounds, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table 1. We confirmed the biased action of aripiprazole, which displayed a 400-fold bias toward cAMP (ΔΔlog(τ/<i>K</i><sub>A</sub>) = 2.65 ± 0.32) when compared to our reference agonist dopamine. Ligands <b>34d</b> and <b>35</b> both displayed no significant bias to either pathway; however, the linker derivative of <b>6</b> (<b>19</b>) showed a significant bias toward cAMP (ΔΔlog(τ/<i>K</i><sub>A</sub>) = 1.73 ± 0.40). Conversely, the linker derivative of <b>5</b> (<b>18d</b>) did not display significantly different bias compared to dopamine. Compound <b>36</b> displayed biased agonism toward cAMP (ΔΔlog(τ/<i>K</i><sub>A</sub>) = 2.04 ± 0.67), a bias profile that is statistically indistinguishable from that of aripiprazole and equates to a 100-fold bias toward the cAMP pathway. Compound <b>37</b> did not produce a response in pERK1/2 signaling assays but acted as a partial agonist in the cAMP assay. As such, we were unable to quantify the bias of this compound compared to dopamine. If we compare the transduction coefficient determined in the cAMP assay for <b>37</b> (log(τ/<i>K</i><sub>A</sub>) = 8.45 ± 0.36) with those determined for <b>36</b> (changes in the phenyl substitution), <b>34d</b> (changes in the thienopyridine substitution pattern), and <b>18d</b> (no heterocyclic group), then compound <b>37</b> has a higher log(τ/<i>K</i><sub>A</sub>) value in comparison to <b>34d</b> and <b>18d</b> and is similar to <b>36</b>. This means that compound <b>37</b> is at least as efficacious in the cAMP assay as compounds <b>34d</b>, <b>18d</b>, and <b>36</b> and suggests that compound <b>37</b> may also be a biased ligand. However, it is important to note that of all the compounds, <b>37</b> displays the lowest maximal effect (<i>E</i><sub>max</sub> = 33 ± 5) in the cAMP assay (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> Table 1). It is therefore possible that compound <b>37</b> is not a biased ligand relative to dopamine but that its action in the pERK1/2 assay was too weak to be detected.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) ERK1/2 phosphorylation concentration–response assays. (B) Inhibition of FSK-induced cAMP production. (C) Bias plot representing the bias factor (ΔΔlog(τ/<i>K</i><sub>A</sub>)) of ligands between pERK1/2 and cAMP signaling pathways. Values are represented in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Calculated Bias Factors and Functional Affinities for Selected Full Agonists and Partial Agonists at the Dopamine D<sub>2L</sub> Receptor</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0014.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn3"><div class="footnote" id="t6fn3"><sup>Table a</sup><p class="last">Data are the mean of <i>n</i> = 4 experiments ± SEM. ND: no agonist activity detected.</p></div><div class="footnote" id="t6fn4"><sup>Table b</sup><p class="last">Bias is defined as the fold bias relative to the reference agonist dopamine: (∗) <i>P</i> < 0.05, (∗∗∗) <i>P</i> < 0.001, significantly different from the reference agonist dopamine determined by a one-way ANOVA, Tukey post hoc test.</p></div></div><div></div></div><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> illustrates that the 2,3-dichlorophenylpiperazine derivative containing the <i>tert</i>-butylcarbamate five-carbon linker (<b>19</b>) is biased toward the cAMP pathway. Altering the substitution pattern on the phenyl ring from 2,3-dichloro to 2-methoxy gives compound <b>18d</b> that exhibits no bias for either the cAMP or pERK1/2 end points, thus highlighting that the substitution pattern on the phenylpiperazine moiety can itself confer differences in bias. Substitution around the phenyl ring on the phenylpiperazine moieties also seems to be important for bias for compounds that incorporate a tail heterocycle (<b>34d</b> versus <b>36</b>). Differences between 2-methoxyphenylpiperazine- and 2,3-dichlorophenylpiperazine-substituted analogues could be attributed to the electronic effects of these substituents, i.e., weakly inductively electron-withdrawing (-Cl) compared to moderately electron-donating (-OCH<sub>3</sub>). Tschammer et al. also provided evidence that differential substitution of the phenyl moiety of phenylpiperazine ligands can modulate biased agonism at the D<sub>2</sub>R.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Such observations are an extension of those made by Newman et al. whereby measuring G protein activation by the D<sub>2</sub>R revealed that addition of linkers of different length and/or tail heterocyclic groups modulated agonist efficacy for derivatives of <b>6</b> whereas derivatives of <b>5</b> displayed no agonism.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> However, replacing the 2-methoxyphenylpiperazine moiety on <b>34d</b> with <b>6</b> to give <b>35</b> does not produce significant biased agonism when compared to the reference agonist dopamine. If we simplify the thienopyridine core by altering the 5-chloro-6-methoxy-4-methyl substitution pattern with that of the 4,6-dimethyl substitution to give compound <b>36</b>, the biased agonism profile is recapitulated. This suggests that (1) the signaling pathway bias does not simply arise from the 2,3-dichlorophenylpiperazine moiety and (2) the substitution of the thienopyridine core has an important role in determining the bias profile of such compounds. The influence of the addition of a heterocycle upon both ligand affinity and efficacy suggests that this heterocycle makes an interaction with the D<sub>2</sub>R. Newman et al. provided evidence of a secondary binding pocket that was exploited by extended phenylpiperazine ligands to gain subtype selectivity and modulate ligand efficacy.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> It is tempting to speculate that our novel extended phenylpiperazine derivatives interact with an analogous secondary binding pocket and the nature of this interaction influences biased agonism.</div><div class="NLM_p">Taking advantage of the partial agonism displayed by the compounds in this study, we were able to determine values of functional affinity (<i>K</i><sub>A</sub>) and efficacy (τ) as separate parameters rather than the composite transduction coefficient (log τ/<i>K</i><sub>A</sub>) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). By doing this, we can observe which of these parameters might be important drivers for signal bias at the D<sub>2</sub>R. First, if we compare our partial agonists in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>, there are no significant differences between the ligands in terms of functional affinity (p<i>K</i><sub>A</sub>) in the pERK1/2 signaling pathway or efficacy (τ) at both pathways. However, in the cAMP signaling pathway, compound <b>36</b> exhibits a functional affinity that is significantly different from analogues <b>18d</b>, <b>34d</b>, and <b>35</b> (<i>P</i> < 0.05). As such, the distinct bias profile displayed by compound <b>36</b> is largely driven through a change in functional affinity at the cAMP assay. This is consistent with the findings of an SAR exploration of biased agonsim at the D<sub>2</sub>R focused on cariprazine.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It is also of interest to compare the different parameters of compound <b>36</b> with that of aripiprazole. Both have very similar scaffolds and display a bias profile that is not statistically different. Although both have a similar transduction coefficient in the cAMP assay, compound <b>36</b> has a 10-fold higher functional affinity but a 10-fold lower efficacy at this pathway compared to aripiprazole. Similarly, in the pERK1/2 end point, compound <b>36</b> displays a 10-fold higher functional affinity than aripirazole but a smaller value of efficacy (τ).</div><div class="NLM_p">As previously mentioned in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>, aripiprazole has a high affinity at serotonin receptors, particularly 5-HT<sub>1A</sub>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Therefore, in light of the structural similarities of aripiprazole with some of our analogues, particularly the biased analogue (<b>36</b>), it is worth mentioning that these ligands may also have high affinities at serotonin receptors. As such, the action of these ligands may have an unprecedented complexity of action that should be considered in the characterization of bias not only at the D<sub>2</sub>R but also at serotonin receptors as potential dual dopamine–serotonin biased ligands.</div><div class="NLM_p">We have revealed that the SAR of biased agonism at the D<sub>2</sub>R is complex and, depending on the functional scaffold explored, cannot be defined by a single functional group or transformation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The differential bias observed for compounds <b>18d</b> and <b>19</b> is governed only by the nature of the privileged structure, i.e., <b>5</b> or <b>6</b>, with the latter conferring bias toward the cAMP assay. For the extended structures, it appears that the 4-methyl-5-chloro-6-methoxy substitution pattern on the thienopyridine scaffold (<b>34d</b> and <b>35</b>) engenders no bias irrespective of the privileged structure used. However, the 4,6-dimethyl substitution pattern on the thienopyridine motif appears to confer bias regardless of the privileged structure implemented (<b>36</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Therefore, for these compounds, this suggests that the bias is driven primarily by the thienopyridine heterocycle and more specifically the substitution pattern upon this heterocycle whereby the influence of the privileged structure is overridden.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Progression of functionalizing privileged structure <b>6</b> with a linker (<b>19</b>) and substituted thienopyridine heterocycles (<b>35</b>, <b>36</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We explored the determinants of efficacy and affinity for three distinct privileged structures for the D<sub>2</sub>R. The privileged structure <b>7</b> showed little gain in affinity in both the precursors containing the linkers (<b>17a</b>–<b>e</b>) and also the extended structures incorporating an additional thienopyridine heterocycle (<b>33a</b>–<b>e</b>). Focusing on the privileged structure <b>5</b>, we confirm that the addition of linker groups resulted in a gain in affinity (<b>18a</b>–<b>e</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and in efficacy (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In particular, we observed a linker length relationship with efficacy with three to five carbon atoms engendering partial agonism (<b>18b</b>–<b>d</b>). Inclusion of a heterocyclic structure (<b>34a</b>–<b>e</b>) resulted in a different pattern of linker length dependent efficacy, as only extended compounds containing linker lengths of five and six carbon atoms (<b>34d</b>–<b>e</b>) exhibited partial agonism. It is therefore likely that compounds that possess only the linker component bind the D<sub>2</sub>R in a different orientation to the extended structures incorporating a thienopyridine motif. Extending our studies around the novel partial agonist <b>34d</b>, we generated a focused set of compounds that explored the SAR around the two privileged structures <b>5</b> and <b>6</b>. Of note is that not only can the type of substitution on the phenylpiperazine influence bias, the substitution on the thienopyridine scaffold can have dramatic effects on bias to the point whereby the type of privileged structure used is no longer the principal driver of bias. This observation is consistent with the interaction of the thienopyridine scaffold with a secondary pocket previously identified to interact with other extended D<sub>2</sub>R ligands. Our findings suggest that the nature of this interaction confers bias at the D<sub>2</sub>R receptor. Our novel D<sub>2</sub>R partial agonists <b>35</b> and <b>36</b> display a similar affinity for the D<sub>2</sub>R as aripiprazole but exhibit distinct bias profiles. As such, they may represent useful tools to explore the contribution of biased agonism to antipsychotic efficacy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemistry</h3><div class="NLM_p">All solvents and chemicals were purchased from standard suppliers and were used without any further purification. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were acquired at 400.13 and 100.62 MHz, respectively, on a Bruker Advance III 400 MHz Ultrashield Plus NMR spectrometer using TOPSPIN 2.1 software. Chemical shifts (δ) for all <sup>1</sup>H spectra are reported in parts per million (ppm) using tetramethylsilane (TMS, 0 ppm) as the reference. The data for all spectra are reported in the following format: chemical shift (δ), (multiplicity, coupling constants <i>J</i> (Hz), integral), where the multiplicity is defined as s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, and m = multiplet. For <sup>13</sup>C NMR spectra C = quaternary carbon, CH = methine carbon, CH<sub>2</sub> = methylene carbon, and CH<sub>3</sub> = methyl carbon.</div><div class="NLM_p">The purity and retention time of final products were determined on an analytical reverse-phase HPLC system fitted with a Luna C8 (2) 100 Å column (50 mm × 4.60 mm, 5 μm) using a binary solvent system: solvent A of 0.1% TFA/H<sub>2</sub>O; solvent B of 0.1% TFA/80% MeOH/20% H<sub>2</sub>O. Gradient elution was achieved using 100% A for 10 min, 20% A and 80% B over 2 min, and 100% A over 10 min at a flow rate of 1 mL/min monitored at 214 nm using a Waters 996 photodiode array detector.</div><div class="NLM_p last">Thin layer chromatography (TLC) was carried out routinely on silica gel 60F<sub>254</sub> precoated plates (0.25 mm, Merck). Flash column chromatography was carried out using Merck silica gel 60, 230–400 mesh ASTM. Melting points were determined using an electronic MP50 melting point system by Mettler Toledo analytical 2009 and are uncorrected.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Synthesis of Linkers. General Procedure A</h3><div class="NLM_p last">The required aminoalkanol <b>12c</b>–<b>e</b> (1 equiv) was added to 10–30 mL of dichloromethane. Di-<i>tert</i>-butyl dicarbonate (1 equiv) was then added followed by dropwise addition of triethylamine (1.1 equiv) at room temperature. The reaction mixture was stirred for 1 h. After this time, the solvent was removed in vacuo and the resulting oil purified via column chromatography (ethyl acetate).</div></div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>tert</i>-Butyl (4-Hydroxybutyl)carbamate (<b>13c</b>)</h3><div class="NLM_p last"><b>12c</b> (0.41 mL, 4.49 mmol) and di-<i>tert</i>-butyl dicarbonate (979 mg, 4.49 mmol) were added to dichloromethane (10 mL). Triethylamine (0.69 mL, 4.94 mmol) was added dropwise and the mixture stirred for 1 h at room temperature and worked up according to general procedure A. Purification gave the product as a pale yellow oil (809 mg, 95%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.44 (s, 9H), 1.53–1.62 (m, 4H), 2.52 (br s, 1H, OH), 3.14 (m, 2H), 3.65 (m, 2H), 4.78 (br s, 1H, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 26.7 (CH<sub>2</sub>), 28.5 (CH<sub>3</sub>), 29.8 (CH<sub>2</sub>), 40.4 (CH<sub>2</sub>), 62.3 (CH<sub>2</sub>), 79.2 (C), 156.3 (C).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure B</h3><div class="NLM_p last">The required bromoalkanamine <b>15a</b>,<b>b</b> (1.1 equiv) was added to 20–30 mL of dichloromethane. Di-<i>tert</i>-butyl dicarbonate (1 equiv) was then added followed by dropwise addition of triethylamine (1.1 equiv) at room temperature. The reaction mixture was stirred for 1–1.5 h. After this time, an additional 20 mL of dichloromethane was added and the reaction mixture was washed with 3 × 50 mL portions of saturated potassium hydrogen sulfate solution. The organic layer was then dried over anhydrous sodium sulfate, filtered and the solvent removed to afford the crude product. Further purification of the product was achieved via column chromatography (9:1 petroleum spirits/ethyl acetate).</div></div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>tert</i>-Butyl (2-Bromoethyl)carbamate (<b>16a</b>)</h3><div class="NLM_p last"><b>15a</b> (1.50 g, 7.32 mmol) and di-<i>tert</i>-butyl dicarbonate (1.45 g, 6.66 mmol) were added to dichloromethane (20 mL). Triethylamine (1.02 mL, 7.32 mmol) was added dropwise and the mixture stirred for 1.5 h at room temperature and worked up according to general procedure B to give the product as a colorless oil (413 mg, 28%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.45 (s, 9H), 3.45 (m, 2H), 3.53 (m, 2H), 5.01 (br s, 1H, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 28.5 (CH<sub>3</sub>), 32.9 (CH<sub>2</sub>), 42.5 (CH<sub>2</sub>), 80.0 (C), 155.7 (C).</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Coupling of Linkers with Privileged Structures <b>5</b>, <b>6</b>, and <b>7</b>. General Procedure C</h3><div class="NLM_p last">To a solution of <b>5</b> or <b>7</b> (1 equiv) in acetonitrile (30 mL) at room temperature under N<sub>2</sub> were added sodium iodide (1 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (2 equiv). The required Boc protected amines <b>16a</b>,<b>b</b> (1.1–1.5 equiv) were dissolved in 1–2 mL of acetonitrile and added slowly to the reaction mixture which was then heated at reflux for 24 h. The reaction was then concentrated in vacuo and the resulting residue partitioned between ethyl acetate (50 mL) and 1 M potassium carbonate (50 mL). The organic layer was removed, and the aqueous layer was further extracted with 2 × 50 mL portions of ethyl acetate. The organic fractions were pooled, washed with water (50 mL), brine (50 mL), dried over anhydrous sodium sulfate, and filtered and the solvent was removed to afford the crude product. Purification is achieved by column chromatography as indicated.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure D</h3><div class="NLM_p last">The Boc protected aminoalkanol <b>13c</b>–<b>e</b> (1 equiv) was added to dichloromethane (5 mL). Triethylamine (3 equiv) was added and the reaction mixture cooled to 0 °C via an ice bath. Methanesulfonyl chloride (2 equiv) was then added slowly, and stirring continued for 30 min at 0 °C. After this time the temperature was warmed to room temperature and stirring continued for 1–12 h. The reaction mixture is then diluted with dichloromethane (10 mL), washed with water (3 × 15 mL), dried over anhydrous sodium sulfate, filtered and the solvent removed in vacuo. The mesylates were then reacted immediately with <b>5</b>, <b>6</b>, or <b>7</b> (2–2.5 equiv) in acetonitrile (5 mL) and heated at reflux for 8–24 h. The solvent was then removed in vacuo and the resulting residue redissolved in dichloromethane and washed with saturated sodium bicarbonate (3 × 20 mL). The organic layer was then dried over anhydrous sodium sulfate, filtered, and evaporated to dryness to give the crude product. Further purification was achieved by column chromatography as indicated.</div></div><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>tert</i>-Butyl (2-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)ethyl)carbamate (<b>17a</b>)</h3><div class="NLM_p last"><b>7</b> (300 mg, 1.21 mmol), sodium iodide (181 mg, 1.21 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (0.21 mL, 1.21 mmol) were added to acetonitrile (30 mL) at room temperature under N<sub>2</sub>. <b>16a</b> (350 mg, 1.56 mmol) was then combined with acetonitrile (2 mL) and added slowly to the reaction mixture (full amount added after 1.5 h). After 6 h of reflux, the reaction mixture was worked up as described in general procedure C to give the product as a white foam (348 mg, 81%). Mp: 129.8–131.1 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.46 (s, 9H), 1.71–1.75 (m, 2H), 2.11 (td, <i>J</i> 13.2, 4.3 Hz, 2H), 2.46–2.55 (m, 4H), 2.79 (m, 2H), 3.26 (m, 2H), 5.02 (br s, 1H, NH), 7.31 (m, 2H), 7.44 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 28.6 (CH<sub>3</sub>), 38.5 (CH<sub>2</sub>), 40.7 (CH<sub>2</sub>), 49.4 (CH<sub>2</sub>), 57.4 (CH<sub>2</sub>), 71.1 (C), 79.4 (C), 126.3 (CH), 128.6 (CH), 133.0 (C), 147.0 (C), 156.1 (C). HPLC purity (λ = 214 nm): 97%, <i>t</i><sub>R</sub> = 7.68 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 355.1788 calcd for C<sub>18</sub>H<sub>27</sub>ClN<sub>2</sub>O<sub>3</sub>; found [M + H]<sup>+</sup> 355.1796.</div></div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>tert</i>-Butyl (6-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)hexyl)carbamate (<b>17e</b>)</h3><div class="NLM_p last"><b>7</b> (292 mg, 1.38 mmol) was added to acetonitrile (5 mL) followed by dropwise addition of <b>14e</b> (204 mg, 0.691 mmol). Reflux occurred overnight, and then the reaction mixture was worked up as described in general procedure D to give the product as a white foam (183 mg, 64%). Mp: 64.4–65.7 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.32–1.35 (m, 4H), 1.44 (s, 9H), 1.48 (m, 2H), 1.54 (m, 2H), 1.73 (m, 2H), 2.15 (m, 2H), 2.39–2.45 (m, 4H), 2.84 (m, 2H), 3.1 (m, 2H), 4.53 (br s, 1H, NH), 7.31 (m, 2H), 7.45 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 26.8 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 27.4 (CH<sub>2</sub>), 28.6 (CH<sub>3</sub>), 30.2 (CH<sub>2</sub>), 38.5 (CH<sub>2</sub>), 40.7 (CH<sub>2</sub>), 49.6 (CH<sub>2</sub>), 58.9 (CH<sub>2</sub>), 71.2 (C), 79.2 (C), 126.3 (CH), 128.6 (CH), 132.9 (C), 147 (C), 156.2 (C). HPLC purity (λ = 214 nm): 95%, <i>t</i><sub>R</sub> = 8.77 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 411.2414 calcd for C<sub>22</sub>H<sub>35</sub>ClN<sub>2</sub>O<sub>3</sub>; found [M + H]<sup>+</sup> 411.2429.</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>tert</i>-Butyl (3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)carbamate (<b>18b</b>)</h3><div class="NLM_p last"><b>5</b> (200 mg, 0.87 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (0.15 mL, 1.87 mmol) were added to acetonitrile (5 mL) and stirred at room temperature under N<sub>2</sub> for 2 min to generate the free amine. Sodium iodide (131 mg, 0.87 mmol) and additional <i>N</i>,<i>N</i>-diisopropylethylamine (0.15 mL, 1.87 mmol) were then also added. <b>16b</b> (280 mg, 1.18 mmol) was then combined with acetonitrile (2 mL) and added slowly to the reaction mixture. After heating at reflux for 24 h, the reaction mixture was worked up as described in general procedure C and purified via a silica plug (ethanol) to give the product as a colorless oil (286 mg, 93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.44 (s, 9H), 1.70 (p, <i>J</i> 6.6 Hz, 2H), 2.49 (t, <i>J</i> 6.8 Hz, 2H), 2.65 (m, 4H), 3.10 (m, 4H), 3.22 (m, 2H), 3.86 (s, 3H), 5.49 (br s, 1H, NH), 6.85–7.02 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 26.5 (CH<sub>2</sub>), 28.6 (CH<sub>3</sub>), 40.2 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.6 (CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 57.1 (CH<sub>2</sub>), 78.9 (C), 111.3 (CH), 118.3 (CH), 121.1 (CH), 123.0 (CH), 141.4 (C), 152.4 (C), 156.2 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 7.74 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 350.2444 calcd for C<sub>19</sub>H<sub>31</sub>N<sub>3</sub>O<sub>3</sub>; found [M + H]<sup>+</sup> 350.2455.</div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl (5-(4-(2-Methoxyphenyl)piperazin-1-yl)pentyl)carbamate (<b>18d</b>)</h3><div class="NLM_p last"><b>5</b> (683 mg, 2.99 mmol) was dissolved in acetonitrile (10 mL) and triethylamine (0.21 mL, 1.49 mmol) and stirred for 5 min. <b>14d</b> (420 mg, 1.49 mmol) was then added dropwise to the reaction mixture which was refluxed for 24 h. Workup proceeded as described in general procedure D and the crude product was purified by column chromatography (10% chloroform/methanol–100% acetonitrile) to give a yellow/orange oil (334 mg, 59%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.36 (m, 2H), 1.44 (s, 9H), 1.47–1.59 (m, 4H), 2.43 (m, 2H), 2.68 (m, 4H), 3.09–3.15 (m, 6H), 3.86 (s, 3H), 4.63 (br s, 1H, NH), 6.84–7.01 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 24.8 (CH<sub>2</sub>), 26.4 (CH<sub>2</sub>), 28.5 (CH<sub>3</sub>), 40.6 (CH<sub>2</sub>), 50.5 (CH<sub>2</sub>), 53.4 (CH<sub>2</sub>), 55.4 (CH<sub>3</sub>), 58.6 (CH<sub>2</sub>), 79.1 (C), 111.2 (CH), 118.3 (CH), 121.1 (CH), 123.0 (CH), 141.3 (C), 152.3 (C), 156.1 (C). HPLC purity (λ = 214 nm): 98%, <i>t</i><sub>R</sub> = 8.18 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 378.2757 calcd for C<sub>21</sub>H<sub>35</sub>N<sub>3</sub>O<sub>3</sub>; found [M + H]<sup>+</sup> 378.2768.</div></div><div id="sec4_3_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl (5-(4-(2,3-Dichlorophenyl)piperazin-1-yl)pentyl)carbamate (<b>19</b>)</h3><div class="NLM_p last"><b>6</b> (1.09 g, 4.07 mmol) was added to acetonitrile (15 mL) followed by <b>14d</b> (572 mg, 2.03 mmol) and triethylamine (0.57 mL, 4.07 mmol) and the mixture refluxed for 19 h. Workup proceeded as described in general procedure D and the crude product was purified by column chromatography (chloroform/methanol 99:1) to give a yellow oil (431 mg, 51%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.36 (m, 2H), 1.44 (s, 9H), 1.47–1.59 (m, 4H), 2.41 (m, 2H), 2.63 (m, 4H), 3.07 (m, 4H), 3.12 (m, 2H), 4.62 (br s, 1H, NH), 6.96 (m, 1H), 7.12–7.17 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 24.8 (CH<sub>2</sub>), 26.6 (CH<sub>2</sub>), 28.5 (CH<sub>3</sub>), 30.1 (CH<sub>2</sub>), 40.6 (CH<sub>2</sub>), 51.4 (CH<sub>2</sub>), 53.4 (CH<sub>2</sub>), 58.6 (CH<sub>2</sub>), 79.1 (C), 118.7 (CH), 124.6 (CH), 127.5 (CH), 127.6 (C), 134.1 (C), 151.4 (C), 156.1 (C). HPLC purity (λ = 214 nm): 98%, <i>t</i><sub>R</sub> = 10.43 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 416.1872 calcd for C<sub>20</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>; found [M + H]<sup>+</sup> 416.1870.</div></div><div id="sec4_3_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Synthesis of Substituted Thienopyridine Scaffolds. 2-Cyanothioacetamide (<b>21</b>)</h3><div class="NLM_p last">P<sub>4</sub>S<sub>10</sub> (1.00 g, 4.52 mmol) and 2-cyanoacetamide (<b>20</b>, 1.00 g, 11.89 mmol) were dissolved in ethyl acetate (12 mL). The mixture was heated at reflux for 1.5–4 h. The reaction mixture was then cooled to room temperature and the orange solid filtered off and washed with ethyl acetate (100 mL). The solid was recrystallized from toluene to give sharp yellow needles (389 mg, ∼30%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 3.98 (s, 2H), 9.48 (s, 1H, NHa), 9.83 (s, 1H, NHb). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 33.9 (CH<sub>2</sub>), 116.5 (C), 194.5 (C).</div></div><div id="sec4_3_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4,6-Dimethyl-2-thioxo-1,2-dihydropyridine-3-carbonitrile (<b>22</b>)</h3><div class="NLM_p last">2-Cyanothioacetamide (<b>21</b>, 1.02 g, 10.2 mmol) and acetylacetone (1.04 mL, 10.2 mmol) were suspended in methanol (10 mL) and warmed until dissolved. Potassium hydroxide (0.75 g) dissolved in methanol (50 mL) was added to the solution, which was stirred for 2 h and then heated at reflux for a further 2 h. The mixture was cooled to room temperature and acidified with 6 M aqueous hydrochloric acid to pH 2–3, and a precipitate resulted. The precipitous mixture was then cooled overnight, filtered, and washed with water. The product was recrystallized from methanol to afford the title compound as yellow needles (1.13 g, 67%). Mp: 266.9–270 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.34 (s, 3H), 2.35 (s, 3H), 6.69 (s, 1H), 13.83 (br s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 18.8 (CH<sub>3</sub>), 20.8 (CH<sub>3</sub>), 113.4 (C), 114.9 (CH), 116.3 (C), 152.6 (C), 156.9 (C), 177.5 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 5.56 min.</div></div><div id="sec4_3_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Ethyl 2-((3-Cyano-4,6-dimethylpyridin-2-yl)thio)acetate (<b>23</b>)</h3><div class="NLM_p last">Compound <b>22</b> (1.00 g, 6.09 mmol) and triethylamine (0.93 mL, 6.70 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (15 mL) and cooled to 0 °C. Ethyl-2-chloroacetate (0.65 mL, 6.09 mmol) was added to 1 mL of <i>N</i>,<i>N</i>-dimethylformamide and then added dropwise to the reaction mixture. The mixture was then warmed to room temperature for 3.5 h, and a yellow precipitate resulted. The solvent was then removed and the resulting residue partitioned between dichloromethane (50 mL) and water (50 mL). The organic layer was removed, and the aqueous layer was then washed with further 3 × 50 mL portions of dichloromethane. The organic fractions were combined, dried over anhydrous sodium sulfate, and filtered, and the solvent was removed to leave a yellow solid. Further purification using a silica plug afforded the final compound as a white solid (1.30 g, 86%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.17–1.21 (t, <i>J</i> 7.1 Hz, 3H), 2.41 (s, 3H), 2.43 (s, 3H), 4.07 (s, 2H), 4.09- 4.14 (q, <i>J</i> 7.1 Hz, 2H), 7.12 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 14.1 (CH<sub>3</sub>), 19.6 (CH<sub>3</sub>), 24.2 (CH<sub>3</sub>), 32.2 (CH<sub>2</sub>), 61.0 (CH<sub>2</sub>), 103.6 (C), 114.6 (C), 120.6 (CH), 152.6 (C), 159.7 (C), 161.4 (C), 168.5 (C).</div></div><div id="sec4_3_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Ethyl 3-Amino-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxylate (<b>24</b>)</h3><div class="NLM_p last"><b>23</b> (1.29 g, 5.15 mmol) was dissolved in 4–5 mL of <i>N</i>,<i>N</i>-dimethylformamide followed by 1 M potassium hydroxide (5.15 mL, 5.15 mmol). The reaction mixture was stirred for 15 min at room temperature. Quenching with water (15 mL) caused precipitation of the product that was then filtered to leave a yellow crystalline solid (1.20 g, 93%). Mp: 154.7–155.6 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.39 (t, <i>J</i> 7.1 Hz, 3H), 2.58 (s, 3H), 2.72 (s, 3H), 4.34 (q, <i>J</i> 7.1 Hz, 2H), 6.14 (br s, 2H, NH<sub>2</sub>), 6.84 (s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 14.6 (CH<sub>3</sub>), 20.3 (CH<sub>3</sub>), 24.5 (CH<sub>3</sub>), 60.6 (CH<sub>2</sub>), 91.2 (C), 121.9 (CH), 122.5 (C), 143.7 (C), 149.1 (C), 159.8 (C), 161.5 (C), 165.9 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 8.38 min.</div></div><div id="sec4_3_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-Amino-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxylic Acid (<b>25</b>)</h3><div class="NLM_p last">To a solution of <b>24</b> (1.16 g, 4.62 mmol) in ethanol (15 mL) was added an aqueous solution of sodium hydroxide (2 M, 8 mL), and the mixture was refluxed for 4 h. The solvent was removed in vacuo and the resulting residue dissolved in water (20 mL). Excess aqueous hydrochloric acid (1 M, 10 mL) was added which caused precipitation of the desired compound. Filtration of the precipitate gave the title compound as a yellow solid (856 mg, 83%). Mp: 151.9–152.9 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.50 (s, 3H), 2.72 (s, 3H), 7.05 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 19.9 (CH<sub>3</sub>), 23.4 (CH<sub>3</sub>), 95.2 (C), 121.9 (CH), 122.9 (C), 145.8 (C), 149.3 (C), 158.8 (C), 159.0 (C), 166.5 (C).</div></div><div id="sec4_3_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Mercapto-4-methyl-6-oxo-1,6-dihydropyridine-3-carbonitrile (<b>26</b>)</h3><div class="NLM_p last">A mixture of <b>21</b> (8.00 g, 79.89 mmol) and morpholine (6.99 mL, 79.9 mmol) in ethanol (50 mL) was warmed until all components dissolved. Methyl acetoacetate (8.59 mL, 79.9 mmol) was then added and the mixture heated at reflux for 8 h. After cooling to room temperature, the mixture was filtered and the residue washed with cold dichloromethane to give morpholinium 3-cyano-4-methyl-6-oxo-1,6-dihydropyridine-2-thiolate. The desired thiol was isolated by dissolving the thiolate in a minimum amount of water and then acidifying with excess 1 M aqueous hydrochloric acid, which caused precipitation of the molecule. The mixture was refrigerated overnight and then filtered to give the title compound as a pale yellow powder (6.83 g, 51%). Mp: 267–268.9 °C. LRMS (ESI) <i>m</i>/<i>z</i>: 165.1 [M – H]<sup>+</sup> (100%).</div></div><div id="sec4_3_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Ethyl 2-((3-Cyano-4-methyl-6-oxo-1,6-dihydropyridin-2-yl)thio)acetate (<b>27</b>)</h3><div class="NLM_p last">Compound <b>26</b> (200 mg, 1.2 mmol) and triethylamine (0.18 mL, 1.32 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (8 mL) and cooled to 0 °C. Ethyl 2-chloroacetate (0.13 mL, 1.2 mmol) was added to 1 mL of <i>N</i>,<i>N</i>-dimethylformamide and then added dropwise to the reaction mixture. The mixture was then warmed to room temperature and stirred for 5 h. The solvent was then removed and the resulting residue dissolved in dichloromethane (50 mL) and partitioned between water (50 mL). The aqueous layer was then washed with further 3 × 50 mL portions of dichloromethane, and the organic layers were combined, dried over anhydrous sodium sulfate, and filtered. The solvent was removed to leave a yellow solid. Further purification by column chromatography afforded the final compound as a white solid (247 mg, 81%). Mp: 102.7–103.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.28 (t, <i>J</i> 7.1 Hz, 3H), 2.38 (d, <i>J</i> 0.9 Hz, 3H), 3.93 (s, 2H), 4.23 (q, <i>J</i> 7.1 Hz, 2H), 6.33–6.35 (m, 1H), 11.03 (br s, 1H, NH). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.1 (CH<sub>3</sub>), 20.9 (CH<sub>3</sub>), 34.1 (CH<sub>2</sub>), 62.8 (CH<sub>2</sub>), 98.2 (C), 113.9 (CH), 114.9 (C), 153.4 (C), 154.3 (C), 163.6 (C), 169.6 (C).</div></div><div id="sec4_3_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ethyl 3-Amino-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxylate (<b>28</b>)</h3><div class="NLM_p last">Compound <b>27</b> (1.52 g, 6.02 mmol) was added to <i>N</i>,<i>N</i>-dimethylformamide (20 mL) followed by potassium carbonate (1.25 g, 9.04 mmol) and methyl iodide (0.41 mL, 6.63 mmol). The reaction mixture was then stirred at room temperature for 2 h before another 0.5–1 equiv of the methyl iodide was added. After 4 h, 1 M aqueous potassium hydroxide is added and the reaction mixture stirred for 15 min. Water (15 mL) is then added and the resulting white precipitate is filtered and dried overnight over high vacuum (0.91 g, 58%). Mp: 149.5–150.2 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.38 (t, <i>J</i> 7.1 Hz, 3H), 2.68 (d, <i>J</i> 0.9 Hz, 3H), 3.98 (s, 3H), 4.33 (q, <i>J</i> 7.1 Hz, 2H), 6.11 (br s, 2H, NH<sub>2</sub>), 6.43 (m, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.7 (CH<sub>3</sub>), 20.4 (CH<sub>3</sub>), 54.0 (CH<sub>3</sub>), 60.4 (CH<sub>2</sub>), 95.2 (C), 110.0 (CH), 119.4 (C), 145.9 (C), 149.5 (C), 160.6 (C),164.6 (C), 165.9 (C).</div></div><div id="sec4_3_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Ethyl 3-(1,3-Dioxoisoindolin-2-yl)-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxylate (<b>29</b>)</h3><div class="NLM_p last">To a solution of <b>28</b> (65 mg, 0.244 mmol) in acetic acid (5 mL), a total of 4 equiv of phthalic anhydride (150 mg, 1.01 mmol) was added over the 20 h period. The reaction was stopped by cooling the mixture to room temperature and then over an ice bath to initiate precipitation of the final product as a white solid (53 mg, 55%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.11 (t, <i>J</i> 7.1 Hz, 3H), 2.37 (s, 3H), 4.02 (s, 3H), 4.20 (q, <i>J</i> 7.1 Hz, 2H), 6.59 (s, 1H), 7.83 (m, 2H), 8.00 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.9 (CH<sub>3</sub>), 18.5 (CH<sub>3</sub>), 54.2 (CH<sub>3</sub>), 61.7 (CH<sub>2</sub>), 112.2 (CH), 124.2 (CH), 124.7 (C), 125.4 (C), 127.6 (C), 132.4 (C), 134.7 (CH), 145.9 (C), 159.1 (C), 161.1 (C), 164.5 (C), 167.6 (C).</div></div><div id="sec4_3_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl 5-Chloro-3-(1,3-dioxoisoindolin-2-yl)-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxylate (<b>30</b>)</h3><div class="NLM_p last">Compound <b>29</b> (500 mg, 1.26 mmol), <i>N</i>-chlorosuccinimide (337 mg, 2.52 mmol), and 3 drops of concentrated HCl were refluxed in acetonitrile (10 mL) for 1.5 h. The solvent was then removed in vacuo and the resulting residue redissolved in chloroform (50 mL) and washed with water (3 × 20 mL) and brine (50 mL). The organic layer was then dried over anhydrous sodium sulfate, filtered, and evaporated to dryness to give the compound as a white solid (506 mg, 93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.12 (t, <i>J</i> 7.1 Hz, 3H), 2.49 (s, 3H), 4.13 (s, 3H), 4.21 (q, <i>J</i> 7.1 Hz, 2H), 7.85 (m, 2H), 8.01 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 13.9 (CH<sub>3</sub>), 14.7 (CH<sub>3</sub>), 55.4 (CH<sub>3</sub>), 61.9 (CH<sub>2</sub>), 118.8 (C), 124.3 (CH), 125.1 (C), 127.0 (C), 127.4 (C), 132.4 (C), 134.9 (CH), 143.0 (C), 155.9 (C), 159.5 (C), 160.9 (C), 167.6 (C).</div></div><div id="sec4_3_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Ethyl 3-Amino-5-chloro-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxylate (<b>31</b>)</h3><div class="NLM_p last">A mixture of <b>30</b> (144 mg, 0.33 mmol) and hydrazine monohydrate (65 μL, 1.34 mmol) in ethanol (10 mL) was refluxed for 3 h. Upon cooling to room temperature, the white precipitate was filtered off and washed with cold chloroform (5 mL). The filtrate was then collected and diluted with a further 20 mL of chloroform and washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and filtered and the solvent removed in vacuo to give the product as a pale yellow solid (85 mg, 84%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.38 (t, <i>J</i> 7.1 Hz, 3H), 2.83 (s, 3H), 4.08 (s, 3H), 4.33 (q, <i>J</i> 7.1 Hz, 2H), 6.14 (br s, 2H, NH<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 14.6 (CH<sub>3</sub>), 16.4 (CH<sub>3</sub>), 55.2 (CH<sub>3</sub>), 60.6 (CH<sub>2</sub>), 116.3 (C), 120.1 (C), 142.9 (C), 149.1 (C), 157.3 (C), 159.5 (C), 165.7 (C), 168.4 (C).</div></div><div id="sec4_3_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Amino-5-chloro-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxylic Acid (<b>32</b>)</h3><div class="NLM_p last">Compound <b>31</b> (236 mg, 0.783 mmol) was was added to a 50:50 mix of ethanol and 2 M sodium hydroxide. Reflux occurs for 1.5 h before the mixture was cooled to room temperature. An excess of 2 M HCl is added to cause precipitation of the product which is then filtered and washed with a small amount of cold water, giving the product as a beige-yellow solid (179 mg, 84%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 2.77 (s, 3H), 3.96 (s, 3H), 6.41 (br s, 2H, NH<sub>2</sub>). LCMS (ESI) <i>m</i>/<i>z</i>: 273.0 [M + H]<sup>+</sup> (90%), 275.0 (30%).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure E for Amide Coupling Reactions Using BOP Reagent</h3><div class="NLM_p last">The required carboxylic acids (1 equiv) were added to <i>N</i>,<i>N</i>-dimethylformamide (10 mL), followed by <i>N</i>,<i>N</i>-diisopropylethylamine (1.05 equiv) and BOP (1.05 equiv) under N<sub>2</sub> at room temperature and stirred for 5–10 min. The amine (1 equiv) was subsequently added and the reaction mixture stirred at room temperature for 2–3 h. The solvent was then removed in vacuo and the resulting residue partitioned between dichloromethane (30 mL) and sodium bicarbonate (50 mL). The organic layer was removed, and the aqueous phase was further extracted with 3 × 20 mL portions of dichloromethane. The organic fractions were combined, washed with water (50 mL), brine (50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated to yield the crude product as an oily residue. To remove excess HMPA, crude products are dissolved in ethyl acetate and washed with 3 × 50 mL portions of 2 M brine. Purification of the product was performed by column chromatography and/or recrystalisation as indicated.</div></div><div id="sec4_3_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-Amino-<i>N</i>-(2-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)ethyl)-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>33a</b>)</h3><div class="NLM_p last">Carboxylic acid <b>25</b> (50 mg, 0.225 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.041 mL, 0.24 mmol), and BOP (104 mg 0.24 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (2 mL). <b>17a</b> (92 mg, 0.28 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide and <i>N</i>,<i>N</i>-diisopropylethylamine (0.078 mL, 0.450 mmol) and then added to the reaction mixture. After the mixture was stirred for 16 h at room temperature, the crude product was worked up as per general procedure E to give an amber solid (32 mg, 31%). Mp: 159–163 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.58 (d, <i>J</i> 12.1 Hz, 2H), 1.91 (td, <i>J</i> 12.9, 4.1 Hz, 2H), 2.44–2.53 (m, 7H), 2.71–2.72 (m, 5H), 3.36 (m, 2H), 4.9 (s, 1H, OH), 6.78 (s, 2H, NH<sub>2</sub>), 7.02 (s, 1H), 7.36 (m, 2H), 7.50 (m, 2H), 7.55 (t, <i>J</i> 5.5 Hz, 1H, NH). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 19.7 (CH<sub>3</sub>), 23.8 (CH<sub>3</sub>), 36.7 (CH<sub>2</sub>), 37.9 (CH<sub>2</sub>), 49.1 (CH<sub>2</sub>), 57.2 (CH<sub>2</sub>), 69.4 (C), 97.6 (C), 121.8 (CH), 123.2 (C), 126.8 (CH), 127.7 (CH), 130.8 (C), 144.5 (C), 147.5 (C), 149.1 (C), 158.4 (C), 158.5 (C), 165.2 (C). HPLC purity (λ = 214 nm): 98%, <i>t</i><sub>R</sub> = 8.06 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 459.1621 calcd for C<sub>23</sub>H<sub>27</sub>ClN<sub>4</sub>O<sub>2</sub>S; found [M + H]<sup>+</sup> 459.1634.</div></div><div id="sec4_3_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-Amino-<i>N</i>-(6-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)hexyl)-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>33e</b>)</h3><div class="NLM_p last">Carboxylic acid <b>25</b> (61 mg, 0.274 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.146 mL, 0.837 mmol), and BOP (128 mg, 0.288 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (2 mL). <b>17e</b> (116 mg, 0.302 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide and <i>N</i>,<i>N</i>-diisopropylethylamine (0.096 mL, 0.550 mmol) and then added to the reaction mixture. After the mixture was stirred for 5 h at room temperature, the crude product was worked up as per general procedure E to give the product as a pale yellow solid (49 mg, 35%). Mp: 137.2–140.3 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.39–1.42 (m, 4H), 1.57–1.65 (m, 4H), 1.72–7.75 (m, 3H), 2.19 (m, 2H), 2.43–2.5 (m, 4H), 2.58 (s, 3H), 2.74 (s, 1H), 2.87 (m, 2H), 3.42 (dd, <i>J</i> 13.1, 7 Hz, 2H), 5.55 (t, <i>J</i> 5.3 Hz, 1H, NH), 6.3 (s, 2H, NH<sub>2</sub>), 6.87 (s, 1H), 7.29 (m, 2H), 7.44 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 20.2 (CH<sub>3</sub>), 24.3 (CH<sub>3</sub>), 26.8 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 27.4 (CH<sub>2</sub>), 29.9 (CH<sub>2</sub>), 38.4 (CH<sub>2</sub>), 39.8 (CH<sub>2</sub>), 49.5 (CH<sub>2</sub>), 58.7 (CH<sub>2</sub>), 71.1 (C), 98.7 (C), 122.3 (CH), 123.8 (C), 126.3 (CH), 128.5 (CH), 132.9 (C), 143.8 (C), 147.0 (C), 147.3 (C), 159.1 (C), 159.2 (C), 166 (C). HPLC purity (λ = 214 nm): 98%, <i>t</i><sub>R</sub> = 8.39 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 515.2247 calcd for C<sub>27</sub>H<sub>35</sub>ClN<sub>4</sub>O<sub>2</sub>S; found [M + H]<sup>+</sup> 515.2254.</div></div><div id="sec4_3_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-Amino-5-chloro-6-methoxy-<i>N</i>-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>34c</b>)</h3><div class="NLM_p last">Carboxylic acid <b>32</b> (100 mg, 0.367 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.067 mL, 0.385 mmol), and BOP (176 mg, 0.398 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (10 mL). <b>18c</b> (121 mg, 0.403 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide, and <i>N</i>,<i>N</i>-diisopropylethylamine (0.077 mL, 0.403 mmol) was then added to convert to the free base, which was added dropwise to the reaction mixture. The reaction mixture was then worked up as described in general procedure E to give the product as a tan crystalline solid (55 mg, 29%). Mp: 99.1–101.6 °C (methanol/water). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.62–1.69 (m, 4H), 2.46 (m, 2H), 2.67 (m, 4H), 2.80 (s, 3H), 3.11 (m, 4H), 3.44 (q, <i>J</i> 6.5 Hz, 2H), 3.86 (s, 3H), 4.06 (s, 3H), 5.66 (t, <i>J</i> 5.6 Hz, 1H, NH), 6.28 (s, 2H, NH<sub>2</sub>), 6.84–7.01 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 16.4 (CH<sub>3</sub>), 24.4 (CH<sub>2</sub>), 27.0 (CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.7 (CH<sub>2</sub>), 55.2 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 58.3 (CH<sub>2</sub>), 98.4 (C), 111.3 (CH), 116.6 (C), 118.4 (CH), 121.1 (CH), 121.3 (C), 123.1 (CH), 141.5 (C), 143.1 (C), 147.4 (C), 152.4 (C), 154.5 (C), 159.3 (C), 165.8 (C). HPLC purity (λ = 214 nm): 97%, <i>t</i><sub>R</sub> = 9.30 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 518.1993 calcd for C<sub>25</sub>H<sub>32</sub>ClN<sub>5</sub>O<sub>3</sub>S; found [M + H]<sup>+</sup> 518.2005.</div></div><div id="sec4_3_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 3-Amino-5-chloro-6-methoxy-<i>N</i>-(5-(4-(2-methoxyphenyl)piperazin-1-yl)pentyl)-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>34d</b>)</h3><div class="NLM_p last">Carboxylic acid <b>32</b> (100 mg, 0.367 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.067 mL, 0.385 mmol), and BOP (170 mg, 0.385 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (10 mL). <b>18d</b> (127 mg, 0.403 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide, and <i>N</i>,<i>N</i>-diisopropylethylamine (0.11 mL, 0.403 mmol) was then added to convert to the free base, which was added dropwise to the reaction mixture. The reaction mixture was then worked up as described in general procedure E to give the product as pale red microneedles (97 mg, 50%). Mp: 96–97.7 °C (methanol/water). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.43 (m, 2H), 1.56–1.69 (m, 4H), 2.43 (m, 2H), 2.66 (m, 4H), 2.83 (s, 3H), 3.10 (m, 4H), 3.42 (m, 2H), 3.86 (s, 3H), 4.07 (s, 3H), 5.44 (t, <i>J</i> 5.6 Hz, 1H, NH), 6.30 (br s, 2H, NH<sub>2</sub>), 6.84–7.02 (m, 4H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 16.4 (CH<sub>3</sub>), 25.1 (CH<sub>2</sub>), 26.7 (CH<sub>2</sub>), 29.9 (CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 50.8 (CH<sub>2</sub>), 53.6 (CH<sub>2</sub>), 55.2 (CH<sub>3</sub>), 55.5 (CH<sub>3</sub>), 58.7 (CH<sub>2</sub>), 98.3 (C), 111.3 (CH), 116.6 (C), 118.3 (CH), 121.1 (CH), 121.3 (C), 123.0 (CH), 141.5 (C), 143.1 (C), 147.4 (C), 152.4 (C), 154.4 (C), 159.3 (C), 165.8 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 9.84 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 532.2149 calcd for C<sub>26</sub>H<sub>34</sub>ClN<sub>5</sub>O<sub>3</sub>S; found [M + H]<sup>+</sup> 532.2166.</div></div><div id="sec4_3_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 3-Amino-5-chloro-<i>N</i>-(5-(4-(2,3-dichlorophenyl)piperazin-1-yl)pentyl)-6-methoxy-4-methylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Carboxylic acid 32 (80 mg, 0.293 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.05 mL, 0.308 mmol), and BOP (136 mg, 0.308 mmol) were added together. Compound <b>19</b>, which was Boc deprotected and isolated as the HCl salt (114 mg, 0.298 mmol), was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide, and <i>N</i>,<i>N</i>-diisopropylethylamine (0.05 mL) was then added to convert to the free base, which was added dropwise to the reaction mixture. The reaction mixture was then worked up as described in general procedure E to give the product as a beige solid (106 mg, 63%). Mp: 114.5–116.5 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.41 (m, 2H), 1.57–1.67 (m, 4H), 2.44 (m, 2H), 2.64 (m, 4H), 2.81 (s, 3H), 3.07 (m, 4H), 3.42 (m, 2H), 4.06 (s, 3H), 5.48 (t, <i>J</i> 5.7 Hz, 1H, NH), 6.30 (br s, 2H, NH<sub>2</sub>), 6.94 (dd, <i>J</i> 7.2, 2.4, 1H), 7.10–7.16 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 16.3 (CH<sub>3</sub>), 24.9 (CH<sub>2</sub>), 26.6 (CH<sub>2</sub>), 29.9 (CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 51.3 (CH<sub>2</sub>), 53.4 (CH<sub>2</sub>), 55.1 (CH<sub>3</sub>), 58.5 (CH<sub>2</sub>), 98.2 (C), 116.5 (C), 118.7 (CH), 121.2 (C), 124.6 (CH), 127.5 (CH), 127.5 (C), 134.1 (C), 143.0 (C), 147.3 (C), 151.4 (C), 154.3 (C), 159.2 (C), 165.7 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 11.66 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 570.1264 calcd for C<sub>25</sub>H<sub>30</sub>Cl<sub>3</sub>N<sub>5</sub>O<sub>2</sub>S; found [M + H]<sup>+</sup> 570.1265.</div></div><div id="sec4_3_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 3-Amino-<i>N</i>-(5-(4-(2,3-dichlorophenyl)piperazin-1-yl)pentyl)-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>36</b>)</h3><div class="NLM_p last">Carboxylic acid <b>25</b> (73 mg, 0.32 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.059 mL, 0.34 mmol), and BOP (150 mg, 0.34 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (2 mL). Compound <b>19</b>, which was Boc deprotected and isolated as the HCl salt (126 mg, 0.36 mmol), was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide and <i>N</i>,<i>N</i>-diisopropylethylamine (0.062 mL, 0.36 mmol) and then added to the reaction mixture. The reaction mixture was then worked up as described in general procedure E to give the product as a fluffy beige solid (119 mg, 70%). Mp: 142.9–143.8 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.42 (m, 2H), 1.57–1.67 (m, 4H), 2.44 (m, 2H), 2.58 (s, 3H), 2.63 (m, 4H), 2.73 (s, 3H), 3.07 (m, 4H), 3.42 (m, 2H), 5.59 (t, <i>J</i> 5.6, 1H, NH), 6.31 (br s, 2H, NH<sub>2</sub>), 6.86 (s, 1H), 6.94 (dd, <i>J</i> 7.0, 2.6 Hz, 1H), 7.10–7.15 (m, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 20.3 (CH<sub>3</sub>), 24.4 (CH<sub>3</sub>), 24.9 (CH<sub>2</sub>), 26.6 (CH<sub>2</sub>), 29.9 (CH<sub>2</sub>), 39.7 (CH<sub>2</sub>), 51.4 (CH<sub>2</sub>), 53.4 (CH<sub>2</sub>), 58.5 (CH<sub>2</sub>), 98.6 (C), 118.7 (CH), 122.3 (CH), 123.7 (C), 124.6 (CH), 127.5 (CH), 127.6 (C), 134.1 (C), 143.7 (C), 147.3 (C),151.4 (C), 159.0 (C), 159.1 (C), 165.9 (C). HPLC purity (λ = 214 nm): 99%, <i>t</i><sub>R</sub> = 10.13 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 520.1705 calcd for C<sub>25</sub>H<sub>31</sub>Cl<sub>2</sub>N<sub>5</sub>OS; found [M + H]<sup>+</sup> 520.1703.</div></div><div id="sec4_3_3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 3-Amino-<i>N</i>-(5-(4-(2-methoxyphenyl)piperazin-1-yl)pentyl)-4,6-dimethylthieno[2,3-<i>b</i>]pyridine-2-carboxamide (<b>37</b>)</h3><div class="NLM_p last">Carboxylic acid <b>25</b> (80 mg, 0.36 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.066 mL, 0.38 mmol), and BOP (167 mg, 0.38 mmol) were added to <i>N</i>,<i>N</i>-dimethylformamide (2 mL). <b>18d</b> (124 mg, 0.40 mmol) was dissolved in 2 mL of <i>N</i>,<i>N</i>-dimethylformamide and <i>N</i>,<i>N</i>-diisopropylethylamine (0.069 mL, 0.40 mmol) and then added to the reaction mixture. The reaction mixture was then worked up as described in general procedure E to give the product as a yellow-orange solid (66 mg, 38%). Mp: 127.6–128.2 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 1.42 (m, 2H), 1.57–1.67 (m, 4H), 2.53 (m, 2H), 2.58 (s, 3H), 2.72 (s, 3H), 2.77 (m, 4H), 3.14 (m, 4H), 3.40 (m, 2H), 3.85 (s, 3H), 5.64 (t, <i>J</i> 5.7, 1H, NH), 6.30 (br s, 2H, NH<sub>2</sub>), 6.84–7.02 (m, 5H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 20.2 (CH<sub>3</sub>), 24.4 (CH<sub>3</sub>), 24.8 (CH<sub>2</sub>), 26.1 (CH<sub>2</sub>), 29.8 (CH<sub>2</sub>), 39.6 (CH<sub>2</sub>), 50.2 (CH<sub>2</sub>), 53.5 (CH<sub>2</sub>), 55.5 (CH<sub>3</sub>), 58.5 (CH<sub>2</sub>), 98.7 (C), 111.3 (CH), 118.4 (CH), 121.1 (CH), 122.3 (CH), 123.2 (CH), 123.7 (C), 141.0 (C), 143.7 (C), 147.3 (C), 152.3 (C), 159.0 (C), 159.1 (C), 166.0 (C). HPLC purity (λ = 214 nm): 97%, <i>t</i><sub>R</sub> = 8.89 min. HRMS (ESI) TOF (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> 482.2590 calcd for C<sub>26</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub>S; found [M + H]<sup>+</sup> 482.2590.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Pharmacology. Cell Lines and Transfection</h3><div class="NLM_p last">FlpIn CHO cells (Invitrogen) were grown in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and maintained at 37 °C in a humidified incubator containing 5% CO<sub>2</sub>. The FlpIn CHO cells were transfected with the pOG44 vector encoding Flp recombinase and the pDEST vector encoding the wild-type long isoform of the human D<sub>2</sub> receptor (D<sub>2L</sub>R) at a ratio of 9:1 using polyethylenimine as the transfection reagent. At 24 h after transfection, the cells were subcultured, and the medium was supplemented with 700 μg/mL HygroGold as a selection agent. Cells were grown and maintained in DMEM containing 20 mM HEPES, 5% fetal bovine serum, and 200 μg/mL hygromycin B. Cells were maintained at 37 °C in a humidified incubator containing 5% CO<sub>2</sub> and 95% O<sub>2</sub>.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Preparation of FlpIN CHO Cell Membranes</h3><div class="NLM_p last">When cells were approximately 90% confluent, they were harvested and centrifuged (300<i>g</i>, 3 min). The resulting pellet was resuspended in assay buffer (20 mM HEPES, 100 mM NaCl, 6 mM MgCl<sub>2</sub>, 1 mM EGTA, and 1 mM EDTA, pH 7.4), and the centrifugation procedure was repeated. The intact cell pellet was then resuspended in assay buffer and homogenized using a Polytron homogenizer for three 10 s intervals on the maximum setting, with 30 s periods on ice between each burst. The homogenate volume was brought up to 30 mL. The sample was centrifuged (1000<i>g</i>, 10 min, 25 °C). The pellet was discarded, and the supernatant was recentrifuged at 30 000<i>g</i> for 1 h at 4 °C. The resulting pellet was resuspended in 5 mL of assay buffer, and the protein content was determined using the method of Bradford. The homogenate was then separated into 0.5 mL aliquots and stored frozen at −80 °C until it was required for binding assays.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> [<sup>3</sup>H]Spiperone Binding Assay</h3><div class="NLM_p last">Cell membranes (D<sub>2L</sub>-FlpIn CHO, 3 μg) were incubated with varying concentrations of test compound in binding buffer (20 mM HEPES, 100 mM NaCl, 6 mM MgCl<sub>2</sub>, 1 mM EGTA, and 1 mM EDTA, pH 7.4) containing 0.05 nM of [<sup>3</sup>H]spiperone and 100 μM GppNHp to a final volume of 1 mL and were incubated at 37 °C for 3 h. Binding was terminated by fast-flow filtration over GF/B membranes using a Brandel harvester followed by three washes with ice-cold 0.9% NaCl. Bound radioactivity was measured in a Tri-Carb 2900TR liquid scintillation counter (PerkinElmer).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> ERK1/2 Phosphorylation Assay</h3><div class="NLM_p last">FlpIn CHO cells stably expressing the D<sub>2L</sub>R were seeded into 96-well plates at a density of 50 000 cells/well. After 5 h, cells were washed with phosphate buffered saline (PBS) and incubated in serum-free DMEM overnight before assaying. Initially, time-course experiments were conducted at least twice for each ligand to determine the time required to maximally promote ERK1/2 phosphorylation via the dopamine D<sub>2L</sub>R. Dose–response experiments were performed in the absence and presence of increasing concentrations of each ligand at 37 °C. Stimulation of the cells was terminated by removing the media followed by the addition of 100 μL of SureFire lysis buffer (PerkinElmer) to each well. The plate was shaken for 5 min at room temperature before transferring 5 μL of the lysates to a white 384-well Proxiplate (PerkinElmer). Then 8 μL of a 240:1440:7:7 mixture of Surefire activation buffer/Surefire reaction buffer/Alphascreen acceptor beads/Alphascreen donor beads was added to the samples and incubated in the dark at 37 °C for 1.5 h. Plates were read using a Fusion plate reader.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> cAMP Accumulation Assays</h3><div class="NLM_p last">The cells were grown and incubated overnight and then preincubated for 45 min in 80 μL of stimulation buffer (Hank’s buffered salt solution: 0.14 M NaCl, 5.4 mM KCl, 0.8 μM MgSO<sub>4</sub>, 1.3 mM CaCl<sub>2</sub>, 0.2 mM Na<sub>2</sub>HPO<sub>4</sub>, 0.44 mM KH<sub>2</sub>PO<sub>4</sub>, 5.6 mM <span class="smallcaps smallerCapital">d</span>-glucose, 1 mg/mL BSA, 0.5 mM 3-isobutyl-1-methylxanthine, and 5 mM HEPES, pH 7.4). The agonists (10 μL) and 300 nM forskolin (10 μL) were added simultaneously to the cells and incubated for 30 min at 37 °C. Stimulation was terminated via the removal of the stimulation buffer and addition of 50 μL of ice cold 100% ethanol. The plates were then incubated at 37 °C to allow evaporation of the ethanol. Then 50 μL of detection buffer (1 mg/mL BSA, 0.3% Tween-20, and 5 mM HEPES, pH 7.4) was added and 5 μL of each well transferred to a 384-well Optiplate (PerkinElmer, Waltham, MA, U.S.). Anti-cAMP acceptor beads (0.2 units/μL) diluted in stimulation buffer was added under green light for 30 min before the addition of 15 μL of the donor beads/biotinylated cAMP (0.07 units/μL) diluted in detection buffer. The plates were incubated for 1 h at room temperature and read using a Fusion-α plate reader using AlphaScreen presettings.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Inhibition Assays for Analogues <b>5</b>, <b>18a</b>, and <b>18e</b></h3><div class="NLM_p last">The required analogues were added to the cells at the appropriate dilutions and incubated at 37 °C for 30 min before the addition of 10 nM dopamine. After an additional 5 min stimulation time, termination of the ERK1/2 phosphorylation was as stated above.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Concentration–Response Assays for Analogues <b>18b</b>–<b>d</b>, <b>19</b>, <b>34d</b>, <b>35</b>, and <b>36</b></h3><div class="NLM_p last">The required analogues were added to the cells at the appropriate dilutions and incubated at 37 °C for 5–10 min as predetermined for each compound in the time-course assays. Termination of the ERK1/2 phosphorylation was as stated above.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Interaction Studies with Dopamine for Compounds <b>34a</b>–<b>e</b></h3><div class="NLM_p last">The required analogues and dopamine were added to the cells simulataneously at the appropriate dilutions and incubated at 37 °C for 5 min. Termination of the ERK1/2 phosphorylation was as stated above.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Data Analysis</h3><div class="NLM_p">Computerized nonlinear regression was performed using Prism 6.0 (GraphPad Software, San Diego, CA).</div><div class="NLM_p">Agonist concentration–response curves were fitted via nonlinear regression to the three-parameter logistic function (eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>):<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/jm-2014-00457x_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>E</i> is response, <i>E</i><sub>max</sub> and basal are the top and bottom asymptotes of the curve, respectively, log[A] is the logarithm of the agonist concentration, and pEC<sub>50</sub> is the negative logarithm of the agonist concentration that gives a response halfway between <i>E</i><sub>max</sub> and basal.</div><div class="NLM_p">To compare agonist profiles and quantify stimulus bias, agonist concentration–response curves were fitted to the following form of the operational model of agonism (eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a>):<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/jm-2014-00457x_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>E</i><sub>m</sub> is the maximal possible response of the system; basal is the basal level of response; <i>K</i><sub>A</sub> denotes the equilibrium dissociation constant of the agonist (A); τ is an index of the signaling efficacy of the agonist and is defined as <i>R</i><sub>T</sub>/<i>K</i><sub>E</sub>, where <i>R</i><sub>T</sub> is the total number of receptors and <i>K</i><sub>E</sub> is the coupling efficiency of each agonist-occupied receptor; and <i>n</i> is the slope of the transducer function that links occupancy to response. The analysis assumes that the maximal system responsiveness (<i>E</i><sub>m</sub>) and the transduction machinery utilized for a given cellular pathway are the same for all agonists such that the <i>E</i><sub>m</sub> and transducer slope (<i>n</i>) are shared between agonists. The ratio τ/<i>K</i><sub>A</sub> (determined as a logarithm, i.e., log(τ/<i>K</i><sub>A</sub>)) is referred to herein as the “transduction coefficient”, as this composite parameter is sufficient to describe agonism and bias for a given pathway; i.e., stimulus-biased agonism can result from either a selective affinity (<i>K</i><sub>A-1</sub>) of an agonist for a given receptor state(s) and/or a differential coupling efficacy (τ) toward certain pathways. To cancel the impact of cell-dependent effects on the observed agonism at each pathway, the log(τ/<i>K</i><sub>A</sub>) values were then normalized to that determined for the endogenous agonist dopamine at each pathway to yield a “normalized transduction coefficient”, Δlog(τ/<i>K</i><sub>A</sub>), i.e., Δlog(τ/<i>K</i><sub>A</sub>) = log(τ/<i>K</i><sub>A</sub>)<sub>test</sub> – log(τ/<i>K</i><sub>A</sub>)<sub>dopamine</sub>.</div><div class="NLM_p last">To determine the actual bias of each agonist for different signaling pathways, the Δlog(τ/<i>K</i><sub>A</sub>) values were evaluated statistically between the pathways. The ligand bias of an agonist for one pathway, j1, over another, j2 is given as (eq <a class="ref internalNav" href="#eq3" aria-label="3">3</a>)<span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/jm-2014-00457x_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>A lack of stimulus bias compared to a reference agonist (in this case dopamine) will result in values of ΔΔlog(τ/<i>K</i><sub>A</sub>) not significantly different from 0 between pathways. To account for the propagation of error associated with the determination of composite parameters, eq <a class="ref internalNav" href="#eq5" aria-label="5">5</a> was used:<span class="NLM_disp-formula" id="eq4"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/jm-2014-00457x_m004.gif" alt="" /></img><span class="labelSpan">(4)</span></span>where σ is the standard deviation and <i>n</i> is the number of experiments,<span class="NLM_disp-formula" id="eq5"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/jm-2014-00457x_m005.gif" alt="" /></img><span class="labelSpan">(5)</span></span>All affinity, potency, and transduction ratio parameters were estimated as logarithms. All results are expressed as the mean ± SEM. Statistical analyses were performed where appropriate using one-way ANOVA with the Tukey’s post hoc test. Statistical significance was taken as <i>p</i> < 0.05. For a more detailed explanation and analysis of using bias calculations see van der Westhuizen et al.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/jm500457x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Values of potency (pEC<sub>50</sub>) and maximal stimulation (<i>E</i><sub>max</sub>) for dopamine, aripiprazole, <b>18d</b>, <b>19</b>, <b>34d</b>, and <b>35</b>–<b>37</b> for cAMP and pERK1/2 signaling assays; full experimental and characterization of compounds <b>13d</b>–<b>e</b>, <b>16b</b>, <b>17b</b>–<b>d</b>, <b>18a</b>,<b>c</b>,<b>e</b>, <b>33b</b>–<b>d</b>, <b>34a</b>,<b>b</b>,<b>e</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500457x/suppl_file/jm500457x_si_001.pdf">jm500457x_si_001.pdf (212.76 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500457x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Robert Lane</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry and ‡Drug Discovery
Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville 3052, Victoria, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#96e4f9f4b8faf7f8f3d6fbf9f8f7e5feb8f3f2e3"><span class="__cf_email__" data-cfemail="b4c6dbd69ad8d5dad1f4d9dbdad5c7dc9ad1d0c1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Capuano</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry and ‡Drug Discovery
Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville 3052, Victoria, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c4a6a1aaeaa7a5b4b1a5aaab84a9abaaa5b7aceaa1a0b1"><span class="__cf_email__" data-cfemail="d0b2b5befeb3b1a0a5b1bebf90bdbfbeb1a3b8feb5b4a5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monika Szabo</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry and ‡Drug Discovery
Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Klein Herenbrink</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry and ‡Drug Discovery
Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arthur Christopoulos</span> - <span class="hlFld-Affiliation affiliation">†Medicinal Chemistry and ‡Drug Discovery
Biology, Monash Institute of Pharmaceutical
Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d135e5033-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by Project Grants 1049564 and 1011920 of the National Health and Medical Research Council (NHMRC). A.C. is a Principle Research Fellow (NHMRC). J.R.L. is a R. D. Wright Biomedical Career Development Fellow (Grant 1052304, NHMRC) and a Larkin’s Fellow (Monash University, Australia). M.S. acknowledges an Australian postgraduate award. C.K.H. acknowledges a Monash graduate scholarship. Special thanks are given to Dr. Jason Dang for running HRMS on final compounds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">FSK</td><td class="NLM_def"><p class="first last">forskolin</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Missale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Dopamine receptors: from structure to function</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1152%2Fphysrev.1998.78.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=9457173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=189-225&author=C.+Missaleauthor=S.+R.+Nashauthor=S.+W.+Robinsonauthor=M.+Jaberauthor=M.+G.+Caron&title=Dopamine+receptors%3A+from+structure+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptors: from structure to function</span></div><div class="casAuthors">Missale, Cristina; Nash, S. Russel; Robinson, Susan W.; Jaber, Mohamed; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-225</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The diverse physiol. actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes.  Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase.  The other receptor subtypes belong to the D2-like subfamily (D2, D3, and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels.  The genes for the D1 and D5 receptors are intron-less, but pseudogenes of the D5 exist.  The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation.  In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion.  In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion.  Numerous genetic linkage anal. studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiol. of various central nervous system disorders.  However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaajNmBxnkYbVg90H21EOLACvtfcHk0lhb99P8JFF9hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D&md5=a505d0e2c640ca205d4470ad69f607ff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1998.78.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1998.78.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DMissale%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DS.%2BR.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDopamine%2520receptors%253A%2520from%2520structure%2520to%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D1998%26volume%3D78%26spage%3D189%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Targeting the dopamine D2 receptor in schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1517%2F14728222.10.4.515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=16848689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-531&author=P.+Seeman&title=Targeting+the+dopamine+D2+receptor+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dopamine D2 receptor in schizophrenia</span></div><div class="casAuthors">Seeman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  After a 12-yr search for the antipsychotic receptor, the binding site was discovered and labeled by [3H]haloperidol in 1975.  Of the various neurotransmitters, dopamine was the most potent in inhibiting the binding of [3H]haloperidol, indicating that the antipsychotic receptor was a dopamine receptor, now named the dopamine D2 receptor, a major targeting site in schizophrenia.  All antipsychotic drugs, including traditional and newer antipsychotics, either bind to D2 in direct relation to their clin. potencies or hinder normal dopamine neurotransmission, as in the case of partial dopamine agonists.  In fact, the antipsychotic concns. found in the plasma water of treated patients closely match the predicted therapeutic abs. concns., adjusted for the 60-75% D2 occupancy needed for clin. efficacy.  Antipsychotics that elicit low or no Parkinsonism or prolactinemia are loosely attached to D2 and rapidly dissoc. from D2, whereas those eliciting Parkinsonism stay tightly attached to D2 for many hours.  Because animal models of psychosis (amfetamine sensitization, brain lesions) all show a marked elevation in the no. of high-affinity states of D2, the antipsychotics are thought to specifically target these D2High states in psychosis in general and schizophrenia in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGjVyTQvf6orVg90H21EOLACvtfcHk0ljtH-xTeNKOhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D&md5=4ac073cabc6f50e8d0e3a2ecc631e781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.4.515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.4.515%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520dopamine%2520D2%2520receptor%2520in%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Shin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F092986711795029546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1380-1404&author=J.+K.+Shinauthor=D.+T.+Maloneauthor=I.+T.+Crosbyauthor=B.+Capuano&title=Schizophrenia%3A+a+systematic+review+of+the+disease+state%2C+current+therapeutics+and+their+molecular+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action</span></div><div class="casAuthors">Shin, J. K.; Malone, D. T.; Crosby, I. T.; Capuano, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1380-1404</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The treatment of schizophrenia, one of the most debilitating mental illnesses, began by the serendipitous discovery of chlorpromazine.  Since then, researchers have endeavored to find the cause of the illness but it remains unresolved.  As a result, literature on the etiol. of schizophrenia is littered with hypotheses and theories that are constantly reviewed, modified and rejected.  Two hypotheses, however, have withstood the test of time and serve as the basis for the drug treatment, namely the dopamine and serotonin hypotheses.  This review introduces the disease state, summarizes in detail the two leading hypotheses on schizophrenia, presents drugs that are currently available for treatment, and discusses some of the promising drug candidates based on their pre and early clin. trial results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEW2ubYcABYbVg90H21EOLACvtfcHk0ljtH-xTeNKOhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOrsrw%253D&md5=a3076e349c481ddd8926495b6435c4a1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986711795029546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795029546%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BK.%26aulast%3DMalone%26aufirst%3DD.%2BT.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DSchizophrenia%253A%2520a%2520systematic%2520review%2520of%2520the%2520disease%2520state%252C%2520current%2520therapeutics%2520and%2520their%2520molecular%2520mechanisms%2520of%2520action%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1380%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Tandon, R.</span><span> </span><span class="NLM_article-title">Pharmacologic treatment of schizophrenia: current status and future trends</span> <span class="citation_source-journal">Curr. Psychosis Ther. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1007%2FBF02629413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=40-49&author=R.+Tandon&title=Pharmacologic+treatment+of+schizophrenia%3A+current+status+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF02629413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02629413%26sid%3Dliteratum%253Aachs%26aulast%3DTandon%26aufirst%3DR.%26atitle%3DPharmacologic%2520treatment%2520of%2520schizophrenia%253A%2520current%2520status%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Psychosis%2520Ther.%2520Rep.%26date%3D2006%26volume%3D4%26spage%3D40%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Rosen, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span> </span><span class="NLM_article-title">Positive and negative symptoms in schizophrenia</span> <span class="citation_source-journal">Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1016%2F0165-1781%2884%2990075-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A280%3ADyaL2M7htlKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1984&pages=277-284&author=W.+G.+Rosenauthor=R.+C.+Mohsauthor=C.+A.+Johnsauthor=N.+S.+Smallauthor=K.+S.+Kendlerauthor=T.+B.+Horvathauthor=K.+L.+Davis&title=Positive+and+negative+symptoms+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Positive and negative symptoms in schizophrenia</span></div><div class="casAuthors">Rosen W G; Mohs R C; Johns C A; Small N S; Kendler K S; Horvath T B; Davis K L</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-84</span>
        ISSN:<span class="NLM_cas:issn">0165-1781</span>.
    </div><div class="casAbstract">Negative and positive symptoms were determined for 46 drug-free patients who met Research Diagnostic Criteria (RDC) and/or Feighner criteria for schizophrenia.  A modified version of the Scale for the Assessment of Negative Symptoms (SANS) was completed for each patient based on items from the Schedule for Affective Disorders and Schizophrenia (SADS) and other scales.  Positive symptoms were scored from the SADS as well as from the following four diagnostic systems: RDC, Schneider's first-rank symptoms, the 12-point Flexible system, and Langfeldt's criteria for poor prognosis schizophrenia.  For all patients, there was no correlation of negative symptoms and positive symptoms defined by any diagnostic system.  Within the paranoid and undifferentiated subtypes, there was a positive correlation of positive and negative symptoms.  Patients moving from stable to exacerbated states had an increase in both positive and negative symptoms, and patients with a poor history of treatment response had both more positive and more negative symptoms than responsive patients in a stable state.  These results do not support the view that subgroups of patients have predominantly either negative or positive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPLmAVPmDrAkEksK8CslK8fW6udTcc2eao-iBg95xItbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7htlKltA%253D%253D&md5=65e3b85232c14cfb0b901c82a8484890</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-1781%2884%2990075-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1781%252884%252990075-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DW.%2BG.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DJohns%26aufirst%3DC.%2BA.%26aulast%3DSmall%26aufirst%3DN.%2BS.%26aulast%3DKendler%26aufirst%3DK.%2BS.%26aulast%3DHorvath%26aufirst%3DT.%2BB.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26atitle%3DPositive%2520and%2520negative%2520symptoms%2520in%2520schizophrenia%26jtitle%3DPsychiatry%2520Res.%26date%3D1984%26volume%3D13%26spage%3D277%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, T.</span><span> </span><span class="NLM_article-title">Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1<i>H</i>)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=8613910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaK28XitlCmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=137-143&author=T.+Inoueauthor=M.+Domaeauthor=K.+Yamadaauthor=T.+Furukawa&title=Effects+of+the+novel+antipsychotic+agent+7-%284-%5B4-%282%2C3-dichlorophenyl%29-1-piperazinyl%5Dbutyloxy%29-3%2C4-dihydro-2%281H%29-quinolinone+%28OPC-14597%29+on+prolactin+release+from+the+rat+anterior+pituitary+gland"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the novel antipsychotic agent 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland</span></div><div class="casAuthors">Inoue, Tsutomu; Domae, Mariko; Yamada, Katsushi; Furukawa, Tatsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-43</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of a novel antipsychotic agent, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597, generic name aripiprazole), on prolactin (PRL) release from isolated rat anterior pituitary slices and on the serum PRL levels were investigated in male rats.  In in vitro expts. on the isolated anterior pituitary, the spontaneous PRL release was decreased by talipexole, a dopamine D2 receptor full agonist, in a dose-dependent manner to 36% of the basal release, and the decrease was antagonized by haloperidol, a D2 receptor antagonist.  OPC-14597 also decreased the release of PRL at the same concn. range with a maximal decrease to 78%, the potency being weaker than that of talipexole.  The decrease in PRL release induced by OPC-14597 was completely antagonized by haloperidol.  Moreover, OPC-14597 antagonized the inhibition of PRL release induced by talipexole.  In in vivo expts., haloperidol increased the serum PRL levels to 8 times the basal PRL level, whereas talipexole decreased the levels to 40% of the basal level.  OPC-14597 increased the serum PRL levels by 2-fold and also antagonized the talipexole-induced decrease.  The hyperprolactinemia induced by estrogen, which was inhibited by talipexole but enhanced by haloperidol was enhanced by OPC-14597, whereas the hyperprolactinemia induced by reserpine, which was inhibited by talipexole but elevated by haloperidol, was inhibited by OPC-14597.  In addn., the OPC-14597-induced inhibition was antagonized by haloperidol.  These results suggest that OPC-14597 has a mixed agonist/antagonist profile at D2 receptors on lactotroph cells and thereby exerts either an antagonistic or an agonistic action, depending on the preexisting tone of the dopaminergic neuronal activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqupnFWqRH-zrVg90H21EOLACvtfcHk0lhtpThPH5mAiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlCmtr0%253D&md5=bdc1a55d2462cc975961396ecb7e476c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DDomae%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DFurukawa%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520novel%2520antipsychotic%2520agent%25207-%25284-%255B4-%25282%252C3-dichlorophenyl%2529-1-piperazinyl%255Dbutyloxy%2529-3%252C4-dihydro-2%25281H%2529-quinolinone%2520%2528OPC-14597%2529%2520on%2520prolactin%2520release%2520from%2520the%2520rat%2520anterior%2520pituitary%2520gland%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprivica, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altar, C. A.</span><span> </span><span class="NLM_article-title">The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1016%2FS0014-2999%2802%2901532-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=12063084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2002&pages=137-140&author=S.+Jordanauthor=V.+Koprivicaauthor=R.+Chenauthor=K.+Tottoriauthor=T.+Kikuchiauthor=C.+A.+Altar&title=The+antipsychotic+aripiprazole+is+a+potent%2C+partial+agonist+at+the+human+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor</span></div><div class="casAuthors">Jordan, Shaun; Koprivica, Vuk; Chen, Ruoyan; Tottori, Katsura; Kikuchi, Tetsuro; Altar, C. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-140</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aripiprazole, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT1A receptors (h5-HT1A) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT1A receptors in a guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]GTPγS)-binding assay that was blocked completely by a selective 5-HT1A receptor antagonist.  An interaction with 5-HT1A receptors may contribute to the overall efficacy of aripiprazole against symptoms of schizophrenia, including anxiety, depression, cognitive and neg. symptoms, and to its favorable side-effect profile.  Combined with previous studies demonstrating the potent partial agonism of aripiprazole at dopamine D2 receptors, this study suggests aripiprazole is the first dopamine-serotonin system stabilizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJJO4Wtm_rYLVg90H21EOLACvtfcHk0lhtpThPH5mAiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVSiurg%253D&md5=61ef193ae9b08505e8ea0ba1c0d54f32</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901532-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901532-7%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DKoprivica%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DAltar%26aufirst%3DC.%2BA.%26atitle%3DThe%2520antipsychotic%2520aripiprazole%2520is%2520a%2520potent%252C%2520partial%2520agonist%2520at%2520the%2520human%25205-HT1A%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D441%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Shapiro, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodo, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R.</span><span> </span><span class="NLM_article-title">Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1400-1411&author=D.+A.+Shapiroauthor=S.+Renockauthor=E.+Arringtonauthor=L.+A.+Chiodoauthor=L.-X.+Liuauthor=D.+R.+Sibleyauthor=B.+L.+Rothauthor=R.+Mailman&title=Aripiprazole%2C+a+novel+atypical+antipsychotic+drug+with+a+unique+and+robust+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DArrington%26aufirst%3DE.%26aulast%3DChiodo%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DL.-X.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMailman%26aufirst%3DR.%26atitle%3DAripiprazole%252C%2520a%2520novel%2520atypical%2520antipsychotic%2520drug%2520with%2520a%2520unique%2520and%2520robust%2520pharmacology%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1400%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Partial dopamine agonists in the treatment of psychosis</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=411-420&author=C.+A.+Tamminga&title=Partial+dopamine+agonists+in+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DPartial%2520dopamine%2520agonists%2520in%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2002%26volume%3D109%26spage%3D411%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0lg9ak3m0oOJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=23411724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+bias+in+new+drug+discovery%3A+detection%2C+quantification+and+therapeutic+impact"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span></div><div class="casAuthors">Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agonists of seven-transmembrane receptors, also known as G protein-coupled receptors (GPCRs), do not uniformly activate all cellular signalling pathways linked to a given seven-transmembrane receptor (a phenomenon termed ligand or agonist bias); this discovery has changed how high-throughput screens are designed and how lead compds. are optimized for therapeutic activity.  The ability to exptl. detect ligand bias has necessitated the development of methods for quantifying agonist bias in a way that can be used to guide structure-activity studies and the selection of drug candidates.  Here, we provide a viewpoint on which methods are appropriate for quantifying bias, based on knowledge of how cellular and intracellular signalling proteins control the conformation of seven-transmembrane receptors.  We also discuss possible predictions of how biased mols. may perform in vivo, and what potential therapeutic advantages they may provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDNsO17tty7Vg90H21EOLACvtfcHk0lg9ak3m0oOJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D&md5=712258b9158f753689e35fa31f1b67f0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520bias%2520in%2520new%2520drug%2520discovery%253A%2520detection%252C%2520quantification%2520and%2520therapeutic%2520impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Stallaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1517%2F17460441.2011.586691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=22651124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVKqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=811-825&author=W.+Stallaertauthor=A.+Christopoulosauthor=M.+Bouvier&title=Ligand+functional+selectivity+and+quantitative+pharmacology+at+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors</span></div><div class="casAuthors">Stallaert, Wayne; Christopoulos, Arthur; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">811-825</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: In recent years, it has become clear that individual GPCRs can elicit multiple G-protein-dependent and -independent cellular responses.  This has led to the discovery that certain ligands can differentially modulate these responses, a concept known as functional selectivity.  Areas covered: In this review, the authors describe the various manifestations of functional selectivity and its potential implication in drug discovery.  The authors provide a historical perspective of the observations and methodologies that led to the evolution of this concept.  The authors also describe the proposed mol. mechanisms responsible for the engagement of distinct subsets of signaling repertoire by different ligands.  The review offers the reader a synthetic view of how functional selectivity could be used in the design of safer and more effective drugs.  Expert opinion: Our better understanding of the various ways by which compds. modulate GPCR activity has led to a parallel expansion of the terminol. used to describe these phenomena.  The authors propose a standardization of this nomenclature as an essential step to both simplify and clarify the language used among researchers to facilitate future collaboration and discovery of these important therapeutic targets.  Such clarification of the various aspects of functional selectivity, coupled with the development of tools for effective monitoring, will undoubtedly bring this emerging concept into the general paradigm of drug discovery at GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooWYzSGmiOs7Vg90H21EOLACvtfcHk0lg9ak3m0oOJWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVKqsrY%253D&md5=43d46becf067f93a4f209284aa47e27b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.586691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.586691%26sid%3Dliteratum%253Aachs%26aulast%3DStallaert%26aufirst%3DW.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DLigand%2520functional%2520selectivity%2520and%2520quantitative%2520pharmacology%2520at%2520G%2520protein-coupled%2520receptors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D811%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D32%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-p.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-p.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+%CE%B2-arrestin-biased+dopamine+D2+ligands+for+probing+signal+transduction+pathways+essential+for+antipsychotic+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520ligands%2520for%2520probing%2520signal%2520transduction%2520pathways%2520essential%2520for%2520antipsychotic%2520efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Structure–functional selectivity relationship studies of β-arrestin-biased dopamine D2 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7141</span><span class="NLM_x">–</span> <span class="NLM_lpage">7153</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure%E2%80%93functional+selectivity+relationship+studies+of+%CE%B2-arrestin-biased+dopamine+D2+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593functional%2520selectivity%2520relationship%2520studies%2520of%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gay, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=97-105&author=E.+A.+Gayauthor=J.+D.+Urbanauthor=D.+E.+Nicholsauthor=G.+S.+Oxfordauthor=R.+B.+Mailman&title=Functional+selectivity+of+D2+receptor+ligands+in+a+Chinese+hamster+ovary+hD2L+cell+line%3A+evidence+for+induction+of+ligand-specific+receptor+states"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DE.%2BA.%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520D2%2520receptor%2520ligands%2520in%2520a%2520Chinese%2520hamster%2520ovary%2520hD2L%2520cell%2520line%253A%2520evidence%2520for%2520induction%2520of%2520ligand-specific%2520receptor%2520states%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Mottola, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottolaauthor=J.+D.+Kiltsauthor=M.+M.+Lewisauthor=H.+S.+Conneryauthor=Q.+D.+Walkerauthor=S.+R.+Jonesauthor=R.+G.+Boothauthor=D.+K.+Hyslopauthor=M.+Pierceyauthor=R.+M.+Wightmanauthor=C.+P.+Lawlerauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0liZZQw9lVh-yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DWalker%26aufirst%3DQ.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DPiercey%26aufirst%3DM.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=575-585&author=N.+Tschammerauthor=S.+Bollingerauthor=T.+Kenakinauthor=P.+Gmeiner&title=Histidine+6.55+is+a+major+determinant+of+ligand-biased+signaling+in+dopamine+D2L+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHistidine%25206.55%2520is%2520a%2520major%2520determinant%2520of%2520ligand-biased%2520signaling%2520in%2520dopamine%2520D2L%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D575%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herenbrink, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">A structure–activity analysis of biased agonism at the dopamine D2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9199</span><span class="NLM_x">–</span> <span class="NLM_lpage">9221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+L%C3%B3pezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure%E2%80%93activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure%25E2%2580%2593activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">DeSimone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span> </span><span class="NLM_article-title">Privileged structures: applications in drug discovery</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F1386207043328544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=15320713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=473-493&author=R.+W.+DeSimoneauthor=K.+S.+Currieauthor=S.+A.+Mitchellauthor=J.+W.+Darrowauthor=D.+A.+Pippin&title=Privileged+structures%3A+applications+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: Applications in drug discovery</span></div><div class="casAuthors">DeSimone, R. W.; Currie, K. S.; Mitchell, S. A.; Darrow, J. W.; Pippin, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-493</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 15 yr the privileged structure concept has emerged as a fruitful approach to the discovery of novel biol. active mols.  Privileged structures are mol. scaffolds with versatile binding properties, such that a single scaffold is able to provide potent and selective ligands for a range of different biol. targets through modification of functional groups.  In addn., privileged structures typically exhibit good drug-like properties, which in turn leads to more drug-like compd. libraries and leads.  The net result is the prodn. of high quality leads that provide a solid foundation for further development.  The identification of privileged structures will be discussed, emphasizing the importance of understanding the structure-target relationships that confer "privileged" status.  This understanding allows privileged structure based libraries to be targeted at distinct target families (e.g. GPCRs, LGIC, enzymes/kinases).  Privileged structures have been successfully exploited across and within different target families and promises to be an effective approach to the discovery and optimization of novel bioactive mols.  The application of the privileged structure approach, both in traditional medicinal chem. and in the design of focused libraries, will be discussed with the aid of illustrative examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIDSZoRtfibVg90H21EOLACvtfcHk0lid7NwqbK-g3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D&md5=165b976f9d6c6d38d752cabf2c647a48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1386207043328544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328544%26sid%3Dliteratum%253Aachs%26aulast%3DDeSimone%26aufirst%3DR.%2BW.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26atitle%3DPrivileged%2520structures%253A%2520applications%2520in%2520drug%2520discovery%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D473%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Privileged structures as leads in medicinal chemistry</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=381-422&author=L.+Costantinoauthor=D.+Barlocco&title=Privileged+structures+as+leads+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DPrivileged%2520structures%2520as%2520leads%2520in%2520medicinal%2520chemistry%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D5%26spage%3D381%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Duarte, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A. M.</span><span> </span><span class="NLM_article-title">Privileged structures: a useful concept for the rational design of new lead drug candidates</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F138955707782331722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=18045214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlarur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1108-1119&author=C.+D.+Duarteauthor=E.+J.+Barreiroauthor=C.+A.+M.+Fraga&title=Privileged+structures%3A+a+useful+concept+for+the+rational+design+of+new+lead+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: a useful concept for the rational design of new lead drug candidates</span></div><div class="casAuthors">Duarte, Carolina D.; Barreiro, Eliezer J.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1108-1119</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Privileged structures are defined as mol. frameworks which are able of providing useful ligands for more than one type of receptor or enzyme target by judicious structural modifications.  In the present work, we describe some examples and applications of the usefulness of the privileged structure concept for the structural design of new drug candidates, by discussing the eligibility of such motifs, including the identification of the N-acylhydrazone template as privileged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kVveFXlhk7Vg90H21EOLACvtfcHk0lid7NwqbK-g3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlarur7E&md5=26644458b92e31309de84f61ea6a2120</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138955707782331722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955707782331722%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DC.%2BD.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DPrivileged%2520structures%253A%2520a%2520useful%2520concept%2520for%2520the%2520rational%2520design%2520of%2520new%2520lead%2520drug%2520candidates%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1108%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bondensgaard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bywater, R. P.</span><span> </span><span class="NLM_article-title">Recognition of privileged structures by G-protein coupled receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0309452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=888-899&author=K.+Bondensgaardauthor=M.+Ankersenauthor=H.+Th%C3%B8gersenauthor=B.+S.+Hansenauthor=B.+S.+Wulffauthor=R.+P.+Bywater&title=Recognition+of+privileged+structures+by+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0309452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309452%26sid%3Dliteratum%253Aachs%26aulast%3DBondensgaard%26aufirst%3DK.%26aulast%3DAnkersen%26aufirst%3DM.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DB.%2BS.%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DBywater%26aufirst%3DR.%2BP.%26atitle%3DRecognition%2520of%2520privileged%2520structures%2520by%2520G-protein%2520coupled%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D888%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawer, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgill, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1941</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9600712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1941-1942&author=J.+J.+Kulagowskiauthor=H.+B.+Broughtonauthor=N.+R.+Curtisauthor=I.+M.+Mawerauthor=M.+P.+Ridgillauthor=R.+Bakerauthor=F.+Emmsauthor=S.+B.+Freedmanauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=P.+D.+Leeson&title=3-%5B%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine%3A+an+antagonist+with+high+affinity+and+selectivity+for+the+human+dopamine+D4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9600712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9600712%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DMawer%26aufirst%3DI.%2BM.%26aulast%3DRidgill%26aufirst%3DM.%2BP.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D3-%255B%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%253A%2520an%2520antagonist%2520with%2520high%2520affinity%2520and%2520selectivity%2520for%2520the%2520human%2520dopamine%2520D4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1941%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular determinants of selectivity and efficacy at the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+determinants+of+selectivity+and+efficacy+at+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0ljacL03OwDEMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520determinants%2520of%2520selectivity%2520and%2520efficacy%2520at%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podloucka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. A.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogues of clozapine. IV. The effects of aromaticity and isosteric replacement</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=930-940&author=B.+Capuanoauthor=I.+T.+Crosbyauthor=E.+J.+Lloydauthor=A.+Podlouckaauthor=D.+A.+Taylor&title=Synthesis+and+preliminary+pharmacological+evaluation+of+4%E2%80%B2-arylalkyl+analogues+of+clozapine.+IV.+The+effects+of+aromaticity+and+isosteric+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DLloyd%26aufirst%3DE.%2BJ.%26aulast%3DPodloucka%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520preliminary%2520pharmacological%2520evaluation%2520of%25204%25E2%2580%25B2-arylalkyl%2520analogues%2520of%2520clozapine.%2520IV.%2520The%2520effects%2520of%2520aromaticity%2520and%2520isosteric%2520replacement%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2008%26volume%3D61%26spage%3D930%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Abdel-Fattah, M. A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadi, A. H.</span><span> </span><span class="NLM_article-title">An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1002%2Fcbdv.201300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=24327445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=2247-2266&author=M.+A.+O.+Abdel-Fattahauthor=J.+Lehmannauthor=A.+H.+Abadi&title=An+interactive+SAR+approach+to+discover+novel+hybrid+thieno+probes+as+ligands+for+D2-like+receptors+with+affinities+in+the+subnanomolar+range"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Interactive SAR Approach to Discover Novel Hybrid Thieno Probes as Ligands for D2-Like Receptors with Affinities in the Subnanomolar Range</span></div><div class="casAuthors">Abdel-Fattah, Mohamed A. O.; Lehmann, Jochen; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2266</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Arylpiperazinylalkyl phthalimides I [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; X = (CH2)n; n = 1, 2] and arylpiperazinylalkyl benzamides and thiophenecarboxamides II [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; R1 = Ph, 2-thienyl; X = (CH2)n; n = 1, 2] were prepd. as selective ligands for dopamine D3 and D4 (D2-like) receptors.  Of the arylpiperazinylalkyl phthalimides prepd., I (R = 2-EtOC6H4; n = 2) showed the highest affinity towards D4 and D3 receptors with Ki values in the low nanomolar range, and D2/D4- and D2/D3-selectivity indexes of 72 and 20, resp.  Further optimization led to the D4-selective ligand II (R1 = 2-thienyl; n = 1) with a Ki(D4) value of 0.62 nM, and to II (R1 = 2-thienyl; n = 2) with Ki(D4) and Ki(D3) values of 0.03 and 0.26 nM, resp.  Mol. docking expts. revealed the importance of the unique D4 residue Arg186 in manipulating the D4-subtype-receptor selectivity of the ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgZBlwDG4MbVg90H21EOLACvtfcHk0ljacL03OwDEMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO&md5=1934cb1116cfe22c350668ff1969d076</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201300204%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DM.%2BA.%2BO.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DAn%2520interactive%2520SAR%2520approach%2520to%2520discover%2520novel%2520hybrid%2520thieno%2520probes%2520as%2520ligands%2520for%2520D2-like%2520receptors%2520with%2520affinities%2520in%2520the%2520subnanomolar%2520range%26jtitle%3DChem.%2520Biodiversity%26date%3D2013%26volume%3D10%26spage%3D2247%26epage%3D2266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz-Medina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S.</span><span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D3%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3502</span><span class="NLM_x">–</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+characterization+of+selective+dopamine+D2+receptor+ligands+using+aripiprazole+as+the+lead+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520selective%2520dopamine%2520D2%2520receptor%2520ligands%2520using%2520aripiprazole%2520as%2520the%2520lead%2520compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+K%C3%BChhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Highly+potent+5-aminotetrahydropyrazolopyridines%3A+enantioselective+dopamine+D3+receptor+binding%2C+functional+selectivity%2C+and+analysis+of+receptor%E2%80%93ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DK%25C3%25BChhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520potent%25205-aminotetrahydropyrazolopyridines%253A%2520enantioselective%2520dopamine%2520D3%2520receptor%2520binding%252C%2520functional%2520selectivity%252C%2520and%2520analysis%2520of%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span> </span><span class="NLM_article-title">Operational models of pharmacological agonism</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+models+of+pharmacological+agonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lhWVS1ekmjdVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520models%2520of%2520pharmacological%2520agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">van der Westhuizen, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van+der+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+ligand+bias+for+clinically+relevant+%CE%B22-adrenergic+receptor+ligands%3A+implications+for+drug+taxonomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520ligand%2520bias%2520for%2520clinically%2520relevant%2520%25CE%25B22-adrenergic%2520receptor%2520ligands%253A%2520implications%2520for%2520drug%2520taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, Irene Reyes-Resina, Jhonny Azuaje, Rafael Franco, Aitor García-Rey, Maria Majellaro, Darío Miranda-Pastoriza, Xerardo García-Mera, Willem Jespers, Hugo Gutiérrez-de-Terán, Gemma Navarro, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and Subtype-Selective Dopamine D2 Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8710-8726. <a href="https://doi.org/10.1021/acs.jmedchem.1c00704" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00704%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Band%252BSubtype-Selective%252BDopamine%252BD2%252BReceptor%252BBiased%252BPartial%252BAgonists%252BDiscovered%252Bvia%252Ban%252BUgi-Based%252BApproach%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19042021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8710%26epage%3D8726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher
J. M. Brown, Michael P. Gotsbacher, Jason P. Holland, <span class="NLM_string-name hlFld-ContribAuthor">Rachel Codd</span>. </span><span class="cited-content_cbyCitation_article-title">endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Inorganic Chemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (20)
                                     , 13591-13603. <a href="https://doi.org/10.1021/acs.inorgchem.9b00878" title="DOI URL">https://doi.org/10.1021/acs.inorgchem.9b00878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.inorgchem.9b00878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.inorgchem.9b00878%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520Chemistry%26atitle%3Dendo-Hydroxamic%252BAcid%252BMonomers%252Bfor%252Bthe%252BAssembly%252Bof%252Ba%252BSuite%252Bof%252BNon-native%252BDimeric%252BMacrocyclic%252BSiderophores%252BUsing%252BMetal-Templated%252BSynthesis%26aulast%3DBrown%26aufirst%3DChristopher%2BJ.%2BM.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27032019%26date%3D05062019%26volume%3D58%26issue%3D20%26spage%3D13591%26epage%3D13603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carmen Klein Herenbrink, Ravi Verma, Herman D. Lim, Anitha Kopinathan, Alastair Keen, Jeremy Shonberg, Christopher J. Draper-Joyce, Peter J. Scammells, Arthur Christopoulos, Jonathan A. Javitch, Ben Capuano, Lei Shi, <span class="NLM_string-name hlFld-ContribAuthor">J. Robert Lane</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Determinants of the Intrinsic Efficacy of the Antipsychotic Aripiprazole. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (8)
                                     , 1780-1792. <a href="https://doi.org/10.1021/acschembio.9b00342" title="DOI URL">https://doi.org/10.1021/acschembio.9b00342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00342%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DMolecular%252BDeterminants%252Bof%252Bthe%252BIntrinsic%252BEfficacy%252Bof%252Bthe%252BAntipsychotic%252BAripiprazole%26aulast%3DKlein%2BHerenbrink%26aufirst%3DCarmen%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01052019%26date%3D24072019%26date%3D05082019%26date%3D24072019%26volume%3D14%26issue%3D8%26spage%3D1780%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yudao Shen, John D. McCorvy, Michael L. Martini, Ramona M. Rodriguiz, Vladimir M. Pogorelov, Karen M. Ward, William C. Wetsel, Jing Liu, Bryan L. Roth, <span class="NLM_string-name hlFld-ContribAuthor">Jian Jin</span>. </span><span class="cited-content_cbyCitation_article-title">D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4755-4771. <a href="https://doi.org/10.1021/acs.jmedchem.9b00508" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00508%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DD2%252BDopamine%252BReceptor%252BG%252BProtein-Biased%252BPartial%252BAgonists%252BBased%252Bon%252BCariprazine%26aulast%3DShen%26aufirst%3DYudao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22032019%26date%3D18042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4755%26epage%3D4771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alessandro Bonifazi, Hideaki Yano, Adrian M. Guerrero, Vivek Kumar, Alexander F. Hoffman, Carl R. Lupica, Lei Shi, <span class="NLM_string-name hlFld-ContribAuthor">Amy Hauck Newman</span>. </span><span class="cited-content_cbyCitation_article-title">Novel and Potent Dopamine D2 Receptor Go-Protein Biased Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2019,</strong> <em>2 </em>
                                    (1)
                                     , 52-65. <a href="https://doi.org/10.1021/acsptsci.8b00060" title="DOI URL">https://doi.org/10.1021/acsptsci.8b00060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.8b00060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.8b00060%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DNovel%252Band%252BPotent%252BDopamine%252BD2%252BReceptor%252BGo-Protein%252BBiased%252BAgonists%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D21122018%26date%3D28012019%26date%3D14012019%26volume%3D2%26issue%3D1%26spage%3D52%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liang Tan, Wenzhong Yan, John D. McCorvy, <span class="NLM_string-name hlFld-ContribAuthor">Jianjun Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9841-9878. <a href="https://doi.org/10.1021/acs.jmedchem.8b00435" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiased%252BLigands%252Bof%252BG%252BProtein-Coupled%252BReceptors%252B%252528GPCRs%252529%25253A%252BStructure%2525E2%252580%252593Functional%252BSelectivity%252BRelationships%252B%252528SFSRs%252529%252Band%252BTherapeutic%252BPotential%26aulast%3DTan%26aufirst%3DLiang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19032018%26date%3D10072018%26date%3D25062018%26volume%3D61%26issue%3D22%26spage%3D9841%26epage%3D9878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xudong Cao, Yifang Zhang, Yin Chen, Yinli Qiu, Minquan Yu, Xiangqing Xu, Xin Liu, Bi-Feng Liu, Liangren Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Guisen Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10017-10039. <a href="https://doi.org/10.1021/acs.jmedchem.8b01096" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFused%252BTricyclic%252BHeterocycle%252BPiperazine%252B%252528Piperidine%252529%252BDerivatives%252BAs%252BPotential%252BMultireceptor%252BAtypical%252BAntipsychotics%26aulast%3DCao%26aufirst%3DXudong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D12072018%26date%3D09112018%26date%3D01112018%26volume%3D61%26issue%3D22%26spage%3D10017%26epage%3D10039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yibiao Li, Xianglin Luo, Yan Shao, <span class="NLM_string-name hlFld-ContribAuthor">Lu Chen</span>. </span><span class="cited-content_cbyCitation_article-title">2-Acetylthienopyridine Synthesis via Thiolation and Copper-Catalyzed Cyclization of o-Propynol Fluoropyridine Using Xanthate as a Thiol Surrogate. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (15)
                                     , 8768-8774. <a href="https://doi.org/10.1021/acs.joc.8b01037" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01037%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2-Acetylthienopyridine%252BSynthesis%252Bvia%252BThiolation%252Band%252BCopper-Catalyzed%252BCyclization%252Bof%252Bo-Propynol%252BFluoropyridine%252BUsing%252BXanthate%252Bas%252Ba%252BThiol%252BSurrogate%26aulast%3DLi%26aufirst%3DYibiao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28042018%26date%3D26072018%26date%3D16072018%26volume%3D83%26issue%3D15%26spage%3D8768%26epage%3D8774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michel Weïwer, Qihong Xu, Jennifer P. Gale, Michael Lewis, Arthur J. Campbell, Frederick A. Schroeder, Genevieve C. Van de Bittner, Michelle Walk, Aldo Amaya, Ping Su, Luka D̵ordevic, Joshua R. Sacher, Adam Skepner, David Fei, Kelly Dennehy, Shannon Nguyen, Patrick W. Faloon, Jose Perez, Jeffrey R. Cottrell, Fang Liu, Michelle Palmer, Jen Q. Pan, Jacob M. Hooker, Yan-Ling Zhang, Edward Scolnick, Florence F. Wagner, <span class="NLM_string-name hlFld-ContribAuthor">Edward B. Holson</span>. </span><span class="cited-content_cbyCitation_article-title">Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic Treatment. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 1038-1047. <a href="https://doi.org/10.1021/acschembio.8b00168" title="DOI URL">https://doi.org/10.1021/acschembio.8b00168</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00168%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DFunctionally%252BBiased%252BD2R%252BAntagonists%25253A%252BTargeting%252Bthe%252B%2525CE%2525B2-Arrestin%252BPathway%252Bto%252BImprove%252BAntipsychotic%252BTreatment%26aulast%3DWe%25C3%25AFwer%26aufirst%3DMichel%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16022018%26date%3D27022018%26date%3D14032018%26date%3D27022018%26volume%3D13%26issue%3D4%26spage%3D1038%26epage%3D1047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Dong  Shao</span>, <span class="hlFld-ContribAuthor ">Jia  Su</span>, <span class="hlFld-ContribAuthor ">Baixin  Ye</span>, <span class="hlFld-ContribAuthor ">Jiang-Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Zhi-Li  Zuo</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Yue-Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Chengfeng  Xia</span>, and <span class="hlFld-ContribAuthor ">Qin-Shi  Zhao</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 9053-9066. <a href="https://doi.org/10.1021/acs.jmedchem.7b01395" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01395%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivities%252Bof%252BVibsanin%252BB%252BDerivatives%25253A%252BA%252BNew%252BClass%252Bof%252BHSP90%252BC-Terminal%252BInhibitors%26aulast%3DShao%26aufirst%3DLi-Dong%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20092017%26date%3D24102017%26date%3D09112017%26date%3D11102017%26volume%3D60%26issue%3D21%26spage%3D9053%26epage%3D9066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Bosc</span>, <span class="hlFld-ContribAuthor ">Mélaine A.  Kuenemann</span>, <span class="hlFld-ContribAuthor ">Jerome  Bécot</span>, <span class="hlFld-ContribAuthor ">Marek  Vavrusa</span>, <span class="hlFld-ContribAuthor ">Adrien H.  Cerdan</span>, and <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>  . </span><span class="cited-content_cbyCitation_article-title">Privileged Substructures to Modulate Protein–Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (10)
                                     , 2448-2462. <a href="https://doi.org/10.1021/acs.jcim.7b00435" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00435%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrivileged%252BSubstructures%252Bto%252BModulate%252BProtein%2525E2%252580%252593Protein%252BInteractions%26aulast%3DBosc%26aufirst%3DNicolas%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19072017%26date%3D27092017%26date%3D23102017%26date%3D18092017%26volume%3D57%26issue%3D10%26spage%3D2448%26epage%3D2462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Männel</span>, <span class="hlFld-ContribAuthor ">Mariama  Jaiteh</span>, <span class="hlFld-ContribAuthor ">Alexey  Zeifman</span>, <span class="hlFld-ContribAuthor ">Alena  Randakova</span>, <span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>, and <span class="hlFld-ContribAuthor ">Jens  Carlsson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2017,</strong> <em>12 </em>
                                    (10)
                                     , 2652-2661. <a href="https://doi.org/10.1021/acschembio.7b00493" title="DOI URL">https://doi.org/10.1021/acschembio.7b00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00493%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DStructure-Guided%252BScreening%252Bfor%252BFunctionally%252BSelective%252BD2%252BDopamine%252BReceptor%252BLigands%252Bfrom%252Ba%252BVirtual%252BChemical%252BLibrary%26aulast%3DM%25C3%25A4nnel%26aufirst%3DBarbara%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D15062017%26date%3D28082017%26date%3D19092017%26date%3D20102017%26date%3D28082017%26volume%3D12%26issue%3D10%26spage%3D2652%26epage%3D2661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Taygun C.  Uzuneser</span>, <span class="hlFld-ContribAuthor ">Marika  Skultety</span>, <span class="hlFld-ContribAuthor ">Tobias  Huth</span>, <span class="hlFld-ContribAuthor ">Bianca  Plouffe</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Christian  Alzheimer</span>, <span class="hlFld-ContribAuthor ">Kristina  Friedland</span>, <span class="hlFld-ContribAuthor ">Christian P.  Müller</span>, <span class="hlFld-ContribAuthor ">Michel  Bouvier</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased Dopaminergics with a Pyrazolo[1,5-a]pyridine Substructure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2908-2929. <a href="https://doi.org/10.1021/acs.jmedchem.6b01857" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BDopaminergics%252Bwith%252Ba%252BPyrazolo%25255B1%25252C5-a%25255Dpyridine%252BSubstructure%26aulast%3DM%25C3%25B6ller%26aufirst%3DDorothee%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21122016%26date%3D22032017%26date%3D13042017%26date%3D01032017%26volume%3D60%26issue%3D7%26spage%3D2908%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Bonifazi</span>, <span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Michael P.  Ellenberger</span>, <span class="hlFld-ContribAuthor ">Ludovic  Muller</span>, <span class="hlFld-ContribAuthor ">Vivek  Kumar</span>, <span class="hlFld-ContribAuthor ">Mu-Fa  Zou</span>, <span class="hlFld-ContribAuthor ">Ning Sheng  Cai</span>, <span class="hlFld-ContribAuthor ">Adrian M.  Guerrero</span>, <span class="hlFld-ContribAuthor ">Amina S.  Woods</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, and <span class="hlFld-ContribAuthor ">Amy Hauck  Newman</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (7)
                                     , 2890-2907. <a href="https://doi.org/10.1021/acs.jmedchem.6b01875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BBivalent%252BLigands%252BBased%252Bon%252Bthe%252BSumanirole%252BPharmacophore%252BReveal%252BDopamine%252BD2%252BReceptor%252B%252528D2R%252529%252BBiased%252BAgonism%26aulast%3DBonifazi%26aufirst%3DAlessandro%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D20122016%26date%3D16032017%26date%3D13042017%26volume%3D60%26issue%3D7%26spage%3D2890%26epage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaozhao  Wang</span>, <span class="hlFld-ContribAuthor ">Aaron M.  Tocker</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Maarten E. A.  Reith</span>, <span class="hlFld-ContribAuthor ">Lee-Yuan  Liu-Chen</span>, <span class="hlFld-ContribAuthor ">Amos B.  Smith, III</span>, and <span class="hlFld-ContribAuthor ">Sandhya  Kortagere</span>  . </span><span class="cited-content_cbyCitation_article-title">Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 486-500. <a href="https://doi.org/10.1021/acschemneuro.6b00221" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00221%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFunctional%252BCharacterization%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BBiased%252BSignaling%252BDopamine%252BD3%252BReceptor%252BAgonists%26aulast%3DXu%26aufirst%3DWei%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29072016%26date%3D01112016%26date%3D23112016%26date%3D15032017%26date%3D01112016%26volume%3D8%26issue%3D3%26spage%3D486%26epage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">John D.  McCorvy</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Fischer</span>, <span class="hlFld-ContribAuthor ">Kyle V.  Butler</span>, <span class="hlFld-ContribAuthor ">Yudao  Shen</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, and <span class="hlFld-ContribAuthor ">Jian  Jin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10601-10618. <a href="https://doi.org/10.1021/acs.jmedchem.6b01208" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01208%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BG%252BProtein-Biased%252BD2%252BDopamine%252BReceptor%252BPartial%252BAgonists%26aulast%3DChen%26aufirst%3DXin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D16112016%26date%3D08122016%26date%3D02112016%26volume%3D59%26issue%3D23%26spage%3D10601%26epage%3D10618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Christopher  Draper-Joyce</span>, <span class="hlFld-ContribAuthor ">Shailesh N.  Mistry</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, and <span class="hlFld-ContribAuthor ">Ben  Capuano</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Study of N-((trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a Bitopic Ligand That Acts as a Negative Allosteric Modulator of the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (13)
                                     , 5287-5307. <a href="https://doi.org/10.1021/acs.jmedchem.5b00581" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BStudy%252Bof%252BN-%252528%252528trans%252529-4-%2525282-%2525287-Cyano-3%25252C4-dihydroisoquinolin-2%2525281H%252529-yl%252529ethyl%252529cyclohexyl%252529-1H-indole-2-carboxamide%252B%252528SB269652%252529%25252C%252Ba%252BBitopic%252BLigand%252BThat%252BActs%252Bas%252Ba%252BNegative%252BAllosteric%252BModulator%252Bof%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DShonberg%26aufirst%3DJeremy%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D14042015%26date%3D24062015%26date%3D09072015%26date%3D08062015%26volume%3D58%26issue%3D13%26spage%3D5287%26epage%3D5307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Ramu  Yadav</span>, <span class="hlFld-ContribAuthor ">Majji  Shankar</span>, <span class="hlFld-ContribAuthor ">E.  Ramesh</span>, <span class="hlFld-ContribAuthor ">Koushik  Ghosh</span>, and <span class="hlFld-ContribAuthor ">Akhila K.  Sahoo</span>  . </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed ortho-C–H Mono- and Di-imidation of Arenes with N-Tosyloxyphthalimide. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (8)
                                     , 1886-1889. <a href="https://doi.org/10.1021/acs.orglett.5b00570" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b00570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b00570%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRuthenium-Catalyzed%252Bortho-C%2525E2%252580%252593H%252BMono-%252Band%252BDi-imidation%252Bof%252BArenes%252Bwith%252BN-Tosyloxyphthalimide%26aulast%3DYadav%26aufirst%3DM.%2BRamu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25022015%26date%3D02042015%26date%3D17042015%26volume%3D17%26issue%3D8%26spage%3D1886%26epage%3D1889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dietmar  Weichert</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Banerjee</span>, <span class="hlFld-ContribAuthor ">Christine  Hiller</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, and <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Determinants of Biased Agonism at the Dopamine D2 Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2703-2717. <a href="https://doi.org/10.1021/jm501889t" title="DOI URL">https://doi.org/10.1021/jm501889t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501889t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501889t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BDeterminants%252Bof%252BBiased%252BAgonism%252Bat%252Bthe%252BDopamine%252BD2%252BReceptor%26aulast%3DWeichert%26aufirst%3DDietmar%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D12032015%26date%3D26032015%26date%3D03032015%26volume%3D58%26issue%3D6%26spage%3D2703%26epage%3D2717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Herman D.  Lim</span>, <span class="hlFld-ContribAuthor ">Carmen  Klein Herenbrink</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, and <span class="hlFld-ContribAuthor ">Ben  Capuano</span>  . </span><span class="cited-content_cbyCitation_article-title">Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1550-1555. <a href="https://doi.org/10.1021/jm5013243" title="DOI URL">https://doi.org/10.1021/jm5013243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5013243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5013243%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProof%252Bof%252BConcept%252BStudy%252Bfor%252BDesigned%252BMultiple%252BLigands%252BTargeting%252Bthe%252BDopamine%252BD2%25252C%252BSerotonin%252B5-HT2A%25252C%252Band%252BMuscarinic%252BM1%252BAcetylcholine%252BReceptors%26aulast%3DSzabo%26aufirst%3DMonika%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D29082014%26date%3D30012015%26date%3D12022015%26date%3D15012015%26volume%3D58%26issue%3D3%26spage%3D1550%26epage%3D1555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ee  Von Moo</span>, <span class="hlFld-ContribAuthor ">Kasper  Harpsøe</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Hauser</span>, <span class="hlFld-ContribAuthor ">Ikuo  Masuho</span>, <span class="hlFld-ContribAuthor ">Hans  Bräuner-Osborne</span>, <span class="hlFld-ContribAuthor ">David E.  Gloriam</span>, <span class="hlFld-ContribAuthor ">Kirill A.  Martemyanov</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-directed bias of G protein signaling at the dopamine D2 receptor. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2021,</strong> <em>176 </em><a href="https://doi.org/10.1016/j.chembiol.2021.07.004" title="DOI URL">https://doi.org/10.1016/j.chembiol.2021.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2021.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2021.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DLigand-directed%252Bbias%252Bof%252BG%252Bprotein%252Bsignaling%252Bat%252Bthe%252Bdopamine%252BD2%252Breceptor%26aulast%3DVon%2BMoo%26aufirst%3DEe%26date%3D2021%26volume%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bangqing  Wu</span>, <span class="hlFld-ContribAuthor ">Lijun  Wu</span>, <span class="hlFld-ContribAuthor ">Yingju  He</span>, <span class="hlFld-ContribAuthor ">Zongning  Yin</span>, <span class="hlFld-ContribAuthor ">Li  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Engineered PLGA microspheres for extended release of Brexpiprazole:
              in vitro
              and
              in vivo
              studies. </span><span class="cited-content_cbyCitation_journal-name">Drug Development and Industrial Pharmacy</span><span> <strong>2021,</strong> <em> </em>, 1-43. <a href="https://doi.org/10.1080/03639045.2021.1934859" title="DOI URL">https://doi.org/10.1080/03639045.2021.1934859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/03639045.2021.1934859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F03639045.2021.1934859%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Development%2520and%2520Industrial%2520Pharmacy%26atitle%3DEngineered%252BPLGA%252Bmicrospheres%252Bfor%252Bextended%252Brelease%252Bof%252BBrexpiprazole%25253A%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bstudies%26aulast%3DWu%26aufirst%3DBangqing%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sait  Sari</span>, <span class="hlFld-ContribAuthor ">Mehmet  Yilmaz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, acetylcholinesterase inhibition, and molecular docking studies of new piperazine substituted dihydrofuran compounds. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (10)
                                     , 1804-1818. <a href="https://doi.org/10.1007/s00044-020-02599-0" title="DOI URL">https://doi.org/10.1007/s00044-020-02599-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02599-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02599-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Bacetylcholinesterase%252Binhibition%25252C%252Band%252Bmolecular%252Bdocking%252Bstudies%252Bof%252Bnew%252Bpiperazine%252Bsubstituted%252Bdihydrofuran%252Bcompounds%26aulast%3DSari%26aufirst%3DSait%26date%3D2020%26date%3D2020%26volume%3D29%26issue%3D10%26spage%3D1804%26epage%3D1818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Soave</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Briddon</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Hill</span>, <span class="hlFld-ContribAuthor ">Leigh A.  Stoddart</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent ligands: Bringing light to emerging GPCR paradigms. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>177 </em>
                                    (5)
                                     , 978-991. <a href="https://doi.org/10.1111/bph.14953" title="DOI URL">https://doi.org/10.1111/bph.14953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14953%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DFluorescent%252Bligands%25253A%252BBringing%252Blight%252Bto%252Bemerging%252BGPCR%252Bparadigms%26aulast%3DSoave%26aufirst%3DMark%26date%3D2020%26date%3D2020%26volume%3D177%26issue%3D5%26spage%3D978%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Gherbi</span>, <span class="hlFld-ContribAuthor ">Nickolaj J.  Groenewoud</span>, <span class="hlFld-ContribAuthor ">Nicholas D.  Holliday</span>, <span class="hlFld-ContribAuthor ">Kathy  Sengmany</span>, <span class="hlFld-ContribAuthor ">Steven J.  Charlton</span>. </span><span class="cited-content_cbyCitation_article-title">Kinetics of ligand binding and signaling. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 171-194. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00010-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00010-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00010-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00010-6%26sid%3Dliteratum%253Aachs%26atitle%3DKinetics%252Bof%252Bligand%252Bbinding%252Band%252Bsignaling%26aulast%3DGherbi%26aufirst%3DKarolina%26date%3D2020%26spage%3D171%26epage%3D194%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean S.  So</span>, <span class="hlFld-ContribAuthor ">Tony  Ngo</span>, <span class="hlFld-ContribAuthor ">Peter  Keov</span>, <span class="hlFld-ContribAuthor ">Nicola J.  Smith</span>, <span class="hlFld-ContribAuthor ">Irina  Kufareva</span>. </span><span class="cited-content_cbyCitation_article-title">Tackling the complexities of orphan GPCR ligand discovery with rationally assisted approaches. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 295-334. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00016-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00016-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00016-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00016-7%26sid%3Dliteratum%253Aachs%26atitle%3DTackling%252Bthe%252Bcomplexities%252Bof%252Borphan%252BGPCR%252Bligand%252Bdiscovery%252Bwith%252Brationally%252Bassisted%252Bapproaches%26aulast%3DSo%26aufirst%3DSean%2BS.%26date%3D2020%26spage%3D295%26epage%3D334%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor V.  Dotsenko</span>, <span class="hlFld-ContribAuthor ">Dmitrii S.  Buryi</span>, <span class="hlFld-ContribAuthor ">Darya Yu.  Lukina</span>, <span class="hlFld-ContribAuthor ">Angelica N.  Stolyarova</span>, <span class="hlFld-ContribAuthor ">Nicolai A.  Aksenov</span>, <span class="hlFld-ContribAuthor ">Inna V.  Aksenova</span>, <span class="hlFld-ContribAuthor ">Vladimir D.  Strelkov</span>, <span class="hlFld-ContribAuthor ">Lyudmila V.  Dyadyuchenko</span>. </span><span class="cited-content_cbyCitation_article-title">Substituted N-(thieno[2,3-b]pyridine-3-yl)acetamides: synthesis, reactions, and biological activity. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2019,</strong> <em>150 </em>
                                    (11)
                                     , 1973-1985. <a href="https://doi.org/10.1007/s00706-019-02505-4" title="DOI URL">https://doi.org/10.1007/s00706-019-02505-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-019-02505-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-019-02505-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSubstituted%252BN-%252528thieno%25255B2%25252C3-b%25255Dpyridine-3-yl%252529acetamides%25253A%252Bsynthesis%25252C%252Breactions%25252C%252Band%252Bbiological%252Bactivity%26aulast%3DDotsenko%26aufirst%3DVictor%2BV.%26date%3D2019%26date%3D2019%26volume%3D150%26issue%3D11%26spage%3D1973%26epage%3D1985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marlene  Jacobson</span>, <span class="hlFld-ContribAuthor ">Wayne  Childers</span>, <span class="hlFld-ContribAuthor ">Magid  Abou‐Gharbia</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D
              2
              Partial Agonists – Discovery, Evolution, and Therapeutic Potential. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 83-130. <a href="https://doi.org/10.1002/9783527814695.ch4" title="DOI URL">https://doi.org/10.1002/9783527814695.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527814695.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527814695.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DDopamine%252BD%252B2%252BPartial%252BAgonists%252B%2525E2%252580%252593%252BDiscovery%25252C%252BEvolution%25252C%252Band%252BTherapeutic%252BPotential%26aulast%3DJacobson%26aufirst%3DMarlene%26date%3D2019%26date%3D2019%26spage%3D83%26epage%3D130%26pub%3DWiley%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2019%26date%3D2019%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Seyedabadi</span>, <span class="hlFld-ContribAuthor ">Mohammad Hossein  Ghahremani</span>, <span class="hlFld-ContribAuthor ">Paul R.  Albert</span>. </span><span class="cited-content_cbyCitation_article-title">Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2019,</strong> <em>200 </em>, 148-178. <a href="https://doi.org/10.1016/j.pharmthera.2019.05.006" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DBiased%252Bsignaling%252Bof%252BG%252Bprotein%252Bcoupled%252Breceptors%252B%252528GPCRs%252529%25253A%252BMolecular%252Bdeterminants%252Bof%252BGPCR%25252Ftransducer%252Bselectivity%252Band%252Btherapeutic%252Bpotential%26aulast%3DSeyedabadi%26aufirst%3DMohammad%26date%3D2019%26volume%3D200%26spage%3D148%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Dai</span>, <span class="hlFld-ContribAuthor ">Kaimin  Mao</span>, <span class="hlFld-ContribAuthor ">Zhengbing  Pan</span>, <span class="hlFld-ContribAuthor ">Liangce  Rong</span>. </span><span class="cited-content_cbyCitation_article-title">Green metal-free synthesis of spiro-fused 3,4′-pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidine derivatives via deamination cyclization reactions in aqueous medium. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2019,</strong> <em>45 </em>
                                    (2)
                                     , 769-788. <a href="https://doi.org/10.1007/s11164-018-3642-3" title="DOI URL">https://doi.org/10.1007/s11164-018-3642-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-018-3642-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-018-3642-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DGreen%252Bmetal-free%252Bsynthesis%252Bof%252Bspiro-fused%252B3%25252C4%2525E2%252580%2525B2-pyrazolo%25255B4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A5%25252C6%25255Dpyrido%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bvia%252Bdeamination%252Bcyclization%252Breactions%252Bin%252Baqueous%252Bmedium%26aulast%3DDai%26aufirst%3DLei%26date%3D2019%26date%3D2018%26volume%3D45%26issue%3D2%26spage%3D769%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mikhail Yu.  Kornev</span>, <span class="hlFld-ContribAuthor ">Denis S.  Tishin</span>, <span class="hlFld-ContribAuthor ">Vyacheslav Ya.  Sosnovskikh</span>. </span><span class="cited-content_cbyCitation_article-title">Reactions of chromone-3-carboxamides with 2-cyanothioacetamides. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2019,</strong> <em>29 </em>
                                    (1)
                                     , 67-68. <a href="https://doi.org/10.1016/j.mencom.2019.01.022" title="DOI URL">https://doi.org/10.1016/j.mencom.2019.01.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2019.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2019.01.022%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DReactions%252Bof%252Bchromone-3-carboxamides%252Bwith%252B2-cyanothioacetamides%26aulast%3DKornev%26aufirst%3DMikhail%2BYu.%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D67%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideaki  Yano</span>, <span class="hlFld-ContribAuthor ">Ning-Sheng  Cai</span>, <span class="hlFld-ContribAuthor ">Min  Xu</span>, <span class="hlFld-ContribAuthor ">Ravi Kumar  Verma</span>, <span class="hlFld-ContribAuthor ">William  Rea</span>, <span class="hlFld-ContribAuthor ">Alexander F.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Antonello  Bonci</span>, <span class="hlFld-ContribAuthor ">Sergi  Ferré</span>. </span><span class="cited-content_cbyCitation_article-title">Gs- versus Golf-dependent functional selectivity mediated by the dopamine D1 receptor. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02606-w" title="DOI URL">https://doi.org/10.1038/s41467-017-02606-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02606-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02606-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DGs-%2525C2%2525A0versus%252BGolf-dependent%252Bfunctional%252Bselectivity%252Bmediated%252Bby%252Bthe%252Bdopamine%252BD1%252Breceptor%26aulast%3DYano%26aufirst%3DHideaki%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly A  Berg</span>, <span class="hlFld-ContribAuthor ">William P  Clarke</span>. </span><span class="cited-content_cbyCitation_article-title">Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>21 </em>
                                    (10)
                                     , 962-977. <a href="https://doi.org/10.1093/ijnp/pyy071" title="DOI URL">https://doi.org/10.1093/ijnp/pyy071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/ijnp/pyy071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fijnp%2Fpyy071%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Neuropsychopharmacology%26atitle%3DMaking%252BSense%252Bof%252BPharmacology%25253A%252BInverse%252BAgonism%252Band%252BFunctional%252BSelectivity%26aulast%3DBerg%26aufirst%3DKelly%2BA%26date%3D2018%26date%3D2018%26volume%3D21%26issue%3D10%26spage%3D962%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Stępnicki</span>, <span class="hlFld-ContribAuthor ">Magda  Kondej</span>, <span class="hlFld-ContribAuthor ">Agnieszka A.  Kaczor</span>. </span><span class="cited-content_cbyCitation_article-title">Current Concepts and Treatments of Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (8)
                                     , 2087. <a href="https://doi.org/10.3390/molecules23082087" title="DOI URL">https://doi.org/10.3390/molecules23082087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23082087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23082087%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCurrent%252BConcepts%252Band%252BTreatments%252Bof%252BSchizophrenia%26aulast%3DSt%25C4%2599pnicki%26aufirst%3DPiotr%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D8%26spage%3D2087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tobias  Schwalbe</span>, <span class="hlFld-ContribAuthor ">Jonas  Kaindl</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">Potent haloperidol derivatives covalently binding to the dopamine D2 receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (19)
                                     , 5084-5094. <a href="https://doi.org/10.1016/j.bmc.2017.06.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Bhaloperidol%252Bderivatives%252Bcovalently%252Bbinding%252Bto%252Bthe%252Bdopamine%252BD2%252Breceptor%26aulast%3DSchwalbe%26aufirst%3DTobias%26date%3D2017%26volume%3D25%26issue%3D19%26spage%3D5084%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Lauren T  May</span>, <span class="hlFld-ContribAuthor ">Robert G  Parton</span>, <span class="hlFld-ContribAuthor ">Patrick M  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">A kinetic view of GPCR allostery and biased agonism. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (9)
                                     , 929-937. <a href="https://doi.org/10.1038/nchembio.2431" title="DOI URL">https://doi.org/10.1038/nchembio.2431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2431%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DA%252Bkinetic%252Bview%252Bof%252BGPCR%252Ballostery%252Band%252Bbiased%252Bagonism%26aulast%3DLane%26aufirst%3DJ%2BRobert%26date%3D2017%26date%3D2017%26volume%3D13%26issue%3D9%26spage%3D929%26epage%3D937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sajad  Asadbegi</span>, <span class="hlFld-ContribAuthor ">Akbar  Mobinikhaledi</span>, <span class="hlFld-ContribAuthor ">Mohammad Ali  Bodaghifard</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic study on a novel pseudo-five-component synthesis of 4
              H
              -thiopyrans. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2017,</strong> <em>192 </em>
                                    (5)
                                     , 526-529. <a href="https://doi.org/10.1080/10426507.2016.1268138" title="DOI URL">https://doi.org/10.1080/10426507.2016.1268138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2016.1268138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2016.1268138%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DMechanistic%252Bstudy%252Bon%252Ba%252Bnovel%252Bpseudo-five-component%252Bsynthesis%252Bof%252B4%252BH%252B-thiopyrans%26aulast%3DAsadbegi%26aufirst%3DSajad%26date%3D2017%26date%3D2017%26volume%3D192%26issue%3D5%26spage%3D526%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-An  Guo</span>, <span class="hlFld-ContribAuthor ">Wonchul  Lee</span>, <span class="hlFld-ContribAuthor ">Michael J.  Krische</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of Oxetanes Bearing All-Carbon Quaternary Stereocenters via Iridium-Catalyzed C−C Bond-Forming Transfer Hydrogenation. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2017,</strong> <em>23 </em>
                                    (11)
                                     , 2557-2559. <a href="https://doi.org/10.1002/chem.201606046" title="DOI URL">https://doi.org/10.1002/chem.201606046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201606046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201606046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DEnantioselective%252BSynthesis%252Bof%252BOxetanes%252BBearing%252BAll-Carbon%252BQuaternary%252BStereocenters%252Bvia%252BIridium-Catalyzed%252BC%2525E2%252588%252592C%252BBond-Forming%252BTransfer%252BHydrogenation%26aulast%3DGuo%26aufirst%3DYi-An%26date%3D2017%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D2557%26epage%3D2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arthur A.  Grigor’ev</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Karpov</span>, <span class="hlFld-ContribAuthor ">Yakov S.  Kayukov</span>, <span class="hlFld-ContribAuthor ">Oleg E.  Nasakin</span>, <span class="hlFld-ContribAuthor ">Iuliia A.  Gracheva</span>, <span class="hlFld-ContribAuthor ">Victor A.  Tafeenko</span>. </span><span class="cited-content_cbyCitation_article-title">A new route to highly substituted thieno[2,3-b]pyridines via cascade heterocyclization of 2-acyl-1,1,3,3-tetracyanopropenide salts. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (2)
                                     , 230-235. <a href="https://doi.org/10.1007/s10593-017-2044-6" title="DOI URL">https://doi.org/10.1007/s10593-017-2044-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2044-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2044-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DA%252Bnew%252Broute%252Bto%252Bhighly%252Bsubstituted%252Bthieno%25255B2%25252C3-b%25255Dpyridines%252Bvia%252Bcascade%252Bheterocyclization%252Bof%252B2-acyl-1%25252C1%25252C3%25252C3-tetracyanopropenide%252Bsalts%26aulast%3DGrigor%25E2%2580%2599ev%26aufirst%3DArthur%2BA.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D2%26spage%3D230%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.M.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Privileged Structures and Motifs (Synthetic and Natural Scaffolds). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 116-152. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12316-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12316-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12316-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12316-9%26sid%3Dliteratum%253Aachs%26atitle%3DPrivileged%252BStructures%252Band%252BMotifs%252B%252528Synthetic%252Band%252BNatural%252BScaffolds%252529%26aulast%3DJones%26aufirst%3DA.M.%26date%3D2017%26spage%3D116%26epage%3D152%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Fischer</span>, <span class="hlFld-ContribAuthor ">Matthias  Lamping</span>, <span class="hlFld-ContribAuthor ">Maike  Gold</span>, <span class="hlFld-ContribAuthor ">Yvonne  Röttger</span>, <span class="hlFld-ContribAuthor ">Dörte  Brödje</span>, <span class="hlFld-ContribAuthor ">Richard  Dodel</span>, <span class="hlFld-ContribAuthor ">Renate  Frantz</span>, <span class="hlFld-ContribAuthor ">Mobarak Abu  Mraheil</span>, <span class="hlFld-ContribAuthor ">Trinad  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Armin  Geyer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a biological active β-hairpin peptide by addition of two structural motifs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 603-608. <a href="https://doi.org/10.1016/j.bmc.2016.11.022" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252Bbiological%252Bactive%252B%2525CE%2525B2-hairpin%252Bpeptide%252Bby%252Baddition%252Bof%252Btwo%252Bstructural%252Bmotifs%26aulast%3DFischer%26aufirst%3DSabrina%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D603%26epage%3D608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgina L.  Thompson</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Thomas  Coudrat</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Meritxell  Canals</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2016,</strong> <em>113 </em>, 70-87. <a href="https://doi.org/10.1016/j.bcp.2016.05.014" title="DOI URL">https://doi.org/10.1016/j.bcp.2016.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2016.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2016.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DSystematic%252Banalysis%252Bof%252Bfactors%252Binfluencing%252Bobservations%252Bof%252Bbiased%252Bagonism%252Bat%252Bthe%252Bmu-opioid%252Breceptor%26aulast%3DThompson%26aufirst%3DGeorgina%2BL.%26date%3D2016%26volume%3D113%26spage%3D70%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anitha  Kopinathan</span>, <span class="hlFld-ContribAuthor ">Peter J  Scammells</span>, <span class="hlFld-ContribAuthor ">J Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>. </span><span class="cited-content_cbyCitation_article-title">Multivalent approaches and beyond: novel tools for the investigation of dopamine D
              2
              receptor pharmacology. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2016,</strong> <em>8 </em>
                                    (11)
                                     , 1349-1372. <a href="https://doi.org/10.4155/fmc-2016-0010" title="DOI URL">https://doi.org/10.4155/fmc-2016-0010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2016-0010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2016-0010%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultivalent%252Bapproaches%252Band%252Bbeyond%25253A%252Bnovel%252Btools%252Bfor%252Bthe%252Binvestigation%252Bof%252Bdopamine%252BD%252B2%252Breceptor%252Bpharmacology%26aulast%3DKopinathan%26aufirst%3DAnitha%26date%3D2016%26volume%3D8%26issue%3D11%26spage%3D1349%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bachir  Latli</span>, <span class="hlFld-ContribAuthor ">Magnus  Eriksson</span>, <span class="hlFld-ContribAuthor ">Matt  Hrapchak</span>, <span class="hlFld-ContribAuthor ">Carl A.  Busacca</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">A potent IκB kinase-β inhibitor labeled with carbon-14 and deuterium. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 300-304. <a href="https://doi.org/10.1002/jlcr.3398" title="DOI URL">https://doi.org/10.1002/jlcr.3398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3398%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DA%252Bpotent%252BI%2525CE%2525BAB%252Bkinase-%2525CE%2525B2%252Binhibitor%252Blabeled%252Bwith%252Bcarbon-14%252Band%252Bdeuterium%26aulast%3DLatli%26aufirst%3DBachir%26date%3D2016%26date%3D2016%26volume%3D59%26issue%3D8%26spage%3D300%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Klein Herenbrink</span>, <span class="hlFld-ContribAuthor ">David A.  Sykes</span>, <span class="hlFld-ContribAuthor ">Prashant  Donthamsetti</span>, <span class="hlFld-ContribAuthor ">Meritxell  Canals</span>, <span class="hlFld-ContribAuthor ">Thomas  Coudrat</span>, <span class="hlFld-ContribAuthor ">Jeremy  Shonberg</span>, <span class="hlFld-ContribAuthor ">Peter J.  Scammells</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Steven J.  Charlton</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Javitch</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>. </span><span class="cited-content_cbyCitation_article-title">The role of kinetic context in apparent biased agonism at GPCRs. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms10842" title="DOI URL">https://doi.org/10.1038/ncomms10842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms10842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms10842%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Brole%252Bof%252Bkinetic%252Bcontext%252Bin%252Bapparent%252Bbiased%252Bagonism%252Bat%252BGPCRs%26aulast%3DKlein%2BHerenbrink%26aufirst%3DCarmen%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa A.  Stott</span>, <span class="hlFld-ContribAuthor ">David A.  Hall</span>, <span class="hlFld-ContribAuthor ">Nicholas D.  Holliday</span>. </span><span class="cited-content_cbyCitation_article-title">Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2016,</strong> <em>101 </em>, 1-12. <a href="https://doi.org/10.1016/j.bcp.2015.10.011" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DUnravelling%252Bintrinsic%252Befficacy%252Band%252Bligand%252Bbias%252Bat%252BG%252Bprotein%252Bcoupled%252Breceptors%25253A%252BA%252Bpractical%252Bguide%252Bto%252Bassessing%252Bfunctional%252Bdata%26aulast%3DStott%26aufirst%3DLisa%2BA.%26date%3D2016%26volume%3D101%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simone  Di Micco</span>, <span class="hlFld-ContribAuthor ">Carmela  Spatafora</span>, <span class="hlFld-ContribAuthor ">Nunzio  Cardullo</span>, <span class="hlFld-ContribAuthor ">Raffaele  Riccio</span>, <span class="hlFld-ContribAuthor ">Katrin  Fischer</span>, <span class="hlFld-ContribAuthor ">Carlo  Pergola</span>, <span class="hlFld-ContribAuthor ">Andreas  Koeberle</span>, <span class="hlFld-ContribAuthor ">Oliver  Werz</span>, <span class="hlFld-ContribAuthor ">Malik  Chalal</span>, <span class="hlFld-ContribAuthor ">Dominique  Vervandier-Fasseur</span>, <span class="hlFld-ContribAuthor ">Corrado  Tringali</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Bifulco</span>. </span><span class="cited-content_cbyCitation_article-title">2,3-Dihydrobenzofuran privileged structures as new bioinspired lead compounds for the design of mPGES-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (4)
                                     , 820-826. <a href="https://doi.org/10.1016/j.bmc.2016.01.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D2%25252C3-Dihydrobenzofuran%252Bprivileged%252Bstructures%252Bas%252Bnew%252Bbioinspired%252Blead%252Bcompounds%252Bfor%252Bthe%252Bdesign%252Bof%252BmPGES-1%252Binhibitors%26aulast%3DDi%2BMicco%26aufirst%3DSimone%26date%3D2016%26volume%3D24%26issue%3D4%26spage%3D820%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dorothee  Möller</span>, <span class="hlFld-ContribAuthor ">Ismail  Salama</span>, <span class="hlFld-ContribAuthor ">Ralf C.  Kling</span>, <span class="hlFld-ContribAuthor ">Harald  Hübner</span>, <span class="hlFld-ContribAuthor ">Peter  Gmeiner</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 selectivity: Quantitative structure-selectivity investigations, docking, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (18)
                                     , 6195-6209. <a href="https://doi.org/10.1016/j.bmc.2015.07.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D1%25252C4-Disubstituted%252Baromatic%252Bpiperazines%252Bwith%252Bhigh%252B5-HT2A%25252FD2%252Bselectivity%25253A%252BQuantitative%252Bstructure-selectivity%252Binvestigations%25252C%252Bdocking%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DM%25C3%25B6ller%26aufirst%3DDorothee%26date%3D2015%26volume%3D23%26issue%3D18%26spage%3D6195%26epage%3D6209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Kassel</span>, <span class="hlFld-ContribAuthor ">J.S.  Schwed</span>, <span class="hlFld-ContribAuthor ">H.  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Dopamine D3 receptor agonists as pharmacological tools. </span><span class="cited-content_cbyCitation_journal-name">European Neuropsychopharmacology</span><span> <strong>2015,</strong> <em>25 </em>
                                    (9)
                                     , 1480-1499. <a href="https://doi.org/10.1016/j.euroneuro.2014.11.005" title="DOI URL">https://doi.org/10.1016/j.euroneuro.2014.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.euroneuro.2014.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.euroneuro.2014.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Neuropsychopharmacology%26atitle%3DDopamine%252BD3%252Breceptor%252Bagonists%252Bas%252Bpharmacological%252Btools%26aulast%3DKassel%26aufirst%3DS.%26date%3D2015%26volume%3D25%26issue%3D9%26spage%3D1480%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monika  Szabo</span>, <span class="hlFld-ContribAuthor ">Tracey  Huynh</span>, <span class="hlFld-ContribAuthor ">Celine  Valant</span>, <span class="hlFld-ContribAuthor ">J. Robert  Lane</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Sexton</span>, <span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>, <span class="hlFld-ContribAuthor ">Ben  Capuano</span>. </span><span class="cited-content_cbyCitation_article-title">A structure–activity relationship study of the positive allosteric modulator LY2033298 at the M
              4
              muscarinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (11)
                                     , 1998-2003. <a href="https://doi.org/10.1039/C5MD00334B" title="DOI URL">https://doi.org/10.1039/C5MD00334B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00334B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00334B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DA%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252Bthe%252Bpositive%252Ballosteric%252Bmodulator%252BLY2033298%252Bat%252Bthe%252BM%252B4%252Bmuscarinic%252Bacetylcholine%252Breceptor%26aulast%3DSzabo%26aufirst%3DMonika%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D11%26spage%3D1998%26epage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas  Bock</span>, <span class="hlFld-ContribAuthor ">Evi  Kostenis</span>, <span class="hlFld-ContribAuthor ">Christian  Tränkle</span>, <span class="hlFld-ContribAuthor ">Martin J.  Lohse</span>, <span class="hlFld-ContribAuthor ">Klaus  Mohr</span>. </span><span class="cited-content_cbyCitation_article-title">Pilot the pulse: controlling the multiplicity of receptor dynamics. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2014,</strong> <em>35 </em>
                                    (12)
                                     , 630-638. <a href="https://doi.org/10.1016/j.tips.2014.10.002" title="DOI URL">https://doi.org/10.1016/j.tips.2014.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2014.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2014.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DPilot%252Bthe%252Bpulse%25253A%252Bcontrolling%252Bthe%252Bmultiplicity%252Bof%252Breceptor%252Bdynamics%26aulast%3DBock%26aufirst%3DAndreas%26date%3D2014%26volume%3D35%26issue%3D12%26spage%3D630%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeng  Li</span>, <span class="hlFld-ContribAuthor ">Jiye  Huang</span>, <span class="hlFld-ContribAuthor ">Haifeng  Sun</span>, <span class="hlFld-ContribAuthor ">Shengbin  Zhou</span>, <span class="hlFld-ContribAuthor ">Lin  Guo</span>, <span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (21)
                                     , 5838-5846. <a href="https://doi.org/10.1016/j.bmc.2014.09.024" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bbenzo%25255Ba%25255Dthieno%25255B3%25252C2-g%25255Dquinolizines%252Bas%252Bnovel%252Bl-SPD%252Bderivatives%252Bpossessing%252Bdopamine%252BD1%25252C%252BD2%252Band%252Bserotonin%252B5-HT1A%252Bmultiple%252Baction%252Bprofiles%26aulast%3DLi%26aufirst%3DZeng%26date%3D2014%26volume%3D22%26issue%3D21%26spage%3D5838%26epage%3D5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arthur  Christopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in G Protein-Coupled Receptor Allostery: From Function to Structure. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2014,</strong> <em>86 </em>
                                    (5)
                                     , 463-478. <a href="https://doi.org/10.1124/mol.114.094342" title="DOI URL">https://doi.org/10.1124/mol.114.094342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.114.094342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.114.094342%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAdvances%252Bin%252BG%252BProtein-Coupled%252BReceptor%252BAllostery%25253A%252BFrom%252BFunction%252Bto%252BStructure%26aulast%3DChristopoulos%26aufirst%3DArthur%26date%3D2014%26date%3D2014%26volume%3D86%26issue%3D5%26spage%3D463%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Partial agonists: aripiprazole (<b>1</b>), cariprazine (<b>2</b>), brexpiprazole (<b>3</b>), and bifeprunox (<b>4</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Privileged structures: 2-methoxyphenylpiperazine (<b>5</b>), 2,3-dichlorophenylpiperazine (<b>6</b>), and 4,4-chlorophenyl-4-hydroxypiperidine (<b>7</b>). Antipsychotics and/or potent D<sub>2</sub>R antagonists: haloperidol (<b>8</b>), L-741,626 (<b>9</b>), risperidone (<b>10</b>), and ziprasidone (<b>11</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model pharmacophore for the development of novel D<sub>2</sub>R antagonists and/or partial agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Various Linker Lengths Incorporating Privileged Structures<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc anhydride, Et<sub>3</sub>N, DCM, rt, 1–1.5 h, 28–96%; (b) methanesulfonyl chloride, Et<sub>3</sub>N, DCM, 0 °C → rt; (c) <b>5</b>, <b>6</b>, or <b>7</b>, CH<sub>3</sub>CN, reflux, 24 h, 28–64%; (d) <b>5</b> or <b>7</b>, NaI, DIPEA, CH<sub>3</sub>CN, reflux, 24 h, 34–93%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Key Thienopyridine Scaffolds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) P<sub>4</sub>S<sub>10</sub>, EtOAc, reflux 1.5–4 h, 30%; (b) acetylacetone, KOH, MeOH, reflux, 4 h, 67%; (c) ethyl 2-chloroacetate, Et<sub>3</sub>N, 0 °C → rt, 3.5 h, 86%; (d) 1 M KOH, DMF, rt, 15 min, 93%; (e) 2 M NaOH, EtOH, reflux, 4 h, 83%; (f) methyl acetoacetate, morpholine, EtOH, reflux 8 h, 51%; (g) ethyl 2-chloroacetate, Et<sub>3</sub>N, DMF, 0 °C → rt, 5 h, 81%; (h) (i) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF, 4 h, rt; (ii) 1 M KOH, 15 min, 58%; (i) phthalic anhydride, AcOH, reflux, 20 h, 55%; (j) <i>N</i>-chlorosuccinimide, conc HCl, EtOH, reflux, 1.5 h, 93%; (k) (NH<sub>2</sub>)<sub>2</sub>·H<sub>2</sub>O, EtOH, reflux, 3 h, 84%; (l) 2 M NaOH, EtOH, reflux, 1.5 h, 84%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Full Length Structures Including Privileged Structures, Linker, and Thienopyridine Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Compounds <b>17a</b>–<b>e</b>, <b>18a</b>–<b>e</b>, and <b>19</b> were all deprotected prior to performing the coupling reaction. (a) BOP reagent, DIPEA, DMF, rt, 1–12 h, 29–70%.</p></p></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) ERK1/2 phosphorylation concentration–response assays. (B) Inhibition of FSK-induced cAMP production. (C) Bias plot representing the bias factor (ΔΔlog(τ/<i>K</i><sub>A</sub>)) of ligands between pERK1/2 and cAMP signaling pathways. Values are represented in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/medium/jm-2014-00457x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Progression of functionalizing privileged structure <b>6</b> with a linker (<b>19</b>) and substituted thienopyridine heterocycles (<b>35</b>, <b>36</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-11/jm500457x/production/images/large/jm-2014-00457x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500457x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51618" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51618" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Missale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span> </span><span class="NLM_article-title">Dopamine receptors: from structure to function</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1152%2Fphysrev.1998.78.1.189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=9457173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=1998&pages=189-225&author=C.+Missaleauthor=S.+R.+Nashauthor=S.+W.+Robinsonauthor=M.+Jaberauthor=M.+G.+Caron&title=Dopamine+receptors%3A+from+structure+to+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptors: from structure to function</span></div><div class="casAuthors">Missale, Cristina; Nash, S. Russel; Robinson, Susan W.; Jaber, Mohamed; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">189-225</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review, with 481 refs.  The diverse physiol. actions of dopamine are mediated by at least five distinct G protein-coupled receptor subtypes.  Two D1-like receptor subtypes (D1 and D5) couple to the G protein Gs and activate adenylyl cyclase.  The other receptor subtypes belong to the D2-like subfamily (D2, D3, and D4) and are prototypic of G protein-coupled receptors that inhibit adenylyl cyclase and activate K+ channels.  The genes for the D1 and D5 receptors are intron-less, but pseudogenes of the D5 exist.  The D2 and D3 receptors vary in certain tissues and species as a result of alternative splicing, and the human D4 receptor gene exhibits extensive polymorphic variation.  In the central nervous system, dopamine receptors are widely expressed because they are involved in the control of locomotion, cognition, emotion, and affect as well as neuroendocrine secretion.  In the periphery, dopamine receptors are present more prominently in kidney, vasculature, and pituitary, where they affect mainly sodium homeostasis, vascular tone, and hormone secretion.  Numerous genetic linkage anal. studies have failed so far to reveal unequivocal evidence for the involvement of one of these receptors in the etiol. of various central nervous system disorders.  However, targeted deletion of several of these dopamine receptor genes in mice should provide valuable information about their physiol. functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaajNmBxnkYbVg90H21EOLACvtfcHk0liNAcqwJ2V8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXptlOjtg%253D%253D&md5=a505d0e2c640ca205d4470ad69f607ff</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.1998.78.1.189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.1998.78.1.189%26sid%3Dliteratum%253Aachs%26aulast%3DMissale%26aufirst%3DC.%26aulast%3DNash%26aufirst%3DS.%2BR.%26aulast%3DRobinson%26aufirst%3DS.%2BW.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DDopamine%2520receptors%253A%2520from%2520structure%2520to%2520function%26jtitle%3DPhysiol.%2520Rev.%26date%3D1998%26volume%3D78%26spage%3D189%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Seeman, P.</span><span> </span><span class="NLM_article-title">Targeting the dopamine D2 receptor in schizophrenia</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1517%2F14728222.10.4.515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=16848689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-531&author=P.+Seeman&title=Targeting+the+dopamine+D2+receptor+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dopamine D2 receptor in schizophrenia</span></div><div class="casAuthors">Seeman, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-531</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  After a 12-yr search for the antipsychotic receptor, the binding site was discovered and labeled by [3H]haloperidol in 1975.  Of the various neurotransmitters, dopamine was the most potent in inhibiting the binding of [3H]haloperidol, indicating that the antipsychotic receptor was a dopamine receptor, now named the dopamine D2 receptor, a major targeting site in schizophrenia.  All antipsychotic drugs, including traditional and newer antipsychotics, either bind to D2 in direct relation to their clin. potencies or hinder normal dopamine neurotransmission, as in the case of partial dopamine agonists.  In fact, the antipsychotic concns. found in the plasma water of treated patients closely match the predicted therapeutic abs. concns., adjusted for the 60-75% D2 occupancy needed for clin. efficacy.  Antipsychotics that elicit low or no Parkinsonism or prolactinemia are loosely attached to D2 and rapidly dissoc. from D2, whereas those eliciting Parkinsonism stay tightly attached to D2 for many hours.  Because animal models of psychosis (amfetamine sensitization, brain lesions) all show a marked elevation in the no. of high-affinity states of D2, the antipsychotics are thought to specifically target these D2High states in psychosis in general and schizophrenia in particular.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGjVyTQvf6orVg90H21EOLACvtfcHk0liNAcqwJ2V8aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahtro%253D&md5=4ac073cabc6f50e8d0e3a2ecc631e781</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.10.4.515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.10.4.515%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520dopamine%2520D2%2520receptor%2520in%2520schizophrenia%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Shin, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malone, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span> </span><span class="NLM_article-title">Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F092986711795029546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktVOrsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1380-1404&author=J.+K.+Shinauthor=D.+T.+Maloneauthor=I.+T.+Crosbyauthor=B.+Capuano&title=Schizophrenia%3A+a+systematic+review+of+the+disease+state%2C+current+therapeutics+and+their+molecular+mechanisms+of+action"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action</span></div><div class="casAuthors">Shin, J. K.; Malone, D. T.; Crosby, I. T.; Capuano, B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1380-1404</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The treatment of schizophrenia, one of the most debilitating mental illnesses, began by the serendipitous discovery of chlorpromazine.  Since then, researchers have endeavored to find the cause of the illness but it remains unresolved.  As a result, literature on the etiol. of schizophrenia is littered with hypotheses and theories that are constantly reviewed, modified and rejected.  Two hypotheses, however, have withstood the test of time and serve as the basis for the drug treatment, namely the dopamine and serotonin hypotheses.  This review introduces the disease state, summarizes in detail the two leading hypotheses on schizophrenia, presents drugs that are currently available for treatment, and discusses some of the promising drug candidates based on their pre and early clin. trial results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEW2ubYcABYbVg90H21EOLACvtfcHk0lgw49RGAwRCXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktVOrsrw%253D&md5=a3076e349c481ddd8926495b6435c4a1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F092986711795029546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795029546%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%2BK.%26aulast%3DMalone%26aufirst%3DD.%2BT.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DCapuano%26aufirst%3DB.%26atitle%3DSchizophrenia%253A%2520a%2520systematic%2520review%2520of%2520the%2520disease%2520state%252C%2520current%2520therapeutics%2520and%2520their%2520molecular%2520mechanisms%2520of%2520action%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1380%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Tandon, R.</span><span> </span><span class="NLM_article-title">Pharmacologic treatment of schizophrenia: current status and future trends</span> <span class="citation_source-journal">Curr. Psychosis Ther. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">40</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1007%2FBF02629413" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=40-49&author=R.+Tandon&title=Pharmacologic+treatment+of+schizophrenia%3A+current+status+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2FBF02629413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02629413%26sid%3Dliteratum%253Aachs%26aulast%3DTandon%26aufirst%3DR.%26atitle%3DPharmacologic%2520treatment%2520of%2520schizophrenia%253A%2520current%2520status%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Psychosis%2520Ther.%2520Rep.%26date%3D2006%26volume%3D4%26spage%3D40%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Rosen, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendler, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, K. L.</span><span> </span><span class="NLM_article-title">Positive and negative symptoms in schizophrenia</span> <span class="citation_source-journal">Psychiatry Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1016%2F0165-1781%2884%2990075-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A280%3ADyaL2M7htlKltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1984&pages=277-284&author=W.+G.+Rosenauthor=R.+C.+Mohsauthor=C.+A.+Johnsauthor=N.+S.+Smallauthor=K.+S.+Kendlerauthor=T.+B.+Horvathauthor=K.+L.+Davis&title=Positive+and+negative+symptoms+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Positive and negative symptoms in schizophrenia</span></div><div class="casAuthors">Rosen W G; Mohs R C; Johns C A; Small N S; Kendler K S; Horvath T B; Davis K L</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry research</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-84</span>
        ISSN:<span class="NLM_cas:issn">0165-1781</span>.
    </div><div class="casAbstract">Negative and positive symptoms were determined for 46 drug-free patients who met Research Diagnostic Criteria (RDC) and/or Feighner criteria for schizophrenia.  A modified version of the Scale for the Assessment of Negative Symptoms (SANS) was completed for each patient based on items from the Schedule for Affective Disorders and Schizophrenia (SADS) and other scales.  Positive symptoms were scored from the SADS as well as from the following four diagnostic systems: RDC, Schneider's first-rank symptoms, the 12-point Flexible system, and Langfeldt's criteria for poor prognosis schizophrenia.  For all patients, there was no correlation of negative symptoms and positive symptoms defined by any diagnostic system.  Within the paranoid and undifferentiated subtypes, there was a positive correlation of positive and negative symptoms.  Patients moving from stable to exacerbated states had an increase in both positive and negative symptoms, and patients with a poor history of treatment response had both more positive and more negative symptoms than responsive patients in a stable state.  These results do not support the view that subgroups of patients have predominantly either negative or positive symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPLmAVPmDrAkEksK8CslK8fW6udTcc2eaVztlC9cViArntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7htlKltA%253D%253D&md5=65e3b85232c14cfb0b901c82a8484890</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2F0165-1781%2884%2990075-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1781%252884%252990075-1%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DW.%2BG.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DJohns%26aufirst%3DC.%2BA.%26aulast%3DSmall%26aufirst%3DN.%2BS.%26aulast%3DKendler%26aufirst%3DK.%2BS.%26aulast%3DHorvath%26aufirst%3DT.%2BB.%26aulast%3DDavis%26aufirst%3DK.%2BL.%26atitle%3DPositive%2520and%2520negative%2520symptoms%2520in%2520schizophrenia%26jtitle%3DPsychiatry%2520Res.%26date%3D1984%26volume%3D13%26spage%3D277%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domae, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, T.</span><span> </span><span class="NLM_article-title">Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1<i>H</i>)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=8613910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaK28XitlCmtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1996&pages=137-143&author=T.+Inoueauthor=M.+Domaeauthor=K.+Yamadaauthor=T.+Furukawa&title=Effects+of+the+novel+antipsychotic+agent+7-%284-%5B4-%282%2C3-dichlorophenyl%29-1-piperazinyl%5Dbutyloxy%29-3%2C4-dihydro-2%281H%29-quinolinone+%28OPC-14597%29+on+prolactin+release+from+the+rat+anterior+pituitary+gland"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the novel antipsychotic agent 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland</span></div><div class="casAuthors">Inoue, Tsutomu; Domae, Mariko; Yamada, Katsushi; Furukawa, Tatsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-43</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The effects of a novel antipsychotic agent, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone (OPC-14597, generic name aripiprazole), on prolactin (PRL) release from isolated rat anterior pituitary slices and on the serum PRL levels were investigated in male rats.  In in vitro expts. on the isolated anterior pituitary, the spontaneous PRL release was decreased by talipexole, a dopamine D2 receptor full agonist, in a dose-dependent manner to 36% of the basal release, and the decrease was antagonized by haloperidol, a D2 receptor antagonist.  OPC-14597 also decreased the release of PRL at the same concn. range with a maximal decrease to 78%, the potency being weaker than that of talipexole.  The decrease in PRL release induced by OPC-14597 was completely antagonized by haloperidol.  Moreover, OPC-14597 antagonized the inhibition of PRL release induced by talipexole.  In in vivo expts., haloperidol increased the serum PRL levels to 8 times the basal PRL level, whereas talipexole decreased the levels to 40% of the basal level.  OPC-14597 increased the serum PRL levels by 2-fold and also antagonized the talipexole-induced decrease.  The hyperprolactinemia induced by estrogen, which was inhibited by talipexole but enhanced by haloperidol was enhanced by OPC-14597, whereas the hyperprolactinemia induced by reserpine, which was inhibited by talipexole but elevated by haloperidol, was inhibited by OPC-14597.  In addn., the OPC-14597-induced inhibition was antagonized by haloperidol.  These results suggest that OPC-14597 has a mixed agonist/antagonist profile at D2 receptors on lactotroph cells and thereby exerts either an antagonistic or an agonistic action, depending on the preexisting tone of the dopaminergic neuronal activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqupnFWqRH-zrVg90H21EOLACvtfcHk0lgw49RGAwRCXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitlCmtr0%253D&md5=bdc1a55d2462cc975961396ecb7e476c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DDomae%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DK.%26aulast%3DFurukawa%26aufirst%3DT.%26atitle%3DEffects%2520of%2520the%2520novel%2520antipsychotic%2520agent%25207-%25284-%255B4-%25282%252C3-dichlorophenyl%2529-1-piperazinyl%255Dbutyloxy%2529-3%252C4-dihydro-2%25281H%2529-quinolinone%2520%2528OPC-14597%2529%2520on%2520prolactin%2520release%2520from%2520the%2520rat%2520anterior%2520pituitary%2520gland%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D277%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jordan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koprivica, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tottori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altar, C. A.</span><span> </span><span class="NLM_article-title">The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1016%2FS0014-2999%2802%2901532-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=12063084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVSiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2002&pages=137-140&author=S.+Jordanauthor=V.+Koprivicaauthor=R.+Chenauthor=K.+Tottoriauthor=T.+Kikuchiauthor=C.+A.+Altar&title=The+antipsychotic+aripiprazole+is+a+potent%2C+partial+agonist+at+the+human+5-HT1A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor</span></div><div class="casAuthors">Jordan, Shaun; Koprivica, Vuk; Chen, Ruoyan; Tottori, Katsura; Kikuchi, Tetsuro; Altar, C. Anthony</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">441</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-140</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aripiprazole, 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy}-3,4-dihydro-2(1H)-quinolinone, a novel antipsychotic with partial agonist activity at dopamine D2 receptors, bound with high affinity to recombinant human 5-HT1A receptors (h5-HT1A) in Chinese hamster ovary cell membranes and displayed potent, partial agonism at 5-HT1A receptors in a guanosine-5'-O-(3-[35S]thio)-triphosphate ([35S]GTPγS)-binding assay that was blocked completely by a selective 5-HT1A receptor antagonist.  An interaction with 5-HT1A receptors may contribute to the overall efficacy of aripiprazole against symptoms of schizophrenia, including anxiety, depression, cognitive and neg. symptoms, and to its favorable side-effect profile.  Combined with previous studies demonstrating the potent partial agonism of aripiprazole at dopamine D2 receptors, this study suggests aripiprazole is the first dopamine-serotonin system stabilizer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJJO4Wtm_rYLVg90H21EOLACvtfcHk0ljM9EkCJfJrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVSiurg%253D&md5=61ef193ae9b08505e8ea0ba1c0d54f32</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2802%2901532-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252802%252901532-7%26sid%3Dliteratum%253Aachs%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DKoprivica%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DTottori%26aufirst%3DK.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DAltar%26aufirst%3DC.%2BA.%26atitle%3DThe%2520antipsychotic%2520aripiprazole%2520is%2520a%2520potent%252C%2520partial%2520agonist%2520at%2520the%2520human%25205-HT1A%2520receptor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D441%26spage%3D137%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Shapiro, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renock, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiodo, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R.</span><span> </span><span class="NLM_article-title">Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1400</span><span class="NLM_x">–</span> <span class="NLM_lpage">1411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=1400-1411&author=D.+A.+Shapiroauthor=S.+Renockauthor=E.+Arringtonauthor=L.+A.+Chiodoauthor=L.-X.+Liuauthor=D.+R.+Sibleyauthor=B.+L.+Rothauthor=R.+Mailman&title=Aripiprazole%2C+a+novel+atypical+antipsychotic+drug+with+a+unique+and+robust+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DD.%2BA.%26aulast%3DRenock%26aufirst%3DS.%26aulast%3DArrington%26aufirst%3DE.%26aulast%3DChiodo%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DL.-X.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMailman%26aufirst%3DR.%26atitle%3DAripiprazole%252C%2520a%2520novel%2520atypical%2520antipsychotic%2520drug%2520with%2520a%2520unique%2520and%2520robust%2520pharmacology%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D1400%26epage%3D1411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Tamminga, C. A.</span><span> </span><span class="NLM_article-title">Partial dopamine agonists in the treatment of psychosis</span> <span class="citation_source-journal">J. Neural Transm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">411</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=411-420&author=C.+A.+Tamminga&title=Partial+dopamine+agonists+in+the+treatment+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26atitle%3DPartial%2520dopamine%2520agonists%2520in%2520the%2520treatment%2520of%2520psychosis%26jtitle%3DJ.%2520Neural%2520Transm.%26date%3D2002%26volume%3D109%26spage%3D411%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kenakin, T.</span><span> </span><span class="NLM_article-title">Functional selectivity and biased receptor signaling</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x">, </span> <span class="NLM_fpage">296</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1124%2Fjpet.110.173948" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=21030484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=296-302&author=T.+Kenakin&title=Functional+selectivity+and+biased+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity and biased receptor signaling</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">296-302</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  With the emergence of information describing functional selectivity and biased agonists and antagonists has come a lack of confidence in "one size fits all" assays for detection of agonism.  Seven-transmembrane receptors are pleiotropic with respect to the signaling protein to which they couple in a cell, and many conformations of the receptor can be formed; this leads to systems where ligands can stabilize unique conformations that go on to selectively activate signaling pathways.  Thus, such "biased" ligands can produce cell-specific agonism that may require targeted assays to detect and quantify.  It also predicts that ligands can have many different efficacies for the many behaviors that the receptor can exhibit (referred to as "pluridimensional efficacy"), leading to a breakdown in the common classifications of agonist and antagonist.  This all poses unique challenges to the pharmacol. nomenclature of drugs, the detection and optimization of new drugs, and the assocn. of phenotypic clin. profiles with pharmacol. properties of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDmshypfoNALVg90H21EOLACvtfcHk0ljM9EkCJfJrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhslWhsr0%253D&md5=83d2c05fec2f9ef9a6e97a98bc0a3616</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.173948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.173948%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DFunctional%2520selectivity%2520and%2520biased%2520receptor%2520signaling%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D296%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span> </span><span class="NLM_article-title">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1038%2Fnrd3954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=23411724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=205-216&author=T.+Kenakinauthor=A.+Christopoulos&title=Signalling+bias+in+new+drug+discovery%3A+detection%2C+quantification+and+therapeutic+impact"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling bias in new drug discovery: detection, quantification and therapeutic impact</span></div><div class="casAuthors">Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Agonists of seven-transmembrane receptors, also known as G protein-coupled receptors (GPCRs), do not uniformly activate all cellular signalling pathways linked to a given seven-transmembrane receptor (a phenomenon termed ligand or agonist bias); this discovery has changed how high-throughput screens are designed and how lead compds. are optimized for therapeutic activity.  The ability to exptl. detect ligand bias has necessitated the development of methods for quantifying agonist bias in a way that can be used to guide structure-activity studies and the selection of drug candidates.  Here, we provide a viewpoint on which methods are appropriate for quantifying bias, based on knowledge of how cellular and intracellular signalling proteins control the conformation of seven-transmembrane receptors.  We also discuss possible predictions of how biased mols. may perform in vivo, and what potential therapeutic advantages they may provide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkDNsO17tty7Vg90H21EOLACvtfcHk0ljM9EkCJfJrBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7c%253D&md5=712258b9158f753689e35fa31f1b67f0</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrd3954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3954%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DSignalling%2520bias%2520in%2520new%2520drug%2520discovery%253A%2520detection%252C%2520quantification%2520and%2520therapeutic%2520impact%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26spage%3D205%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Stallaert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">811</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1517%2F17460441.2011.586691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=22651124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVKqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=811-825&author=W.+Stallaertauthor=A.+Christopoulosauthor=M.+Bouvier&title=Ligand+functional+selectivity+and+quantitative+pharmacology+at+G+protein-coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors</span></div><div class="casAuthors">Stallaert, Wayne; Christopoulos, Arthur; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">811-825</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: In recent years, it has become clear that individual GPCRs can elicit multiple G-protein-dependent and -independent cellular responses.  This has led to the discovery that certain ligands can differentially modulate these responses, a concept known as functional selectivity.  Areas covered: In this review, the authors describe the various manifestations of functional selectivity and its potential implication in drug discovery.  The authors provide a historical perspective of the observations and methodologies that led to the evolution of this concept.  The authors also describe the proposed mol. mechanisms responsible for the engagement of distinct subsets of signaling repertoire by different ligands.  The review offers the reader a synthetic view of how functional selectivity could be used in the design of safer and more effective drugs.  Expert opinion: Our better understanding of the various ways by which compds. modulate GPCR activity has led to a parallel expansion of the terminol. used to describe these phenomena.  The authors propose a standardization of this nomenclature as an essential step to both simplify and clarify the language used among researchers to facilitate future collaboration and discovery of these important therapeutic targets.  Such clarification of the various aspects of functional selectivity, coupled with the development of tools for effective monitoring, will undoubtedly bring this emerging concept into the general paradigm of drug discovery at GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooWYzSGmiOs7Vg90H21EOLACvtfcHk0lie45WAgeULcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVKqsrY%253D&md5=43d46becf067f93a4f209284aa47e27b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1517%2F17460441.2011.586691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2011.586691%26sid%3Dliteratum%253Aachs%26aulast%3DStallaert%26aufirst%3DW.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DLigand%2520functional%2520selectivity%2520and%2520quantitative%2520pharmacology%2520at%2520G%2520protein-coupled%2520receptors%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D811%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zastrow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2006&pages=67-77&author=J.+D.+Urbanauthor=G.+A.+Vargasauthor=M.+von+Zastrowauthor=R.+B.+Mailman&title=Aripiprazole+has+functionally+selective+actions+at+dopamine+D2+receptor-mediated+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BZastrow%26aufirst%3DM.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DAripiprazole%2520has%2520functionally%2520selective%2520actions%2520at%2520dopamine%2520D2%2520receptor-mediated%2520signaling%2520pathways%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D32%26spage%3D67%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Allen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yost, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yadav, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.-p.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">18488</span><span class="NLM_x">–</span> <span class="NLM_lpage">18493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=18488-18493&author=J.+A.+Allenauthor=J.+M.+Yostauthor=V.+Setolaauthor=X.+Chenauthor=M.+F.+Sassanoauthor=M.+Chenauthor=S.+Petersonauthor=P.+N.+Yadavauthor=X.-p.+Huangauthor=B.+Fengauthor=N.+H.+Jensenauthor=X.+Cheauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=M.+G.+Caronauthor=J.+A.+Javitchauthor=B.+L.+Rothauthor=J.+Jin&title=Discovery+of+%CE%B2-arrestin-biased+dopamine+D2+ligands+for+probing+signal+transduction+pathways+essential+for+antipsychotic+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BA.%26aulast%3DYost%26aufirst%3DJ.%2BM.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DYadav%26aufirst%3DP.%2BN.%26aulast%3DHuang%26aufirst%3DX.-p.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DChe%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520ligands%2520for%2520probing%2520signal%2520transduction%2520pathways%2520essential%2520for%2520antipsychotic%2520efficacy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2011%26volume%3D108%26spage%3D18488%26epage%3D18493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sassano, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetsel, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, J.</span><span> </span><span class="NLM_article-title">Structure–functional selectivity relationship studies of β-arrestin-biased dopamine D2 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">7141</span><span class="NLM_x">–</span> <span class="NLM_lpage">7153</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300603y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7141-7153&author=X.+Chenauthor=M.+F.+Sassanoauthor=L.+Zhengauthor=V.+Setolaauthor=M.+Chenauthor=X.+Baiauthor=S.+V.+Fryeauthor=W.+C.+Wetselauthor=B.+L.+Rothauthor=J.+Jin&title=Structure%E2%80%93functional+selectivity+relationship+studies+of+%CE%B2-arrestin-biased+dopamine+D2+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm300603y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300603y%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DBai%26aufirst%3DX.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DStructure%25E2%2580%2593functional%2520selectivity%2520relationship%2520studies%2520of%2520%25CE%25B2-arrestin-biased%2520dopamine%2520D2%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7141%26epage%3D7153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gay, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urban, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxford, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=97-105&author=E.+A.+Gayauthor=J.+D.+Urbanauthor=D.+E.+Nicholsauthor=G.+S.+Oxfordauthor=R.+B.+Mailman&title=Functional+selectivity+of+D2+receptor+ligands+in+a+Chinese+hamster+ovary+hD2L+cell+line%3A+evidence+for+induction+of+ligand-specific+receptor+states"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGay%26aufirst%3DE.%2BA.%26aulast%3DUrban%26aufirst%3DJ.%2BD.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DOxford%26aufirst%3DG.%2BS.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520D2%2520receptor%2520ligands%2520in%2520a%2520Chinese%2520hamster%2520ovary%2520hD2L%2520cell%2520line%253A%2520evidence%2520for%2520induction%2520of%2520ligand-specific%2520receptor%2520states%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Mottola, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connery, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, Q. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyslop, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wightman, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1124%2Fjpet.301.3.1166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=12023552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2002&pages=1166-1178&author=D.+M.+Mottolaauthor=J.+D.+Kiltsauthor=M.+M.+Lewisauthor=H.+S.+Conneryauthor=Q.+D.+Walkerauthor=S.+R.+Jonesauthor=R.+G.+Boothauthor=D.+K.+Hyslopauthor=M.+Pierceyauthor=R.+M.+Wightmanauthor=C.+P.+Lawlerauthor=D.+E.+Nicholsauthor=R.+B.+Mailman&title=Functional+selectivity+of+dopamine+receptor+agonists.+I.+Selective+activation+of+postsynaptic+dopamine+D2+receptors+linked+to+adenylate+cyclase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase</span></div><div class="casAuthors">Mottola, David M.; Kilts, Jason D.; Lewis, Mechelle M.; Connory, Hilary S.; Walker, Q. David; Jones, Sara R.; Booth, Raymond G.; Hyslop, Deborah K.; Piercey, Monford; Wightman, R. Mark; Lawler, Cindy P.; Nichols, David E.; Mailman, Richard B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">301</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1166-1179</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dihydrexidine (DHX), the first high-affinity D1 dopamine receptor full agonist, is only 10-fold selective for D1 vs. D2 receptors, having D2 affinity similar to the prototypical agonist quinpirole.  The D2 functional properties of DHX and its more D2 selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary.  DHX and PrDHX had binding characteristics to D2 receptors in rat striatum typical of D2 agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides.  Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equiv. to that of quinpirole.  Unexpectedly, however, DHX and PrDHX had little functional effect at D2 receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis.  Quant. receptor competition autoradiog. demonstrated that DHX bound to D2 receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D2 sites in the substantia nigra (autoreceptor sites).  The data from these expts., coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D2L and D2S receptors, causes agonist-typical functional changes only at some of these receptors.  This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at sep. functions mediated by a single isoform, yielding novel approaches to drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpif5JbU-Rs9bVg90H21EOLACvtfcHk0ljAfvkOskh-mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGjtrY%253D&md5=b1d65ec3f66b3652deb9f9a4c76b70a3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fjpet.301.3.1166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.301.3.1166%26sid%3Dliteratum%253Aachs%26aulast%3DMottola%26aufirst%3DD.%2BM.%26aulast%3DKilts%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DConnery%26aufirst%3DH.%2BS.%26aulast%3DWalker%26aufirst%3DQ.%2BD.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DBooth%26aufirst%3DR.%2BG.%26aulast%3DHyslop%26aufirst%3DD.%2BK.%26aulast%3DPiercey%26aufirst%3DM.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DFunctional%2520selectivity%2520of%2520dopamine%2520receptor%2520agonists.%2520I.%2520Selective%2520activation%2520of%2520postsynaptic%2520dopamine%2520D2%2520receptors%2520linked%2520to%2520adenylate%2520cyclase%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D301%26spage%3D1166%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollinger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Histidine 6.55 is a major determinant of ligand-biased signaling in dopamine D2L receptor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2011&pages=575-585&author=N.+Tschammerauthor=S.+Bollingerauthor=T.+Kenakinauthor=P.+Gmeiner&title=Histidine+6.55+is+a+major+determinant+of+ligand-biased+signaling+in+dopamine+D2L+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DBollinger%26aufirst%3DS.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHistidine%25206.55%2520is%2520a%2520major%2520determinant%2520of%2520ligand-biased%2520signaling%2520in%2520dopamine%2520D2L%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2011%26volume%3D79%26spage%3D575%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Shonberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herenbrink, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">López, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scammells, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span> </span><span class="NLM_article-title">A structure–activity analysis of biased agonism at the dopamine D2 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9199</span><span class="NLM_x">–</span> <span class="NLM_lpage">9221</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401318w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9199-9221&author=J.+Shonbergauthor=C.+K.+Herenbrinkauthor=L.+L%C3%B3pezauthor=A.+Christopoulosauthor=P.+J.+Scammellsauthor=B.+Capuanoauthor=J.+R.+Lane&title=A+structure%E2%80%93activity+analysis+of+biased+agonism+at+the+dopamine+D2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm401318w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401318w%26sid%3Dliteratum%253Aachs%26aulast%3DShonberg%26aufirst%3DJ.%26aulast%3DHerenbrink%26aufirst%3DC.%2BK.%26aulast%3DL%25C3%25B3pez%26aufirst%3DL.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DScammells%26aufirst%3DP.%2BJ.%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26atitle%3DA%2520structure%25E2%2580%2593activity%2520analysis%2520of%2520biased%2520agonism%2520at%2520the%2520dopamine%2520D2%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9199%26epage%3D9221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">DeSimone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitchell, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darrow, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span> </span><span class="NLM_article-title">Privileged structures: applications in drug discovery</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F1386207043328544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=15320713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=473-493&author=R.+W.+DeSimoneauthor=K.+S.+Currieauthor=S.+A.+Mitchellauthor=J.+W.+Darrowauthor=D.+A.+Pippin&title=Privileged+structures%3A+applications+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: Applications in drug discovery</span></div><div class="casAuthors">DeSimone, R. W.; Currie, K. S.; Mitchell, S. A.; Darrow, J. W.; Pippin, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">473-493</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Over the past 15 yr the privileged structure concept has emerged as a fruitful approach to the discovery of novel biol. active mols.  Privileged structures are mol. scaffolds with versatile binding properties, such that a single scaffold is able to provide potent and selective ligands for a range of different biol. targets through modification of functional groups.  In addn., privileged structures typically exhibit good drug-like properties, which in turn leads to more drug-like compd. libraries and leads.  The net result is the prodn. of high quality leads that provide a solid foundation for further development.  The identification of privileged structures will be discussed, emphasizing the importance of understanding the structure-target relationships that confer "privileged" status.  This understanding allows privileged structure based libraries to be targeted at distinct target families (e.g. GPCRs, LGIC, enzymes/kinases).  Privileged structures have been successfully exploited across and within different target families and promises to be an effective approach to the discovery and optimization of novel bioactive mols.  The application of the privileged structure approach, both in traditional medicinal chem. and in the design of focused libraries, will be discussed with the aid of illustrative examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLIDSZoRtfibVg90H21EOLACvtfcHk0ljAfvkOskh-mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFegsrY%253D&md5=165b976f9d6c6d38d752cabf2c647a48</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F1386207043328544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207043328544%26sid%3Dliteratum%253Aachs%26aulast%3DDeSimone%26aufirst%3DR.%2BW.%26aulast%3DCurrie%26aufirst%3DK.%2BS.%26aulast%3DMitchell%26aufirst%3DS.%2BA.%26aulast%3DDarrow%26aufirst%3DJ.%2BW.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26atitle%3DPrivileged%2520structures%253A%2520applications%2520in%2520drug%2520discovery%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2004%26volume%3D7%26spage%3D473%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Costantino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">Privileged structures as leads in medicinal chemistry</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=381-422&author=L.+Costantinoauthor=D.+Barlocco&title=Privileged+structures+as+leads+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DPrivileged%2520structures%2520as%2520leads%2520in%2520medicinal%2520chemistry%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D5%26spage%3D381%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Duarte, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C. A. M.</span><span> </span><span class="NLM_article-title">Privileged structures: a useful concept for the rational design of new lead drug candidates</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.2174%2F138955707782331722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=18045214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlarur7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1108-1119&author=C.+D.+Duarteauthor=E.+J.+Barreiroauthor=C.+A.+M.+Fraga&title=Privileged+structures%3A+a+useful+concept+for+the+rational+design+of+new+lead+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Privileged structures: a useful concept for the rational design of new lead drug candidates</span></div><div class="casAuthors">Duarte, Carolina D.; Barreiro, Eliezer J.; Fraga, Carlos A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1108-1119</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Privileged structures are defined as mol. frameworks which are able of providing useful ligands for more than one type of receptor or enzyme target by judicious structural modifications.  In the present work, we describe some examples and applications of the usefulness of the privileged structure concept for the structural design of new drug candidates, by discussing the eligibility of such motifs, including the identification of the N-acylhydrazone template as privileged structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2kVveFXlhk7Vg90H21EOLACvtfcHk0ljAfvkOskh-mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlarur7E&md5=26644458b92e31309de84f61ea6a2120</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138955707782331722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955707782331722%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DC.%2BD.%26aulast%3DBarreiro%26aufirst%3DE.%2BJ.%26aulast%3DFraga%26aufirst%3DC.%2BA.%2BM.%26atitle%3DPrivileged%2520structures%253A%2520a%2520useful%2520concept%2520for%2520the%2520rational%2520design%2520of%2520new%2520lead%2520drug%2520candidates%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1108%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bondensgaard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ankersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thøgersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulff, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bywater, R. P.</span><span> </span><span class="NLM_article-title">Recognition of privileged structures by G-protein coupled receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">–</span> <span class="NLM_lpage">899</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0309452" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=888-899&author=K.+Bondensgaardauthor=M.+Ankersenauthor=H.+Th%C3%B8gersenauthor=B.+S.+Hansenauthor=B.+S.+Wulffauthor=R.+P.+Bywater&title=Recognition+of+privileged+structures+by+G-protein+coupled+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0309452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0309452%26sid%3Dliteratum%253Aachs%26aulast%3DBondensgaard%26aufirst%3DK.%26aulast%3DAnkersen%26aufirst%3DM.%26aulast%3DTh%25C3%25B8gersen%26aufirst%3DH.%26aulast%3DHansen%26aufirst%3DB.%2BS.%26aulast%3DWulff%26aufirst%3DB.%2BS.%26aulast%3DBywater%26aufirst%3DR.%2BP.%26atitle%3DRecognition%2520of%2520privileged%2520structures%2520by%2520G-protein%2520coupled%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D888%26epage%3D899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broughton, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtis, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawer, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridgill, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emms, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marwood, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ragan, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeson, P. D.</span><span> </span><span class="NLM_article-title">3-[[4-(4-Chlorophenyl)piperazin-1-yl]methyl]-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1941</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9600712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1941-1942&author=J.+J.+Kulagowskiauthor=H.+B.+Broughtonauthor=N.+R.+Curtisauthor=I.+M.+Mawerauthor=M.+P.+Ridgillauthor=R.+Bakerauthor=F.+Emmsauthor=S.+B.+Freedmanauthor=R.+Marwoodauthor=S.+Patelauthor=S.+Patelauthor=C.+I.+Raganauthor=P.+D.+Leeson&title=3-%5B%5B4-%284-Chlorophenyl%29piperazin-1-yl%5Dmethyl%5D-1H-pyrrolo%5B2%2C3-b%5Dpyridine%3A+an+antagonist+with+high+affinity+and+selectivity+for+the+human+dopamine+D4+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm9600712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9600712%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBroughton%26aufirst%3DH.%2BB.%26aulast%3DCurtis%26aufirst%3DN.%2BR.%26aulast%3DMawer%26aufirst%3DI.%2BM.%26aulast%3DRidgill%26aufirst%3DM.%2BP.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DEmms%26aufirst%3DF.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DMarwood%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRagan%26aufirst%3DC.%2BI.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26atitle%3D3-%255B%255B4-%25284-Chlorophenyl%2529piperazin-1-yl%255Dmethyl%255D-1H-pyrrolo%255B2%252C3-b%255Dpyridine%253A%2520an%2520antagonist%2520with%2520high%2520affinity%2520and%2520selectivity%2520for%2520the%2520human%2520dopamine%2520D4%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1941%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Löber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Recent advances in the search for D3- and D4-selective drugs: probes, models and candidates</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=148-157&author=S.+L%C3%B6berauthor=H.+H%C3%BCbnerauthor=N.+Tschammerauthor=P.+Gmeiner&title=Recent+advances+in+the+search+for+D3-+and+D4-selective+drugs%3A+probes%2C+models+and+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25B6ber%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DRecent%2520advances%2520in%2520the%2520search%2520for%2520D3-%2520and%2520D4-selective%2520drugs%253A%2520probes%252C%2520models%2520and%2520candidates%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D148%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Newman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuming, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banala, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donthamsetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaBounty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitch, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Molecular determinants of selectivity and efficacy at the dopamine D3 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6689</span><span class="NLM_x">–</span> <span class="NLM_lpage">6699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300482h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6689-6699&author=A.+H.+Newmanauthor=T.+Beumingauthor=A.+K.+Banalaauthor=P.+Donthamsettiauthor=K.+Pongettiauthor=A.+LaBountyauthor=B.+Levyauthor=J.+Caoauthor=M.+Michinoauthor=R.+R.+Luedtkeauthor=J.+A.+Javitchauthor=L.+Shi&title=Molecular+determinants+of+selectivity+and+efficacy+at+the+dopamine+D3+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of Selectivity and Efficacy at the Dopamine D3 Receptor</span></div><div class="casAuthors">Newman, Amy Hauck; Beuming, Thijs; Banala, Ashwini K.; Donthamsetti, Prashant; Pongetti, Katherine; LaBounty, Alex; Levy, Benjamin; Cao, Jianjing; Michino, Mayako; Luedtke, Robert R.; Javitch, Jonathan A.; Shi, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6689-6699</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The dopamine D3 receptor (D3R) has been implicated in substance abuse and other neuropsychiatric disorders.  The high sequence homol. between the D3R and D2R, esp. within the orthosteric binding site (OBS) that binds dopamine, has made the development of D3R-selective compds. challenging.  Here, we deconstruct into pharmacophoric elements a series of D3R-selective substituted-4-phenylpiperazine compds. and use computational simulations and binding and activation studies to dissect the structural bases for D3R selectivity and efficacy.  We find that selectivity arises from divergent interactions within a second binding pocket (SBP) sep. from the OBS, whereas efficacy depends on the binding mode in the OBS.  Our findings reveal structural features of the receptor that are crit. to selectivity and efficacy that can be used to design highly D3R-selective ligands with targeted efficacies.  These findings are generalizable to other GPCRs in which the SBP can be targeted by bitopic or allosteric ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmBJU7uyvVg7Vg90H21EOLACvtfcHk0lhf5wnEHBXHGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsFCkt7c%253D&md5=033dd49282723650828a3ec0a31211e5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm300482h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300482h%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DA.%2BH.%26aulast%3DBeuming%26aufirst%3DT.%26aulast%3DBanala%26aufirst%3DA.%2BK.%26aulast%3DDonthamsetti%26aufirst%3DP.%26aulast%3DPongetti%26aufirst%3DK.%26aulast%3DLaBounty%26aufirst%3DA.%26aulast%3DLevy%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DMichino%26aufirst%3DM.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DJavitch%26aufirst%3DJ.%2BA.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DMolecular%2520determinants%2520of%2520selectivity%2520and%2520efficacy%2520at%2520the%2520dopamine%2520D3%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6689%26epage%3D6699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Capuano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, I. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podloucka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. A.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary pharmacological evaluation of 4′-arylalkyl analogues of clozapine. IV. The effects of aromaticity and isosteric replacement</span> <span class="citation_source-journal">Aust. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">940</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=930-940&author=B.+Capuanoauthor=I.+T.+Crosbyauthor=E.+J.+Lloydauthor=A.+Podlouckaauthor=D.+A.+Taylor&title=Synthesis+and+preliminary+pharmacological+evaluation+of+4%E2%80%B2-arylalkyl+analogues+of+clozapine.+IV.+The+effects+of+aromaticity+and+isosteric+replacement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCapuano%26aufirst%3DB.%26aulast%3DCrosby%26aufirst%3DI.%2BT.%26aulast%3DLloyd%26aufirst%3DE.%2BJ.%26aulast%3DPodloucka%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DD.%2BA.%26atitle%3DSynthesis%2520and%2520preliminary%2520pharmacological%2520evaluation%2520of%25204%25E2%2580%25B2-arylalkyl%2520analogues%2520of%2520clozapine.%2520IV.%2520The%2520effects%2520of%2520aromaticity%2520and%2520isosteric%2520replacement%26jtitle%3DAust.%2520J.%2520Chem.%26date%3D2008%26volume%3D61%26spage%3D930%26epage%3D940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Abdel-Fattah, M. A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadi, A. H.</span><span> </span><span class="NLM_article-title">An interactive SAR approach to discover novel hybrid thieno probes as ligands for D2-like receptors with affinities in the subnanomolar range</span> <span class="citation_source-journal">Chem. Biodiversity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1002%2Fcbdv.201300204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=24327445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=2247-2266&author=M.+A.+O.+Abdel-Fattahauthor=J.+Lehmannauthor=A.+H.+Abadi&title=An+interactive+SAR+approach+to+discover+novel+hybrid+thieno+probes+as+ligands+for+D2-like+receptors+with+affinities+in+the+subnanomolar+range"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">An Interactive SAR Approach to Discover Novel Hybrid Thieno Probes as Ligands for D2-Like Receptors with Affinities in the Subnanomolar Range</span></div><div class="casAuthors">Abdel-Fattah, Mohamed A. O.; Lehmann, Jochen; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biodiversity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2266</span>CODEN:
                <span class="NLM_cas:coden">CBHIAM</span>;
        ISSN:<span class="NLM_cas:issn">1612-1872</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">Arylpiperazinylalkyl phthalimides I [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; X = (CH2)n; n = 1, 2] and arylpiperazinylalkyl benzamides and thiophenecarboxamides II [R = 2-EtOC6H4, 2,3-Cl2C6H3, 2-FC6H4, 2-ClC6H4, 2-HOC6H4, 4-FC6H4, 4-ClC6H4, 3,4-Cl2C6H3, 4-HOC6H4, Ph; R1 = Ph, 2-thienyl; X = (CH2)n; n = 1, 2] were prepd. as selective ligands for dopamine D3 and D4 (D2-like) receptors.  Of the arylpiperazinylalkyl phthalimides prepd., I (R = 2-EtOC6H4; n = 2) showed the highest affinity towards D4 and D3 receptors with Ki values in the low nanomolar range, and D2/D4- and D2/D3-selectivity indexes of 72 and 20, resp.  Further optimization led to the D4-selective ligand II (R1 = 2-thienyl; n = 1) with a Ki(D4) value of 0.62 nM, and to II (R1 = 2-thienyl; n = 2) with Ki(D4) and Ki(D3) values of 0.03 and 0.26 nM, resp.  Mol. docking expts. revealed the importance of the unique D4 residue Arg186 in manipulating the D4-subtype-receptor selectivity of the ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsgZBlwDG4MbVg90H21EOLACvtfcHk0lgeg_UdWV6e8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFaltbzO&md5=1934cb1116cfe22c350668ff1969d076</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fcbdv.201300204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbdv.201300204%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Fattah%26aufirst%3DM.%2BA.%2BO.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DAn%2520interactive%2520SAR%2520approach%2520to%2520discover%2520novel%2520hybrid%2520thieno%2520probes%2520as%2520ligands%2520for%2520D2-like%2520receptors%2520with%2520affinities%2520in%2520the%2520subnanomolar%2520range%26jtitle%3DChem.%2520Biodiversity%26date%3D2013%26volume%3D10%26spage%3D2247%26epage%3D2266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kenakin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muniz-Medina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novick, S.</span><span> </span><span class="NLM_article-title">A simple method for quantifying functional selectivity and agonist bias</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200111m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=193-203&author=T.+Kenakinauthor=C.+Watsonauthor=V.+Muniz-Medinaauthor=A.+Christopoulosauthor=S.+Novick&title=A+simple+method+for+quantifying+functional+selectivity+and+agonist+bias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn200111m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200111m%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DMuniz-Medina%26aufirst%3DV.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DNovick%26aufirst%3DS.%26atitle%3DA%2520simple%2520method%2520for%2520quantifying%2520functional%2520selectivity%2520and%2520agonist%2520bias%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D3%26spage%3D193%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Vangveravong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bearden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3502</span><span class="NLM_x">–</span> <span class="NLM_lpage">3511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=3502-3511&author=S.+Vangveravongauthor=Z.+Zhangauthor=M.+Taylorauthor=M.+Beardenauthor=J.+Xuauthor=J.+Cuiauthor=W.+Wangauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+characterization+of+selective+dopamine+D2+receptor+ligands+using+aripiprazole+as+the+lead+compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVangveravong%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DBearden%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520selective%2520dopamine%2520D2%2520receptor%2520ligands%2520using%2520aripiprazole%2520as%2520the%2520lead%2520compound%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D3502%26epage%3D3511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tschammer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elsner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühhorn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whistler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gmeiner, P.</span><span> </span><span class="NLM_article-title">Highly potent 5-aminotetrahydropyrazolopyridines: enantioselective dopamine D3 receptor binding, functional selectivity, and analysis of receptor–ligand interactions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2477</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101639t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2477-2491&author=N.+Tschammerauthor=J.+Elsnerauthor=A.+Goetzauthor=K.+Ehrlichauthor=S.+Schusterauthor=M.+Rubergauthor=J.+K%C3%BChhornauthor=D.+Thompsonauthor=J.+Whistlerauthor=H.+H%C3%BCbnerauthor=P.+Gmeiner&title=Highly+potent+5-aminotetrahydropyrazolopyridines%3A+enantioselective+dopamine+D3+receptor+binding%2C+functional+selectivity%2C+and+analysis+of+receptor%E2%80%93ligand+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm101639t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101639t%26sid%3Dliteratum%253Aachs%26aulast%3DTschammer%26aufirst%3DN.%26aulast%3DElsner%26aufirst%3DJ.%26aulast%3DGoetz%26aufirst%3DA.%26aulast%3DEhrlich%26aufirst%3DK.%26aulast%3DSchuster%26aufirst%3DS.%26aulast%3DRuberg%26aufirst%3DM.%26aulast%3DK%25C3%25BChhorn%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DD.%26aulast%3DWhistler%26aufirst%3DJ.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26atitle%3DHighly%2520potent%25205-aminotetrahydropyrazolopyridines%253A%2520enantioselective%2520dopamine%2520D3%2520receptor%2520binding%252C%2520functional%2520selectivity%252C%2520and%2520analysis%2520of%2520receptor%25E2%2580%2593ligand%2520interactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2477%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Black, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leff, P.</span><span> </span><span class="NLM_article-title">Operational models of pharmacological agonism</span> <span class="citation_source-journal">Proc. R. Soc. London, Ser. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">220</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500457x&amp;key=10.1098%2Frspb.1983.0093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500457x&amp;key=6141562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500457x&amp;key=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=220&publication_year=1983&pages=141-162&author=J.+W.+Blackauthor=P.+Leff&title=Operational+models+of+pharmacological+agonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Operational models of pharmacological agonism</span></div><div class="casAuthors">Black, J. W.; Leff, P.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Royal Society of London, Series B:  Biological Sciences</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">220</span>
        (<span class="NLM_cas:issue">1219</span>),
    <span class="NLM_cas:pages">141-62</span>CODEN:
                <span class="NLM_cas:coden">PRLBA4</span>;
        ISSN:<span class="NLM_cas:issn">0080-4649</span>.
    </div><div class="casAbstract">A general, operational model is presented which explicitly describes pharmacol. agonism in terms of 3 parameters: an agonist-receptor dissocn. const., the total receptor concn. [Ro], and a parameter (KE) which defines the transduction of the agonist-receptor complex into pharmacol. effect.  The ratio RO/KE, the transducer ratio (τ), is a logical definition for the efficacy of an agonist in a system.  The model provides a chem. definition of intrinsic efficacy, making this parameter exptl. accessible in principle.  Alternate models are compared and contrasted with regard to their practical and conceptual utilities in exptl. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonpXVldFQ_nbVg90H21EOLACvtfcHk0lgeg_UdWV6e8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtFaqtA%253D%253D&md5=a0421df9c56495d48d076010acf44b65</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1098%2Frspb.1983.0093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frspb.1983.0093%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BW.%26aulast%3DLeff%26aufirst%3DP.%26atitle%3DOperational%2520models%2520of%2520pharmacological%2520agonism%26jtitle%3DProc.%2520R.%2520Soc.%2520London%252C%2520Ser.%2520B%26date%3D1983%26volume%3D220%26spage%3D141%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">van der Westhuizen, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouvier, M.</span><span> </span><span class="NLM_article-title">Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">492</span><span class="NLM_x">–</span> <span class="NLM_lpage">509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=492-509&author=E.+T.+van+der+Westhuizenauthor=B.+Bretonauthor=A.+Christopoulosauthor=M.+Bouvier&title=Quantification+of+ligand+bias+for+clinically+relevant+%CE%B22-adrenergic+receptor+ligands%3A+implications+for+drug+taxonomy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DBreton%26aufirst%3DB.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DQuantification%2520of%2520ligand%2520bias%2520for%2520clinically%2520relevant%2520%25CE%25B22-adrenergic%2520receptor%2520ligands%253A%2520implications%2520for%2520drug%2520taxonomy%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D492%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/jm500457x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03372"></div></div></div></div></div><hr /></hr><p class="last">Values of potency (pEC<sub>50</sub>) and maximal stimulation (<i>E</i><sub>max</sub>) for dopamine, aripiprazole, <b>18d</b>, <b>19</b>, <b>34d</b>, and <b>35</b>–<b>37</b> for cAMP and pERK1/2 signaling assays; full experimental and characterization of compounds <b>13d</b>–<b>e</b>, <b>16b</b>, <b>17b</b>–<b>d</b>, <b>18a</b>,<b>c</b>,<b>e</b>, <b>33b</b>–<b>d</b>, <b>34a</b>,<b>b</b>,<b>e</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500457x/suppl_file/jm500457x_si_001.pdf">jm500457x_si_001.pdf (212.76 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500457x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm500457x%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-11" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500457x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a57597dd2248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
